0001628280-24-038538.txt : 20240827 0001628280-24-038538.hdr.sgml : 20240827 20240827163212 ACCESSION NUMBER: 0001628280-24-038538 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240827 DATE AS OF CHANGE: 20240827 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Concentra Group Holdings Parent, Inc. CENTRAL INDEX KEY: 0002014596 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 301006613 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-42188 FILM NUMBER: 241249521 BUSINESS ADDRESS: STREET 1: C/O SELECT MEDICAL CORPORATION STREET 2: 4714 GETTYSBURG RD., P.O. BOX 2034 CITY: MECHANICSBURG STATE: PA ZIP: 17055 BUSINESS PHONE: 717-972-1100 MAIL ADDRESS: STREET 1: C/O SELECT MEDICAL CORPORATION STREET 2: 4714 GETTYSBURG RD., P.O. BOX 2034 CITY: MECHANICSBURG STATE: PA ZIP: 17055 10-Q 1 cghp-20240630.htm 10-Q cghp-20240630
0002014596false12/312024Q20.2330.233xbrli:sharesiso4217:USDiso4217:USDxbrli:sharescghp:health_centercghp:cliniccghp:statexbrli:purecghp:less_than_wholly_owned_subsidiarycghp:patientcghp:class_action_lawsuit00020145962024-01-012024-06-3000020145962024-07-3100020145962024-06-3000020145962023-12-310002014596us-gaap:NonrelatedPartyMember2024-06-300002014596us-gaap:NonrelatedPartyMember2023-12-310002014596us-gaap:RelatedPartyMember2024-06-300002014596us-gaap:RelatedPartyMember2023-12-3100020145962024-04-012024-06-3000020145962023-04-012023-06-3000020145962023-01-012023-06-300002014596us-gaap:RelatedPartyMember2024-04-012024-06-300002014596us-gaap:RelatedPartyMember2023-04-012023-06-300002014596us-gaap:RelatedPartyMember2024-01-012024-06-300002014596us-gaap:RelatedPartyMember2023-01-012023-06-300002014596us-gaap:MemberUnitsMember2023-12-310002014596cghp:MembersUnitsContributedCapitalMember2023-12-310002014596us-gaap:CommonStockMember2023-12-310002014596us-gaap:AdditionalPaidInCapitalMember2023-12-310002014596us-gaap:RetainedEarningsMember2023-12-310002014596us-gaap:ParentMember2023-12-310002014596us-gaap:NoncontrollingInterestMember2023-12-310002014596us-gaap:RetainedEarningsMember2024-01-012024-03-310002014596us-gaap:ParentMember2024-01-012024-03-3100020145962024-01-012024-03-310002014596us-gaap:NoncontrollingInterestMember2024-01-012024-03-310002014596cghp:MembersUnitsContributedCapitalMember2024-01-012024-03-310002014596us-gaap:MemberUnitsMember2024-01-012024-03-310002014596us-gaap:CommonStockMember2024-01-012024-03-310002014596us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310002014596us-gaap:MemberUnitsMember2024-03-310002014596cghp:MembersUnitsContributedCapitalMember2024-03-310002014596us-gaap:CommonStockMember2024-03-310002014596us-gaap:AdditionalPaidInCapitalMember2024-03-310002014596us-gaap:RetainedEarningsMember2024-03-310002014596us-gaap:ParentMember2024-03-310002014596us-gaap:NoncontrollingInterestMember2024-03-3100020145962024-03-310002014596us-gaap:RetainedEarningsMember2024-04-012024-06-300002014596us-gaap:ParentMember2024-04-012024-06-300002014596us-gaap:NoncontrollingInterestMember2024-04-012024-06-300002014596us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300002014596us-gaap:MemberUnitsMember2024-06-300002014596cghp:MembersUnitsContributedCapitalMember2024-06-300002014596us-gaap:CommonStockMember2024-06-300002014596us-gaap:AdditionalPaidInCapitalMember2024-06-300002014596us-gaap:RetainedEarningsMember2024-06-300002014596us-gaap:ParentMember2024-06-300002014596us-gaap:NoncontrollingInterestMember2024-06-300002014596us-gaap:CommonClassAMember2022-12-310002014596us-gaap:CommonClassBMember2022-12-310002014596us-gaap:CommonClassCMember2022-12-310002014596cghp:MembersUnitsContributedCapitalMember2022-12-310002014596us-gaap:RetainedEarningsMember2022-12-310002014596us-gaap:MemberUnitsMember2022-12-310002014596us-gaap:NoncontrollingInterestMember2022-12-3100020145962022-12-310002014596us-gaap:RetainedEarningsMember2023-01-012023-03-310002014596us-gaap:MemberUnitsMember2023-01-012023-03-3100020145962023-01-012023-03-310002014596us-gaap:NoncontrollingInterestMember2023-01-012023-03-310002014596cghp:MembersUnitsContributedCapitalMember2023-01-012023-03-310002014596us-gaap:CommonClassCMember2023-01-012023-03-310002014596us-gaap:CommonClassAMember2023-03-310002014596us-gaap:CommonClassBMember2023-03-310002014596us-gaap:CommonClassCMember2023-03-310002014596cghp:MembersUnitsContributedCapitalMember2023-03-310002014596us-gaap:RetainedEarningsMember2023-03-310002014596us-gaap:MemberUnitsMember2023-03-310002014596us-gaap:NoncontrollingInterestMember2023-03-3100020145962023-03-310002014596us-gaap:RetainedEarningsMember2023-04-012023-06-300002014596us-gaap:MemberUnitsMember2023-04-012023-06-300002014596us-gaap:NoncontrollingInterestMember2023-04-012023-06-300002014596cghp:MembersUnitsContributedCapitalMember2023-04-012023-06-300002014596us-gaap:CommonClassAMember2023-06-300002014596us-gaap:CommonClassBMember2023-06-300002014596us-gaap:CommonClassCMember2023-06-300002014596cghp:MembersUnitsContributedCapitalMember2023-06-300002014596us-gaap:RetainedEarningsMember2023-06-300002014596us-gaap:MemberUnitsMember2023-06-300002014596us-gaap:NoncontrollingInterestMember2023-06-3000020145962023-06-300002014596cghp:ConcentraGroupHoldingsParentMembercghp:SelectMedicalCorporationMember2024-06-3000020145962024-03-042024-03-040002014596us-gaap:SubsequentEventMemberus-gaap:IPOMember2024-07-262024-07-260002014596us-gaap:SubsequentEventMemberus-gaap:IPOMember2024-07-2600020145962024-06-252024-06-250002014596us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-06-300002014596us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-12-310002014596us-gaap:RelatedPartyMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-06-300002014596us-gaap:RelatedPartyMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-12-310002014596us-gaap:NotesPayableOtherPayablesMember2024-06-300002014596cghp:OccupationalHealthCenterWorkersCompensationMember2024-04-012024-06-300002014596cghp:OccupationalHealthCenterWorkersCompensationMember2023-04-012023-06-300002014596cghp:OccupationalHealthCenterWorkersCompensationMember2024-01-012024-06-300002014596cghp:OccupationalHealthCenterWorkersCompensationMember2023-01-012023-06-300002014596cghp:OccupationalHealthCenterEmployerServicesMember2024-04-012024-06-300002014596cghp:OccupationalHealthCenterEmployerServicesMember2023-04-012023-06-300002014596cghp:OccupationalHealthCenterEmployerServicesMember2024-01-012024-06-300002014596cghp:OccupationalHealthCenterEmployerServicesMember2023-01-012023-06-300002014596cghp:OccupationalHealthCenterConsumerHealthMember2024-04-012024-06-300002014596cghp:OccupationalHealthCenterConsumerHealthMember2023-04-012023-06-300002014596cghp:OccupationalHealthCenterConsumerHealthMember2024-01-012024-06-300002014596cghp:OccupationalHealthCenterConsumerHealthMember2023-01-012023-06-300002014596cghp:OccupationalHealthCenterOtherMember2024-04-012024-06-300002014596cghp:OccupationalHealthCenterOtherMember2023-04-012023-06-300002014596cghp:OccupationalHealthCenterOtherMember2024-01-012024-06-300002014596cghp:OccupationalHealthCenterOtherMember2023-01-012023-06-300002014596us-gaap:OperatingSegmentsMembercghp:OccupationalHealthCenterMember2024-04-012024-06-300002014596us-gaap:OperatingSegmentsMembercghp:OccupationalHealthCenterMember2023-04-012023-06-300002014596us-gaap:OperatingSegmentsMembercghp:OccupationalHealthCenterMember2024-01-012024-06-300002014596us-gaap:OperatingSegmentsMembercghp:OccupationalHealthCenterMember2023-01-012023-06-300002014596us-gaap:OperatingSegmentsMembercghp:OnsiteClinicsMember2024-04-012024-06-300002014596us-gaap:OperatingSegmentsMembercghp:OnsiteClinicsMember2023-04-012023-06-300002014596us-gaap:OperatingSegmentsMembercghp:OnsiteClinicsMember2024-01-012024-06-300002014596us-gaap:OperatingSegmentsMembercghp:OnsiteClinicsMember2023-01-012023-06-300002014596us-gaap:OperatingSegmentsMembercghp:OtherBusinessesMember2024-04-012024-06-300002014596us-gaap:OperatingSegmentsMembercghp:OtherBusinessesMember2023-04-012023-06-300002014596us-gaap:OperatingSegmentsMembercghp:OtherBusinessesMember2024-01-012024-06-300002014596us-gaap:OperatingSegmentsMembercghp:OtherBusinessesMember2023-01-012023-06-300002014596us-gaap:CommonClassAMember2023-12-310002014596us-gaap:CommonClassBMember2023-12-310002014596us-gaap:CommonClassCMember2023-12-310002014596us-gaap:ProfessionalMalpracticeLiabilityMember2024-01-012024-06-300002014596us-gaap:GeneralLiabilityMember2024-01-012024-06-3000020145962024-02-290002014596us-gaap:SubsequentEventMemberus-gaap:OverAllotmentOptionMember2024-07-262024-07-260002014596cghp:ConcentraHealthServicesInc.CHSIMembercghp:SeniorSecuredCreditFacilitiesMemberus-gaap:SubsequentEventMemberus-gaap:IPOMember2024-07-260002014596cghp:A6.875SeniorNotesDue2032Membercghp:ConcentraHealthServicesInc.CHSIMemberus-gaap:SeniorNotesMemberus-gaap:SubsequentEventMemberus-gaap:IPOMember2024-07-260002014596cghp:ConcentraHealthServicesInc.CHSIMemberus-gaap:SecuredDebtMemberus-gaap:SubsequentEventMemberus-gaap:IPOMember2024-07-260002014596cghp:ConcentraHealthServicesInc.CHSIMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SubsequentEventMemberus-gaap:IPOMember2024-07-260002014596cghp:ConcentraHealthServicesInc.CHSIMemberus-gaap:SecuredDebtMemberus-gaap:SubsequentEventMemberus-gaap:IPOMember2024-07-262024-07-260002014596cghp:ConcentraHealthServicesInc.CHSIMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SubsequentEventMemberus-gaap:IPOMember2024-07-262024-07-260002014596cghp:SelectMedicalRevolvingPromissoryNoteMemberus-gaap:SubsequentEventMemberus-gaap:IPOMember2024-07-262024-07-260002014596cghp:ConcentraGroupHoldingsParentMembercghp:SelectMedicalCorporationMemberus-gaap:SubsequentEventMemberus-gaap:IPOMember2024-07-26


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the Quarterly Period Ended June 30, 2024
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 For the transition period from              to              
Commission file numbers: 001-42188
 
CONCENTRA GROUP HOLDINGS PARENT, INC.
(Exact name of Registrant as specified in its Charter)
Delaware30-1006613
(State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification Number)
 
4714 Gettysburg Road, P.O. Box 2034
Mechanicsburg, PA 17055
(Address of Principal Executive Offices and Zip code)
(717) 972-1100
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareCONNew York Stock Exchange
(NYSE)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods as such Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes  ☐  No ☒
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).   Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer☐Accelerated filer☐
Non-accelerated filer☒Smaller reporting company☐
 Emerging Growth Company☐
 If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐  No ☒
As of July 31, 2024, Concentra Group Holdings Parent, Inc. had outstanding 126,593,503 shares of common stock.
Unless the context indicates otherwise, any reference in this report to “Concentra” refers to Concentra Group Holdings Parent, Inc. and its subsidiaries. References to the “Company,” “we,” “us,” and “our” refer collectively to Concentra and its subsidiaries.


TABLE OF CONTENTS
 
   
 
   
 
   
 
 
   
 
   
 
   
   
   
   
   
   
   
   
   
   
   
   
 




Concentra Group Holdings Parent, Inc.
Condensed Consolidated Balance Sheets
(unaudited)
(in thousands, except per share amounts)
June 30, 2024December 31, 2023
ASSETS 
Current Assets: 
Cash$50,669 $31,374 
Accounts receivable228,964 216,194 
Prepaid income taxes2,010 7,979 
Other current assets38,663 38,871 
Total Current Assets320,306 294,418 
Operating lease right-of-use assets399,464 397,852 
Property and equipment, net186,879 178,370 
Goodwill1,233,406 1,229,745 
Customer relationships105,459 117,259 
Other identifiable intangible assets, net107,409 107,510 
Other assets10,415 8,406 
Total Assets$2,363,338 $2,333,560 
LIABILITIES AND EQUITY 
Current Liabilities: 
Current operating lease liabilities73,517 72,946 
Current portion of long-term debt and notes payable4,682 1,455 
Accounts payable23,674 20,413 
Due to related party4,360 3,354 
Accrued and other liabilities158,920 176,466 
Total Current Liabilities265,153 274,634 
Non-current operating lease liabilities359,736 357,310 
Long-term debt, net of current portion3,048 3,291 
Long-term debt with related party420,000 470,000 
Non-current deferred tax liability21,994 23,364 
Other non-current liabilities23,015 27,522 
Total Liabilities1,092,946 1,156,121 
Commitments and contingencies (Note 11)
Redeemable non-controlling interests18,410 16,477 
Members’ contributed capital— 470,303 
Common stock, $0.01 par value, 447,081 shares authorized, 104,094 shares issued and outstanding at June 30, 2024
1,041 — 
Capital in excess of par461,520 — 
Retained earnings784,217 685,293 
Total Stockholders’ Equity (Members’ Equity at December 31, 2023)1,246,778 1,155,596 
Non-controlling interests5,204 5,366 
Total Equity1,251,982 1,160,962 
Total Liabilities and Equity$2,363,338 $2,333,560 
 The accompanying notes are an integral part of these condensed consolidated financial statements.
3
Concentra Group Holdings Parent, Inc.
Condensed Consolidated Statements of Operations
(unaudited)
(in thousands, except per share amounts)

 For the Three Months Ended June 30,For the Six Months Ended June 30,
 2024202320242023
Revenue$477,915 $467,079 $945,513 $923,377 
Costs and expenses:  
Cost of services, exclusive of depreciation and amortization339,273 329,836 676,263 657,914 
General and administrative, exclusive of depreciation and amortization (1)
36,828 37,003 73,737 71,653 
Depreciation and amortization17,870 18,283 36,355 36,593 
Total costs and expenses393,971 385,122 786,355 766,160 
Other operating income— 151 284 151 
Income from operations83,944 82,108 159,442 157,368 
Other income and expense:  
Equity in losses of unconsolidated subsidiaries(3,676)— (3,676)(526)
Interest expense on related party debt(9,318)(11,500)(19,289)(22,576)
Interest income (expense)205 17 94 (44)
Income before income taxes71,155 70,625 136,571 134,222 
Income tax expense18,096 16,593 33,233 32,759 
Net income53,059 54,032 103,338 101,463 
Less: Net income attributable to non-controlling interests1,322 1,290 2,645 2,457 
Net income attributable to the Company$51,737 $52,742 $100,693 $99,006 
Earnings per common share (Note 9):
  
Basic and diluted$0.50 $0.51 $0.97 $0.95 
 
(1)        Includes the shared service fee from related party of $3.8 million and $3.7 million for the three months ended June 30, 2024 and 2023, respectively, and $7.7 million and $7.3 million for the six months ended June 30, 2024 and 2023, respectively. See Note 10, Related Party Transactions, for additional information.

The accompanying notes are an integral part of these condensed consolidated financial statements.
4
Concentra Group Holdings Parent, Inc.
Condensed Consolidated Statements of Changes in Stockholders’/Members’ Equity
(unaudited)
(in thousands)

For the Six Months Ended June 30, 2024
 Total Members’ Units Members’ Contributed CapitalCommon Stock IssuedCommon Stock Par ValueCapital in excess of parRetained
Earnings		Total Stockholders’ EquityNon-controlling
Interests		Total
Equity
Balance at December 31, 2023447,081 $470,303 — $— $— $685,293 $1,155,596 $5,366 $1,160,962 
Net income attributable to the Company48,956 48,956 48,956 
Net income attributable to non-controlling interests— 270 270 
Distribution to Parent(6,891)(6,891)(6,891)
Distributions to and purchases of non-controlling interests— (369)(369)
Redemption value adjustment on non-controlling interests(1,901)(1,901)(1,901)
Conversion of LLC to Corporation and Impact of Reverse Stock Split(447,081)(463,412)104,094 1,041 462,371 — — 
Balance at March 31, 2024
— $— 104,094 $1,041 $462,371 $732,348 $1,195,760 $5,267 $1,201,027 
Net income attributable to the Company51,737 51,737 51,737 
Net income attributable to non-controlling interests— 244 244 
Distribution to Parent(851)(851)(851)
Distributions to and purchases of non-controlling interests— (307)(307)
Redemption value adjustment on non-controlling interests132 132 132 
Balance at June 30, 2024— $— 104,094 $1,041 $461,520 $784,217 $1,246,778 $5,204 $1,251,982 

For the Six Months Ended June 30, 2023
Members’ Units
 Class A Units
Voting		Class B Units
Non-Voting		Class C Units
Non-Voting		Members’ Contributed CapitalRetained
Earnings		Total Members’ EquityNon-controlling
Interests		Total
Equity
Balance at December 31, 2022435,000 8,498 2,770 $464,725 $508,592 $973,317 $6,026 $979,343 
Net income attributable to the Company46,264 46,264 46,264 
Net income attributable to non-controlling interests— 253 253 
Contribution from Parent2,797 2,797 2,797 
Vesting of restricted interests248 178 178 178 
Distributions to and purchases of non-controlling interests— (221)(221)
Redemption value adjustment on non-controlling interests(435)(435)(435)
Balance at March 31, 2023
435,000 8,498 3,018 $467,700 $554,421 $1,022,121 $6,058 $1,028,179 
Net income attributable to the Company52,742 52,742 52,742 
Net income attributable to non-controlling interests— 297 297 
Distribution to Parent(3,352)(3,352)(3,352)
Repurchase of common shares195 195 (495)(300)
Distributions to and purchases of non-controlling interests— (343)(343)
Redemption value adjustment on non-controlling interests(3)(3)(3)
Balance at June 30, 2023
435,000 8,498 3,018 $464,543 $607,160 $1,071,703 $5,517 $1,077,220 
The accompanying notes are an integral part of these condensed consolidated financial statements.
5
Concentra Group Holdings Parent, Inc.
Condensed Consolidated Statements of Cash Flows
(unaudited)
(in thousands)
 For the Six Months Ended June 30,
 20242023
Operating activities
  
Net income
$103,338 $101,463 
Adjustments to reconcile net income to net cash provided by operating activities:
  
Depreciation and amortization
36,355 36,593 
Provision for expected credit losses
59 185 
Equity in losses of unconsolidated subsidiaries
3,676 526 
(Gain) loss on sale or disposal of assets 42 (14)
Stock compensation expense
332 178 
Deferred income taxes
(1,618)(3,265)
Changes in operating assets and liabilities, net of effects of business combinations:
  
Accounts receivable
(12,829)(27,011)
Other current assets
1,224 (9,944)
Other assets
(4,217)1,796 
Accounts payable and accrued liabilities
(11,307)(966)
Net cash provided by operating activities
115,055 99,541 
Investing activities
  
Business combinations, net of cash acquired
(5,144)(1,446)
Purchase of customer relationships
— (4,382)
Purchases of property and equipment
(32,494)(25,864)
Proceeds from sale of assets
23 20 
Net cash used in investing activities
(37,615)(31,672)
Financing activities
  
Borrowings from related party revolving promissory note
10,000 — 
Payments on related party revolving promissory note
(60,000)(70,000)
Borrowings of other debt
6,618 5,471 
Principal payments on other debt
(4,378)(4,074)
Distributions to and purchases of non-controlling interests
(2,643)(3,130)
Distributions to Parent(7,742)(555)
Net cash used in financing activities
(58,145)(72,288)
Net increase (decrease) in cash
19,295 (4,419)
Cash at beginning of period
31,374 37,657 
Cash at end of period
$50,669 $33,238 
Supplemental information
  
Cash paid for interest
$19,512 $22,784 
Cash paid for taxes
34,009 32,445 

The accompanying notes are an integral part of these condensed consolidated financial statements.
6
Concentra Group Holdings Parent, Inc.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1.    Organization
Concentra Group Holdings Parent, LLC (“Concentra Group Holdings Parent”) was formed in October 2017 and converted to a Delaware corporation, Concentra Group Holdings Parent, Inc., on March 4, 2024. At the time of formation, Concentra Group Holdings Parent elected to be taxed as a corporation. The Company conducts substantially all of its business through Concentra Inc. and its subsidiaries. Concentra Group Holdings Parent and its subsidiaries are collectively referred to as the “Company.”
The Company is the largest provider of occupational health services in the United States based on number of facilities. As of June 30, 2024, the Company operated 547 occupational health centers and 154 onsite clinics at employer worksites in 42 states. The Company provides a diverse and comprehensive array of occupational health services, including workers’ compensation and employers services, and consumer health services.
The Company currently operates as an operating segment of Select Medical Corporation (“Select” or the “Parent”). As of June 30, 2024, Select Medical Corporation (“Select” or the “Parent”) owns 100.0% of the outstanding common shares of the Company on a fully diluted basis.
On January 3, 2024, Select announced its intention to separate the Company into a new, publicly traded company through a spin-off distribution in 2024. On February 27, 2024, Select received a private letter ruling from the U.S. Internal Revenue Service to the effect that the distribution of Concentra’s common stock to Select and its stockholders will be tax-free for U.S. federal income tax purposes. On March 4, 2024, the member interests of the Company converted to common shares on a one-for-one basis. On June 24, 2024, the Company’s Board of Directors approved a reverse stock split at a ratio of one share of common stock for every 4.295 shares of common stock, which was effectuated on June 25, 2024. In accordance with ASC 260, Earnings Per Share, the recapitalization of the Company into a stock corporation and the reverse stock split have been retrospectively reflected in the Company’s earnings per unit calculation for all periods presented, see Note 9, Earning per Share.
On July 26, 2024, Concentra completed an initial public offering (“IPO”) of 22,500,000 shares of its common stock, par value $0.01 per share, at an initial public offering price of $23.50 per share for the net proceeds of $499.7 million after deducting underwriting discounts and commission of $29.1 million. See Note 12, Subsequent Events for additional information on the IPO and the related debt transactions.
2.    Accounting Policies
Basis of Presentation and Consolidation
The Company has historically operated as part of Select. The unaudited condensed consolidated financial statements of the Company have been prepared from Select’s historical accounting records and are derived from the condensed consolidated financial statements of Select to present Concentra as if it had been operating on a standalone basis. The unaudited condensed consolidated financial statements of the Company as of June 30, 2024, and for the three and six month periods ended June 30, 2024 and 2023, have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim reporting and the accounting principles generally accepted in the United States of America (“U.S. GAAP”). Accordingly, certain information and disclosures required by GAAP, which are normally included in the notes to the consolidated financial statements, have been condensed or omitted pursuant to those rules and regulations, although the Company believes the disclosure is adequate to make the information presented not misleading. In the opinion of management, such information contains all adjustments, which are normal and recurring in nature, necessary for a fair statement of the financial position, results of operations and cash flow for such periods.

The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the full fiscal year ended December 31, 2024. These unaudited condensed consolidated financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes as contained in the Company’s registration statement on Form S-1, as amended (File No. 333-280242) (the “Registration Statement”).

The condensed consolidated financial statements include the assets, liabilities, revenue, and expenses based on our legal entity structure as well as direct and indirect costs that are attributable to our operations. Indirect costs are the costs of support functions that are partially provided on a centralized basis by Select and its affiliates, which include finance, human resources, benefits administration, procurement support, information technology, legal, corporate governance and other professional
7
services. Indirect costs have been allocated to us for the purposes of preparing the condensed consolidated financial statements based on a specific identification basis or, when specific identification is not practicable, a proportional cost allocation method, primarily based on headcount or other allocation methodologies that are considered to be a reasonable reflection of the utilization of services provided or the benefit received by us during the periods presented, depending on the nature of the services received.

The income tax amounts in these condensed consolidated financial statements have been calculated based on a separate return methodology and are presented as if our income gave rise to separate federal and state consolidated income tax return filing obligations in the respective jurisdictions in which we operate. Adjustments to income tax expense resulting from the application of the separate return methodology, as compared to tax obligations determined by the Company’s inclusion in the Parent’s consolidated income tax provision, were assumed to be immediately settled with the Parent through Contributed Capital/Capital in Excess of Par as reflected on the Condensed Consolidated Balance Sheets, and reflected as a (Distribution)/Contribution to Parent on the Condensed Consolidated Statements of Changes in Stockholders’/Members’ Equity and the Condensed Consolidated Statements of Cash Flows within financing activities.
The condensed consolidated financial statements include the accounts of Concentra and the subsidiaries and variable interest entities in which Concentra has a controlling financial interest. All intercompany balances and transactions within the Company are eliminated in consolidation. Transactions between the Company and Select have been included in these consolidated financial statements. The transfers with Select are expected to be settled in cash, other than the assumed income tax settlement noted above, and are reflected within the consolidated statement of cash flows as an operating or financing activity determined by the nature of the transaction. Select’s third-party debt and related interest expense have not been attributed to the Company because the Company is not the primary legal obligor of the debt and the borrowings are not specifically identifiable to the Company. However, the Company was a guarantor for Select’s senior notes and credit facilities until the guarantee was released at the closing of the IPO. The Company maintains its own cash management system and does not participate in a centralized cash management arrangement with Select.
Recent Accounting Guidance Not Yet Adopted
Segment Reporting
In November 2023, FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which is intended to improve disclosure of segment information so that investors can better understand an entity’s overall performance. The ASU requires entities to quantitatively disclose significant segment expenses that are regularly provided to the chief operating decision maker for each reportable segment, as well as the amount of other segment items for each reportable segment and a description of what the other segment items are comprised. Disclosure of multiple measures of profit or loss will be permitted by the ASU.
The ASU is effective for annual reporting periods beginning on or after December 15, 2023, and interim periods with fiscal years beginning after December 15, 2024; however, early adoption is permitted. The ASU is required to be applied retrospectively to all periods presented in the financial statements. The Company is currently reviewing the impact that ASU 2023-07 will have on the disclosures in our consolidated financial statements.
Income Taxes
In December 2023, FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which is intended to improve the transparency and decision usefulness of income tax disclosures. The ASU includes enhanced requirements on the rate reconciliation, including specific categories that must be disclosed, and provides a threshold over which reconciling items must be disclosed. The amendments in the update also require annual disclosure of income taxes paid, disaggregated by federal, state, and foreign taxes, as well as any individual jurisdictions in which income taxes paid is greater than 5% of total income taxes paid.
The ASU is effective for annual periods beginning after December 15, 2024; however early adoption is permitted. The ASU can be applied either prospectively or retrospectively. The Company is currently reviewing the impact that ASU 2023-09 will have on the disclosures in our consolidated financial statements.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Actual results could differ from those estimates.
8
3.    Redeemable Non-Controlling Interests
The Company’s redeemable non-controlling interests are comprised of membership interests held by equity holders other than the Company in five less than wholly-owned subsidiaries. These interests are subject to redemption rights. The changes in redeemable non-controlling interests are as follows:
20242023
(in thousands)
Balance as of January 1$16,477 $16,772 
Net income attributable to redeemable non-controlling interests1,053 914 
Distributions to and purchases of redeemable non-controlling interests(1,174)(1,656)
Redemption value adjustment on redeemable non-controlling interests1,901 436 
Balance as of March 31$18,257 $16,466 
Net income attributable to redeemable non-controlling interests1,078 993 
Distributions to and purchases of redeemable non-controlling interests(793)(610)
Redemption value adjustment on redeemable non-controlling interests(132)3 
Balance as of June 30$18,410 $16,852 
4.    Variable Interest Entities
Certain states prohibit the “corporate practice of medicine,” which restricts the Company from owning medical practices that directly employ physicians and from exercising control over medical decisions by physicians. In these states, the Company enters into long-term management agreements with affiliated professional medical groups (referred to as “Managed PCs”) that are owned by licensed physicians which, in turn, employ or contract with physicians who provide professional medical services in its occupational health centers. The Company also enters into a stock transfer restriction agreement with the respective equity holders, which provide for the Company to direct the transfer of ownership of the Managed PCs to other licensed physicians at any time. The long-term management agreements provide for various administrative and management services to be provided by the Company to the Managed PCs, including, but not limited to, billing and collections, accounting, non-physician personnel, supplies, security and maintenance, and insurance. The Company has the right to receive income as an ongoing management fee, and effectively absorbs all of the residual interests of the Managed PCs. Based on the provisions of the management and stock transfer agreements, the Managed PCs are variable interest entities for which the Company is the primary beneficiary and consolidates the Managed PCs under the VIE model. There are no restrictions on the use of the assets of the Managed PCs or on the settlement of its liabilities. Additionally, the Company fully indemnifies the licensed physician owners from all claims, demands, costs, damages, losses, liabilities, and other amounts arising from the ownership and operation of the medical practices, excluding gross negligence.
As of June 30, 2024, and December 31, 2023, the total assets of the Company’s variable interest entities were $224.8 million and $212.3 million, respectively, and are principally comprised of accounts receivable. As of June 30, 2024, and December 31, 2023, the total liabilities of the Company’s variable interest entities were $53.7 million and $56.4 million, respectively, and are principally comprised of accounts payable and accrued expenses. These variable interest entities have obligations payable for services received under their management agreements with the Company of $171.7 million and $156.2 million as of June 30, 2024, and December 31, 2023, respectively. These intercompany balances are eliminated in consolidation.
5.    Leases
The Company’s total lease cost is as follows:
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
(in thousands)
Operating lease cost
$25,077 $24,296 $49,867 $48,424 
Finance lease cost:
Amortization of right-of-use assets
109 261 320 512 
Interest on lease liabilities
77 100 132 203 
Variable lease cost5,293 4,920 10,549 10,034 
Total lease cost$30,556 $29,577 $60,868 $59,173 
9
6.     Long-Term Debt and Notes Payable
The carrying values of the Company’s long-term debt are as follows:
 June 30, 2024December 31, 2023
(in thousands)
Long-term revolving promissory note with related party$420,000 $470,000 
Other debt (1)
7,730 4,746 
Total debt$427,730 $474,746 
_______________________________________________________________________________
(1)        Other debt is primarily comprised of insurance financing arrangements, promissory notes executed in connection with business combinations, and finance leases.
As of June 30, 2024, principal maturities of the Company’s long-term debt were as follows:
 20242025202620272028ThereafterTotal
(in thousands)
Revolving promissory note with related party$— $— $— $— $— $420,000 $420,000 
Other debt, including finance leases3,819 1,024 351 397 447 1,692 7,730 
Total debt$3,819 $1,024 $351 $397 $447 $421,692 $427,730 
See Note 12, Subsequent Events, for a description of the debt financing transactions which occurred in connection with the IPO on July 26, 2024.
7.    Accrued and Other Liabilities
The following table sets forth the components of accrued and other liabilities:
June 30, 2024December 31, 2023
(in thousands)
Accrued payroll$57,439 $62,824 
Accrued vacation42,983 41,488 
Accrued other55,484 71,755 
Income taxes payable3,014 399 
Accrued and other liabilities$158,920 $176,466 
8.     Revenue
The following table disaggregates the Company’s revenue for the three and six months ended June 30, 2024 and 2023:
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
(in thousands)
Occupational health centers:
Workers’ compensation$288,405 $278,554 $568,271 $546,894 
Employer services153,305 153,164 304,040 305,337 
Consumer health7,669 7,802 15,995 15,987 
Other occupational health center revenue1,861 2,254 4,006 4,672 
Total occupational health center revenue451,240 441,774 892,312 872,890 
Onsite clinics15,539 14,705 31,396 29,250 
Other11,136 10,600 21,805 21,237 
Total revenue$477,915 $467,079 $945,513 $923,377 


10
9.    Earnings per Share
At December 31, 2023, there were 435,000 Class A units, 8,498 Class B units, and 3,583 Class C units (in thousands) outstanding which converted to common shares on a one-for-one basis effective March 4, 2024. On June 25, 2024, the Company effectuated a reverse stock split at a ratio of one share of common stock for every 4.295 shares of common stock and resulted in 104,094 shares (in thousands) outstanding. There were no participating shares or securities outstanding during the three and six months ended June 30, 2024.
The following table sets forth the computation of earnings per share (EPS) in 2024:
Three Months Ended June 30, 2024Six Months Ended June 30, 2024
Net Income Attributable to the Company
Shares(1)
Basic and Diluted EPSNet Income Attributable to the Company
Shares(1)
Basic and Diluted EPS
(in thousands, except for per share amounts)
Common shares$51,737 104,094 $0.50 $100,693 104,094 $0.97 
At June 30, 2023, Concentra’s capital structure included Class A, B and C units outstanding and unvested restricted interests and outstanding options. To calculate EPS for the three and six months ended June 30, 2023, Concentra applied the two-class method because its unvested restricted interests and outstanding options were participating securities.
The following table sets forth the net income attributable to the Company, its units outstanding, and its participating units outstanding:
Three Months Ended
June 30, 2023		Six Months Ended
June 30, 2023
(in thousands)
Net income$54,032 $101,463 
Less: net income attributable to non-controlling interests1,290 2,457 
Net income attributable to the Company52,742 99,006 
Less: Distributed and undistributed income attributable to participating shares148 287 
Distributed and undistributed income attributable to outstanding shares$52,594 $98,719 
The following table sets forth the computation of EPS in 2023, under the two-class method:
Three Months Ended June 30, 2023Six Months Ended June 30, 2023
Net Income Allocation
Shares(1)(2)
Basic and Diluted EPSNet Income Allocation
Shares(1)(2)
Basic and Diluted EPS
(in thousands, except for per share amounts)
Outstanding Class A, Class B, and Class C shares$52,594 103,962 $0.51 $98,719 103,952 $0.95 
Participating shares148 292 $0.51 287 302 $0.95 
Total Company$52,742 $99,006 
_______________________________________________________________________________
(1)    The recapitalization of the members units into common shares has been treated as such for earnings per share purposes and has been reflected retrospectively for all periods, along with the one for 4.295 reverse stock split, as described in Note 1, Organization.
(2)    Represents the weighted average units outstanding during the period.







11
10.    Related Party Transactions
Shared Services Agreement - cost allocations from Select
The Company pays Select a fee for the shared support functions provided on a centralized basis by Select and its affiliates. The shared services fee is reassessed and adjusted annually. For the three months ended June 30, 2024 and 2023, the shared service fees were $3.8 million and $3.7 million, respectively. For the six months ended June 30, 2024 and 2023, the shared service fees were $7.7 million and $7.3 million, respectively. These cost allocations reasonably reflect the services and the benefits derived for the periods presented. These allocations may not be indicative of the actual expenses that would have been incurred as a stand-alone entity.
In connection with the IPO, and described in the Registration Statement, Select and Concentra entered into a separation agreement, a transition services agreement, a tax matters agreement, and an employee matters agreement on July 26, 2024, which effects the separation of the Company’s business from Select and provides a framework for the Company’s relationship with Select after the separation.
11.    Commitments and Contingencies
Litigation
The Company is a party to various legal actions, proceedings, and claims, and regulatory and other governmental audits and investigations in the ordinary course of its business, including, but not limited to, legal actions and claims alleging professional malpractice, general liability for property damage, personal and bodily injury, violations of federal and state employment laws, often in the form of wage and hour class action lawsuits, and liability for data breaches. Many of these actions involve large claims and significant defense costs and sometimes, as in the case of wage and hour class actions, are not covered by insurance. The Company cannot predict the ultimate outcome of pending litigation, proceedings, and regulatory and other governmental audits and investigations. These matters could potentially subject the Company to sanctions, damages, recoupments, fines, and other penalties.
To address claims arising out of the Company’s operations, the Company maintains professional malpractice liability insurance and general liability insurance coverages through a number of different programs that are dependent upon such factors as the state where the Company is operating. The Company currently maintains insurance coverages under a combination of policies with a total annual aggregate limit of up to $29.0 million for professional malpractice liability insurance and $29.0 million for general liability insurance. The Company’s insurance for the professional liability coverage is written on a “claims-made” basis, and its commercial general liability coverage is maintained on an “occurrence” basis. These coverages apply after a self-insured retention limit is exceeded. Each of these programs has either a deductible or self-insured retention limit. The Company also maintains additional types of liability insurance covering claims which, due to their nature or amount, are not covered by or not fully covered by the applicable professional malpractice and general liability insurance policies, including workers compensation, property and casualty, directors and officers, cyber liability, and employment practices liability insurance coverages. Our insurance policies generally are silent with respect to punitive damages so coverage is available to the extent insurable under the law of any applicable jurisdiction, and are subject to various deductibles and policy limits. The Company reviews its insurance program annually and may make adjustments to the amount of insurance coverage and self-insured retentions in future years. Significant legal actions, as well as the cost and possible lack of available insurance, could subject the Company to substantial uninsured liabilities.
Physical Therapy Billing. On October 7, 2021, Select received a letter from a Trial Attorney at the U.S. Department of Justice, Civil Division, Commercial Litigation Branch, Fraud Section (“DOJ”) stating that the DOJ, in conjunction with the U.S. Department of Health and Human Services (“HHS”), is investigating Select in connection with potential violations of the False Claims Act, 31 U.S.C. § 3729, et seq. The letter specified that the investigation relates to Select’s billing for physical therapy services, and indicated that the DOJ would be requesting certain records from Select. In October and December 2021, the DOJ requested, and Select furnished, records relating to six of Select’s outpatient therapy clinics in Florida. In 2022 and 2023, the DOJ requested certain data relating to all of Select’s outpatient therapy clinics nationwide, and sought information about the Company’s ability to produce additional data relating to the physical therapy services furnished by Select’s outpatient therapy clinics and the Company. The Company has produced data and other documents requested by the DOJ and is fully cooperating on this investigation. In May 2024, by order of the U.S. District Court for the Middle District of Florida, a qui tam lawsuit that is related to the DOJ’s investigation was unsealed after the U.S. filed a notice declining to intervene in the case, but stating that its investigation is continuing and reserving its right to intervene at a later date. The lawsuit, filed in May 2021 and amended in October 2021 and July 2024, was brought by Kathleen Kane, a physical therapist formerly employed in Select’s outpatient division, against Select Medical Corporation, Select Physical Therapy Holdings, Inc. and Select Employment Services, Inc. The amended complaint alleges that the defendants billed federally funded health programs for one-on-one therapy services when group therapy was performed or overbilled for one-on-one therapy services, and billed for
12
unreimbursable unskilled physical therapy services. At this time, the Company is unable to predict the timing and outcome of this matter.
California Department of Insurance Investigation. On February 5, 2024, the Company received a subpoena from the California Department of Insurance relating to an investigation under the California Insurance Frauds Prevention Act, Cal. Ins. Code § 1871.7 et seq., which allows a whistleblower to file a false claims lawsuit based on the submission of false or fraudulent claims to insurance companies. The subpoena seeks documentation relating mainly to the Company’s billing and coding for physical therapy claims submitted to commercial insurers and workers compensation carriers located or doing business in California. The Company has produced data and other documents requested by the California Department of Insurance and intends to fully cooperate on this investigation. At this time, the Company is unable to predict the timing and outcome of this matter.
Perry Johnson & Associates, Inc. Data Breach. On November 10, 2023, Perry Johnson & Associates, Inc., a third-party vendor of health information technology solutions that provides medical transcription services (“PJ&A”), notified Concentra Health Services, Inc. (“Concentra”) that certain information related to particular Concentra patients was potentially affected by a cybersecurity event. In February 2024, Concentra sent notices to almost four million patients who may have been impacted by the data breach. During the first quarter of 2024, Concentra became aware of six putative class action lawsuits filed against PJ&A and Concentra related to the data breach. The first was filed in the U.S. District Court for the Eastern District of Michigan on February 19, 2024 by Elliot Curry, individually and on behalf of all others similarly situated. Plaintiff alleged, among other things, that he became the victim of identity theft as a result of the PJ&A data breach and that Concentra had lax data security policies. The second was filed in the U.S. District Court for the Eastern District of New York on February 21, 2024 by Tiffany Williams and Jo Joaquim, individually and on behalf of all others similarly situated. Plaintiffs alleged, among other things, that they face an immediate and heightened risk of identity theft as a result of the data breach and that the defendants failed to take measures to properly safeguard their private information. The third was filed in the U.S. District Court for the Eastern District of Missouri on February 26, 2024 by Stephen Tate, a.k.a. Steven Tate, individually and on behalf of all others similarly situated. Plaintiff alleged, among other things, that he faces a heightened and imminent risk of identity theft as a result of the data breach and that the defendants failed to take measures to properly safeguard his private information. The fourth was filed in the U.S. District Court for the Eastern District of Michigan on February 26, 2024 by Eric Franczak, individually and on behalf of all others similarly situated. Plaintiff alleged, among other things, that he faces a substantially increased risk of fraud and identity theft as a result of the data breach and that the defendants failed to take measures to properly safeguard his private information. The fifth was filed in the U.S. District Court for the Eastern District of Michigan on March 6, 2024 by Lazema Johnson, individually and on behalf of all others similarly situated. Plaintiff alleged, among other things, that she faces a substantially increased risk of fraud and identity theft as a result of the data breach and that the defendants failed to take measures to properly safeguard her private information. The sixth was filed in the Superior Court of California, County of Los Angeles, on April 8, 2024 by Robert Valencia, individually and on behalf of all others similarly situated. Plaintiff alleged, among other things, that he faces a substantially increased risk of fraud and identity theft as a result of the data breach and that the defendants failed to take measures to properly safeguard his private information. Concentra is working with its cybersecurity risk insurance policy carrier and does not believe that the data breach or the lawsuits will have a material impact on its operations or financial performance. However, at this time, Concentra is unable to predict the timing and outcome of these matters.
13
12.     Subsequent Events
On July 26, 2024, the Company completed an IPO of 22,500,000 shares of its common stock, par value $0.01 per share, at an initial public offering price of $23.50 per share for the net proceeds of $499.7 million after deducting underwriting discounts and commission of $29.1 million. In addition, the underwriters exercised the option to purchase an additional 750,000 shares of the Company’s common stock for net proceeds of $16.7 million after deducting underwriting discounts and commission of $1.0 million. The Company’s shares began trading on the New York Stock Exchange under the symbol “CON” on July 25, 2024. In connection with the IPO, Concentra Health Services, Inc. (“CHSI”), a wholly-owned subsidiary of the Company, entered into certain financing arrangements which include senior secured credit facilities of $1,250.0 million (the “Credit Facilities”) and a private offering of $650.0 million aggregate principal amount of 6.875% Senior Notes due 2032 (the “Notes”). The Notes are unconditionally guaranteed, jointly and severally, on a senior unsecured basis by Concentra and certain of its wholly-owned subsidiaries. The Credit Facilities consist of an $850.0 million Term Loan and a $400.0 million Revolving Credit Facility. The Revolving Credit Facility was undrawn at the closing of the IPO. The Term Loan matures on July 26, 2031, and has an interest rate of Term SOFR plus 2.25%, subject to a leverage-based pricing grid. The Revolving Credit Facility matures on July 26, 2029, and has an interest rate of Term SOFR plus 2.50%, subject to a leverage-based pricing grid.
The net proceeds of the IPO and the debt financing transactions, except for $34.7 million, were paid to Select through the issuance of a dividend, the repayment of the $420.0 million revolving promissory note outstanding, and the repayment of a new promissory note issued subsequent to June 30, 2024 in contemplation of the IPO.
After the closing of the IPO, and the exercise of the underwriters’ option to purchase additional shares, Select owns 81.74% of the total outstanding shares of the Company’s common stock. Select intends to make a distribution, which is intended to be tax-free for U.S. federal income tax purposes, to its stockholders of all of its remaining equity interest in the Company within twelve months of the IPO.
14
ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
You should read this discussion together with our unaudited condensed consolidated financial statements and accompanying notes.
Forward-Looking Statements
This report on Form 10-Q contains forward-looking statements, which do not relate strictly to historical or current facts and which reflect management’s assumptions, views, plans, objectives and projections about the future. Forward-looking statements may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates” and other words of similar meaning in conjunction with, among other things: discussions of future operations; expected operating results and financial performance; impact of planned acquisitions and dispositions; our strategy for growth; product development activities; regulatory approvals; market position; market size and opportunity; expenditures; and the effects of the separation and the distribution, if pursued, on our business.
Because forward-looking statements are based on current beliefs, expectations and assumptions regarding future events, they are subject to risks, uncertainties and changes that are difficult to predict and many of which are outside of our control. You should realize that if underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, our actual results and financial condition could vary materially from expectations and projections expressed or implied in our forward-looking statements. You are therefore cautioned not to rely on these forward-looking statements. Risks and uncertainties include:
•The frequency of work-related injuries and illnesses;
•The adverse changes to our relationships with employer customers, third-party payors, workers’ compensation provider networks or employer services networks;
•Changes to regulations, new interpretations of existing regulations, or violations of regulations;
•State fee schedule changes undertaken by state workers’ compensation boards or commissions and other third-party payors;
•Our ability to realize reimbursement increases at rates sufficient to keep pace with the inflation of our costs;
•Labor shortages, increased employee turnover or costs, and union activity could significantly increase our operating costs;
•Our ability to compete effectively with other occupational health centers, onsite health clinics at employer worksites, and healthcare providers;
•A security breach of our, or our third-party vendors’, information technology systems which may cause a violation of HIPAA and subject us to potential legal and reputational harm;
•Negative publicity which can result in increased governmental and regulatory scrutiny and possibly adverse regulatory changes;
•Litigation and other legal and regulatory proceedings in the course of our business that could adversely affect our business and financial statements and the effects of claims asserted against us could subject us to substantial uninsured liabilities;
•Acquisitions may use significant resources, may be unsuccessful, and could expose us to unforeseen liabilities;
•Our exposure to additional risk due to our reliance on third parties in many aspects of our business;
•Compliance with applicable laws regarding the corporate practice of medicine and therapy and fee-splitting;
•Our facilities are subject to extensive federal and state laws and regulations relating to the privacy of individually identifiable information;
•Compliance with applicable data interoperability and information blocking rule;
•Facility licensure requirements in some states are costly and time-consuming, limiting or delaying our operations;
•Our ability to adequately protect and enforce our intellectual property and other proprietary rights;
•Adverse economic conditions in the U.S. or globally;
•Any negative impact on the global economy and capital markets resulting from other geopolitical tensions;
15
•Our ability to maintain satisfactory credit ratings;
•The inability to execute on the separation from Select Medical;
•The risk of disruption or unanticipated costs in connection with the separation;
•Our ability to succeed as a standalone publicly traded entity;
•Restrictions on our business, potential tax and indemnification liabilities and substantial charges in connection with the separation, the distribution and related transactions;
•The negative impact of public threats such as a global pandemic or widespread outbreak of an infectious disease similar to the COVID-19 pandemic;
•The loss of key members of our management team and our ability to attract and retain talented, highly skilled employees and a diverse workforce, and on the succession of our senior management; and
•Changes in tax laws or exposures to additional tax liabilities.
You should also carefully read the risk factors and assumptions underlying forward-looking statements described in sections of our Registration Statement, entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” for a description of certain risks that could, among other things, cause our actual results to differ materially from those expressed or implied in our forward-looking statements. You should understand that it is not possible to predict or identify all such factors and you should not consider the risks described above to be a complete statement of all potential risks and uncertainties. We do not undertake to publicly update any forward-looking statement that may be made from time to time, whether as a result of new information or future events or developments, except as required by law.
Overview
We were founded in 1979 and have grown to be the largest provider of occupational health services in the United States by number of locations. Our national presence enables us to provide access to high-quality care that supports our mission to improve the health of America’s workforce. As of June 30, 2024, we operated 547 stand-alone occupational health centers in 41 states and 154 onsite health clinics at employer worksites in 36 states. We also have expanded our reach via our telemedicine program serving 43 states and the District of Columbia. In total, we deliver services across 45 states and the District of Columbia. Our patients are generally employed by our main customers — employers across the United States.
Our business is organized into three operating segments based primarily on the type or location of occupational health services provided:
•Occupational Health Centers: Our Occupational Health Centers operating segment encompasses the occupational health services we deliver at our 547 health center facilities across the United States. In this operating segment, we serve all types of employers, from Fortune 500 to small businesses. The occupational health services provided in this operating segment include Workers’ Compensation and Employer Services. We also provide Consumer Health services.
•Onsite Health Clinics: Our Onsite Health Clinics operating segment delivers occupational health services and/or employer-sponsored primary care services at an employer’s workplace, including mobile health services and episodic specialty testing services. We deliver our services at 154 on-site locations. In this operating segment, we serve medium to large-sized employers.
•Other Businesses: Our Other Businesses operating segment is comprised of several complementary services to our core occupational health services offering and includes Concentra Telemed, Concentra Pharmacy, and Concentra Medical Compliance Administration. In this operating segment, we serve all types of employers.





16

All three operating segments are aggregated into a single reportable segment in our condensed consolidated financial statements based on similar services provided, service delivery process involved, target customers, and similar economic characteristics. The percentage of revenue for each of the three and six months ended June 30, 2024 and 2023, of our Occupational Health Centers, Onsite Health Clinics and Other Businesses segments are represented as follows:
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Occupational Health Centers95 %95 %95 %95 %
Onsite Clinics3 %3 %3 %3 %
Other Businesses2 %2 %2 %2 %
Across our operating segments, we offer a diverse and comprehensive array of occupational health services, including workers’ compensation and employer services, and consumer health services:
•Workers’ compensation services include the support of workers’ compensation injury, physical rehabilitation, and specialist care.
•Employer services consist of drug and alcohol screenings, physical examinations and evaluations, clinical testing, and preventive care, as well as direct-to-employer services that include the services described above and advanced primary care at our onsite health clinics.
•Consumer health services consist of the support of patient-directed urgent care treatment of injuries and illnesses.
The following table sets forth the percentage of our overall visits per day (“VPD”) volume in our Occupational Health Center operating segment by service offering, for the periods presented:
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Workers’ compensation services45 %44 %45 %44 %
Employer services53 %54 %53 %54 %
Consumer health services2 %2 %2 %2 %
The following table sets forth the percentage of visit-related revenue in our Occupational Health Center operating segment by service offering, for the periods presented:
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Workers’ compensation services64 %63 %64 %63 %
Employer services34 %35 %34 %35 %
Consumer health services2 %2 %2 %2 %
Initial Public Offering and Debt Transactions
On July 26, 2024, the Company completed an IPO of 22,500,000 shares of its common stock, par value $0.01 per share, at an initial public offering price of $23.50 per share for net proceeds of $499.7 million after deducting underwriting discounts and commission of $29.1 million. In addition, the underwriters exercised the option to purchase an additional 750,000 shares of the Company’s common stock for net proceeds of $16.7 million after deducting underwriting discounts and commission of $1.0 million. The Company’s shares began trading on the New York Stock Exchange under the symbol “CON” on July 25, 2024. In connection with the IPO, CHSI entered into certain financing arrangements which include senior secured credit facilities of $1,250.0 million (the “Credit Facilities”) and a private offering of $650.0 million aggregate principal amount of 6.875% Senior Notes due 2032. The Notes are unconditionally guaranteed, jointly and severally, on a senior unsecured basis by Concentra and certain of its wholly-owned subsidiaries. The Credit Facilities consist of an $850.0 million Term Loan and a $400.0 million Revolving Credit Facility. The Revolving Credit Facility was undrawn at the closing of the IPO. The Term Loan matures on July 26, 2031, and has an interest rate of Term SOFR plus 2.25%, subject to a leverage-based pricing grid. The Revolving Credit Facility matures on July 26, 2029, and has an interest rate of Term SOFR plus 2.50%, subject to a leverage-based pricing grid.
17
The net proceeds of the IPO and the debt financing transactions, except for $34.7 million, were paid to Select through the issuance of a dividend, the repayment of the $420.0 million revolving promissory note outstanding, and the repayment of a new promissory note issued subsequent to June 30, 2024 in contemplation of the IPO.
18
Regulatory Changes
Our Registration Statement contains a detailed discussion of the regulations that affect our business in the “Government Regulations” section.
Operating Metrics
Management utilizes specific key operating metrics to monitor trends and performance in our business and therefore may be important to investors because management may assess our performance based in part on such metrics. Other healthcare providers may present similar measures; however, these measures are susceptible to varying definitions and our key metrics may not be comparable to other similarly titled measures of other companies.
Patient Visits and Visits Per Day Volume
We monitor the number of patient visits per day (“VPD”) volume for each of our major service lines in our Occupational Health Center operating segment — workers’ compensation services, employer services, and consumer health. Management believes that the number of patient visits is a critical indicator of the volume of services being provided in our centers. VPD volume, which is calculated as total patient visits in a given period divided by total business days for such period, allows for comparability between time periods with different number of business days. Patient visits and VPD volume include only the patients seen in our Occupational Health Centers operating segment and does not include our Onsite Health Clinics or Other Businesses operating segments.
Revenue Per Visit
Management also measures reimbursement rates utilizing patient revenue per visit which is calculated as total patient revenue divided by total patient visits. Revenue per visit as reported includes only the revenue and patient visits in our Occupational Health Centers operating segment and does not include our Onsite Health Clinics or Other Businesses operating segments.
The following table sets forth operating statistics for our Occupational Health Centers operating segment for the periods presented:
 Three Months Ended June 30,Six Months Ended June 30,
 20242023% Change20242023% Change
Number of patient visits
Workers’ Compensation1,455,254 1,429,035 1.8%2,888,338 2,825,602 2.2%
Employer Services1,702,399 1,781,012 (4.4)%3,361,690 3,541,543 (5.1)%
Consumer Health56,602 57,847 (2.2)%119,882 118,694 1.0%
Total3,214,255 3,267,894 (1.6)%6,369,910 6,485,839 (1.8)%
VPD Volume
Workers’ Compensation22,739 22,329 1.8%22,565 22,075 2.2%
Employer Services26,600 27,828 (4.4)%26,263 27,668 (5.1)%
Consumer Health884 904 (2.2)%937 928 1.0%
Total50,223 51,061 (1.6)%49,765 50,671 (1.8)%
Revenue per visit
Workers’ Compensation$198.18 $194.92 1.7%$196.75 $193.55 1.7%
Employer Services90.05 86.00 4.7%90.44 86.22 4.9%
Consumer Health135.49 134.88 0.5%133.42 134.70 (1.0)%
Total$139.81 $134.50 3.9%$139.45 $133.86 4.2%
Business Days64 64 128 128 






19
Facility Counts
The following table sets forth facility counts for our Occupational Health Centers and Onsite Health Clinics operating segments for the periods presented:
 Three Months Ended June 30,Six Months Ended June 30,
 2024202320242023
Number of occupational health centers—start of period547 539 544 540 
Number of occupational health centers acquired— 1 2 1 
Number of occupational health centers de novos1 — 2 — 
Number of occupational health centers closed/sold(1)— (1)(1)
Number of occupational health centers—end of period547 540 547 540 
Number of onsite health clinics operated—end of period154 141 154 141 
20
Results of Operations
The following table sets forth our consolidated results of operations, including as a percentage of revenue, for the periods indicated (in thousands):
 Three Months Ended June 30,
 20242023
AmountPercentAmountPercent
Revenue$477,915 100.0 %$467,079 100.0 %
Costs and expenses:
Cost of services, exclusive of depreciation and amortization339,273 71.0 329,836 70.6 
General and administrative, exclusive of depreciation and amortization36,828 7.7 37,003 7.9 
Depreciation and amortization17,870 3.7 18,283 3.9 
Total costs and expenses393,971 82.4 385,122 82.4 
Other operating income— — 151 0.0 
Income from operations83,944 17.6 82,108 17.6 
Other income and expense:
    Equity in losses of unconsolidated subsidiaries(3,676)(0.8)— — 
    Interest expense on related party debt(9,318)(1.9)(11,500)(2.5)
    Interest income205 0.0 17 0.0 
Income before income taxes71,155 14.9 70,625 15.1 
Income tax expense18,096 3.8 16,593 3.6 
Net income53,059 11.1 54,032 11.6 
Less: Net income attributable to non-controlling interests1,322 0.3 1,290 0.3 
Net income attributable to the Company51,737 10.8 %52,742 11.3 %

 Six Months Ended June 30,
 20242023
AmountPercentAmountPercent
Revenue$945,513 100.0 %$923,377 100.0 %
Costs and expenses:
Cost of services, exclusive of depreciation and amortization676,263 71.5 657,914 71.3 
General and administrative, exclusive of depreciation and amortization73,737 7.8 71,653 7.8 
Depreciation and amortization36,355 3.8 36,593 4.0 
Total costs and expenses786,355 83.1 766,160 83.1 
Other operating income284 0.0 151 0.0 
Income from operations159,442 16.9 157,368 17.0 
Other income and expense:
    Equity in losses of unconsolidated subsidiaries(3,676)(0.4)(526)(0.1)
    Interest expense on related party debt(19,289)(2.0)(22,576)(2.4)
    Interest income (expense)94 0.0 (44)0.0 
Income before income taxes136,571 14.4 134,222 14.5 
Income tax expense33,233 3.5 32,759 3.5 
Net income103,338 10.9 101,463 11.0 
Less: Net income attributable to non-controlling interests2,645 0.3 2,457 0.3 
Net income attributable to the Company100,693 10.6 %99,006 10.7 %


21
Three Months Ended June 30, 2024, Compared to Three Months Ended June 30, 2023
Revenue
Revenue increased 2.3% to $477.9 million for the three months ended June 30, 2024, compared to $467.1 million for the three months ended June 30, 2023, driven primarily by the increase in revenue per visit, as described below.
Our patient visits were 3,214,255 for the three months ended June 30, 2024, compared to 3,267,894 visits for the three months ended June 30, 2023. Total VPD volume was 50,223 for the three months ended June 30, 2024, compared to 51,061 for the three months ended June 30, 2023. Workers’ compensation VPD volume increased 1.8% to 22,739 from 22,329, employer services VPD volume decreased 4.4% to 26,600 from 27,828, and consumer health VPD volume decreased 2.2% to 884 from 904, for the three months ended June 30, 2024, compared to the three months ended June 30, 2023.
Revenue per visit increased 3.9% to $139.81 for the three months ended June 30, 2024, compared to $134.50 for the three months ended June 30, 2023. We experienced a higher revenue per visit principally due to increases in the reimbursement rates payable pursuant to certain state fee schedules for workers’ compensation visits, increases in our employer services rates, and a favorable mix of visit types by service line for the three months ended June 30, 2024. Revenue per visit for workers’ compensation visits increased 1.7% to $198.18 from $194.92, revenue per visit for employer services visits increased 4.7% to $90.05 from $86.00 and revenue per visit for consumer health visits increased by 0.5% to $135.49 from $134.88, for the three months ended June 30, 2024, compared to the three months ended June 30, 2023.
Cost of Services, Exclusive of Depreciation and Amortization
Our cost of services expense includes all direct and indirect support costs related to providing services to our customers. Cost of services was $339.3 million, or 71.0% of revenue, for the three months ended June 30, 2024, compared to $329.8 million, or 70.6% of revenue, for the three months ended June 30, 2023.
General and Administrative, Exclusive of Depreciation and Amortization
General and administrative expense includes corporate overhead such as finance, legal, human resources, marketing, facilities, and other administrative areas as well as executive compensation. Our general and administrative expenses were $36.8 million, or 7.7% of revenue, for the three months ended June 30, 2024, compared to $37.0 million, or 7.9% of revenue, for the three months ended June 30, 2023.
Depreciation and Amortization
Depreciation and amortization expense was $17.9 million for the three months ended June 30, 2024, compared to $18.3 million for the three months ended June 30, 2023.
Other Operating Income
For the three months ended June 30, 2023, we had other operating income of $0.2 million.
Equity in Losses of Unconsolidated Subsidiaries
For the three months ended June 30, 2024, we had equity in losses of unconsolidated subsidiaries of $3.7 million attributable to the impairment of an investment.
Interest Expense on Related Party Debt
For the three months ended June 30, 2024, we had interest expense on our related party debt with Select of $9.3 million, compared to $11.5 million for the three months ended June 30, 2023. The decrease in interest expense is principally due to lower average outstanding borrowings during the three months ended June 30, 2024, as compared to the three months ended June 30, 2023.
Interest Income
For the three months ended June 30, 2024, we had interest income of $0.2 million.
Income Taxes
We recorded income tax expense of $18.1 million for the three months ended June 30, 2024, which represented an effective tax rate of 25.4%. We recorded income tax expense of $16.6 million for the three months ended June 30, 2023, which represented an effective tax rate of 23.5%.
22
Six Months Ended June 30, 2024, Compared to Six Months Ended June 30, 2023
Revenue
Revenue increased 2.4% to $945.5 million for the six months ended June 30, 2024, compared to $923.4 million for the six months ended June 30, 2023, driven primarily by the increase in revenue per visit, as described below.
Our patient visits were 6,369,910 for the six months ended June 30, 2024, compared to 6,485,839 visits for the six months ended June 30, 2023. Total VPD volume was 49,765 for the six months ended June 30, 2024, compared to 50,671 for the six months ended June 30, 2023. Workers’ compensation VPD volume increased 2.2% to 22,565 from 22,075, employer services VPD volume decreased 5.1% to 26,263 from 27,668, and consumer health VPD volume increased 1.0% to 937 from 928, for the six months ended June 30, 2024, compared to the six months ended June 30, 2023.
Revenue per visit increased 4.2% to $139.45 for the six months ended June 30, 2024, compared to $133.86 for the six months ended June 30, 2023. We experienced a higher revenue per visit principally due to increases in the reimbursement rates payable pursuant to certain state fee schedules for workers’ compensation visits, increases in our employer services rates, and a favorable mix of visit types by service line for the six months ended June 30, 2024. Revenue per visit for workers’ compensation visits increased 1.7% to $196.75 from $193.55, revenue per visit for employer services visits increased 4.9% to $90.44 from $86.22 and revenue per visit for consumer health visits decreased by 1.0% to $133.42 from $134.70, for the six months ended June 30, 2024, compared to the six months ended June 30, 2023.
Cost of Services, Exclusive of Depreciation and Amortization
Our cost of services expense includes all direct and indirect support costs related to providing services to our customers. Cost of services was $676.3 million, or 71.5% of revenue, for the six months ended June 30, 2024, compared to $657.9 million, or 71.3% of revenue, for the six months ended June 30, 2023.
General and Administrative, Exclusive of Depreciation and Amortization
General and administrative expense includes corporate overhead such as finance, legal, human resources, marketing, facilities, and other administrative areas as well as executive compensation. Our general and administrative expenses were $73.7 million, or 7.8% of revenue, for the six months ended June 30, 2024, compared to $71.7 million, or 7.8% of revenue, for the six months ended June 30, 2023. General and administrative expenses include $1.6 million of separation transaction costs for the six months ended June 30, 2024.
Depreciation and Amortization
Depreciation and amortization expense was $36.4 million for the six months ended June 30, 2024, compared to $36.6 million for the six months ended June 30, 2023.
Other Operating Income
For the six months ended June 30, 2024, we had other operating income of $0.3 million, compared to $0.2 million for the six months ended June 30, 2023.
Equity in Losses of Unconsolidated Subsidiaries
For the six months ended June 30, 2024, we had equity in losses of unconsolidated subsidiaries of $3.7 million, compared to $0.5 million for the six months ended June 30, 2023. The increase in equity in losses is attributable to the impairment of an investment during the six months ended June 30, 2024.
Interest Expense on Related Party Debt
For the six months ended June 30, 2024, we had interest expense on our related party debt with Select of $19.3 million, compared to $22.6 million for the six months ended June 30, 2023. The decrease in interest expense is principally due to lower average outstanding borrowings during the six months ended June 30, 2024 as compared to the six months ended June 30, 2023.
Interest Income
For the six months ended June 30, 2024, we had interest income of $0.1 million.

23
Income Taxes
We recorded income tax expense of $33.2 million for the six months ended June 30, 2024, which represented an effective tax rate of 24.3%. We recorded income tax expense of $32.8 million for the six months ended June 30, 2023, which represented an effective tax rate of 24.4%.
24
Non-GAAP Information
We believe that the presentation of Adjusted EBITDA and Adjusted EBITDA margin, as defined below, are important to investors because Adjusted EBITDA and Adjusted EBITDA margin are commonly used as an analytical indicator of performance by investors within the healthcare industry. Adjusted EBITDA and Adjusted EBITDA margin are used by management to evaluate financial performance of, and determine resource allocation for, each of our operating segments. However, Adjusted EBITDA and Adjusted EBITDA margin are not measures of financial performance under U.S. GAAP. Items excluded from Adjusted EBITDA and Adjusted EBITDA margin are significant components in understanding and assessing financial performance. Adjusted EBITDA and Adjusted EBITDA margin should not be considered in isolation, or as an alternative to, or substitute for, net income, net income margin, income from operations, cash flows generated by operations, investing or financing activities, or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because Adjusted EBITDA and Adjusted EBITDA margin are not measurements determined in accordance with U.S. GAAP and are thus susceptible to varying definitions, Adjusted EBITDA and Adjusted EBITDA margin as presented may not be comparable to other similarly titled measures of other companies.
We define Adjusted EBITDA as earnings excluding interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, separation transaction costs, gain (loss) on sale of businesses, and equity in earnings (losses) of unconsolidated subsidiaries. We define Adjusted EBITDA margin as Adjusted EBITDA divided by revenue. We will refer to Adjusted EBITDA and Adjusted EBITDA margin throughout the remainder of Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following table reconciles net income to Adjusted EBITDA and net income margin to Adjusted EBITDA margin and should be referenced when we discuss Adjusted EBITDA and Adjusted EBITDA margin.
 Three Months Ended June 30,Six Months Ended June 30,
 2024202320242023
 (in thousands, except for percentages)
Reconciliation of Adjusted EBITDA
Net income$53,059 $54,032 $103,338 $101,463 
Income tax expense18,096 16,593 33,233 32,759 
Interest (income) expense(205)(17)(94)44 
Interest expense on related party debt9,318 11,500 19,289 22,576 
Equity in losses of unconsolidated subsidiaries3,676 — 3,676 526 
Stock compensation expense166 — 332 178 
Depreciation and amortization17,870 18,283 36,355 36,593 
Separation transaction costs (a)
(380)— 1,613 — 
Adjusted EBITDA$101,600 $100,391 $197,742 $194,139 
Adjusted EBITDA margin21.3 %21.5 %20.9 %21.0 %
Net income margin11.1 %11.6 %10.9 %11.0 %
(a)    Separation transaction costs represent incremental consulting, legal, and audit-related fees incurred in connection with the Company’s planned separation into a new, publicly traded company and are included within general and administrative expenses on the Condensed Consolidated Statements of Operations. During the three months ended June 30, 2024, an adjustment was made to capitalize certain separation transaction costs recognized during the first quarter of 2024.
25
Liquidity and Capital Resources
Cash Flows for the Six Months Ended June 30, 2024 and Six Months Ended June 30, 2023
In the following table and analysis, we discuss cash flows from operating activities, investing activities, and financing activities for the periods indicated:
 Six Months Ended June 30,
 20242023
 (in thousands)
Net cash provided by operating activities$115,055 $99,541 
Net cash used in investing activities(37,615)(31,672)
Net cash used in financing activities(58,145)(72,288)
Net increase (decrease) in cash19,295 (4,419)
Cash at beginning of period31,374 37,657 
Cash at end of period$50,669 $33,238 
Operating activities provided $115.1 million and $99.5 million of cash flows during the six months ended June 30, 2024 and 2023, respectively. The increase in cash flows from operating activities for the six months ended June 30, 2024, as compared to the six months ended June 30, 2023, resulted from improvements in earnings and positive working capital contributions to cash.
Investing activities used $37.6 million and $31.7 million of cash flows for the six months ended June 30, 2024 and 2023, respectively. For the six months ended June 30, 2024, the principal uses of cash were $32.5 million for purchases of property and equipment and $5.1 million for acquisitions of businesses. For the six months ended June 30, 2023, the principal uses of cash were $25.9 million for purchases of property and equipment and $4.4 million for purchases of customer relationships.
Financing activities used $58.1 million and $72.3 million of cash flows for the six months ended June 30, 2024 and 2023, respectively. For the six months ended June 30, 2024, the principal uses of cash were $50.0 million of net repayments on our related party revolving promissory note, distributions to Select of $7.7 million for income tax adjustments relating to the application of the separate return methodology, and principal payments on other debt of $4.4 million, partially offset by $6.6 million in borrowings of other debt. For the six months ended June 30, 2023, the principal uses of cash were $70.0 million in payments on the related party revolving promissory note, principal payments on other debt of $4.1 million, and distributions to and purchases of non-controlling interests of $3.1 million, partially offset by $5.5 million in borrowings of other debt.
Capital Resources
We had net working capital of $55.2 million at June 30, 2024, compared to net working capital of $19.8 million at December 31, 2023. The increase in the net working capital surplus was principally due to increases in our cash and accounts receivable.
A significant component of our net working capital is our accounts receivable. Collection of these accounts receivable is our primary source of cash and is critical to our liquidity and capital resources. Because our accounts receivable is primarily paid for by highly-solvent, creditworthy payors, such as workers’ compensation programs, employer programs, third party administrators, commercial insurance companies, and federal and state governmental authorities, our credit losses have historically been infrequent and insignificant in nature, and we believe the possibility of credit default is remote.
Credit Facilities
At June 30, 2024, we had $420.0 million of outstanding borrowings under our related party revolving promissory note. Borrowings under the revolving promissory note bear interest at a rate equal to Term SOFR plus 3.00%. The revolving promissory note was repaid in July 2024 with the net proceeds of the IPO.
On July 26, 2024, CHSI, a wholly-owned subsidiary of the Company, entered into certain financing arrangements which include Credit Facilities of $1,250.0 million and $650.0 million aggregate principal amount of 6.875% Senior Notes due 2032. The Notes are unconditionally guaranteed, jointly and severally, on a senior unsecured basis by the Company and certain of its wholly-owned subsidiaries. The Credit Facilities consist of an $850.0 million Term Loan and a $400.0 million Revolving Credit Facility. The Revolving Credit Facility was undrawn at the closing of the IPO. The Term Loan matures on July 26, 2031, and has an interest rate of Term SOFR plus 2.25%, subject to a leverage-based pricing grid. The Revolving Credit Facility matures on July 26, 2029, and has an interest rate of Term SOFR plus 2.50%, subject to a leverage-based pricing grid.
26
Future Sources of Liquidity
As a result of the completion of the IPO and debt transactions in July of 2024, our capital structure and sources of liquidity have changed as of the date of this filing as compared to our historical capital structure at June 30, 2024. Our ability to fund our future operating needs will depend on our ability to continue to generate positive cash flow from operations, and on our ability to obtain debt financing on acceptable terms or to issue additional equity or equity-linked securities. Based upon our history of generating positive cash flows, we believe our existing cash and cash generated from future operations will be sufficient to meet our needs for at least the next 12 months. Management believes that our cash balances and funds provided by operating activities, along with the borrowing capacity provided by our Revolving Credit Facility, taken as a whole, provide (1) adequate liquidity to meet all of our current and long-term obligations when due, including third-party debt incurred in connection with the Separation, (2) adequate liquidity to fund capital expenditures and (3) flexibility to meet investment opportunities that may arise.
In July of 2024 the net proceeds of the IPO and the debt financing transactions, except for $34.7 million, were paid to Select through the issuance of a dividend and the repayment of promissory notes.
Recent Accounting Pronouncements
Refer to Note 2 – Accounting Policies of the notes to our condensed consolidated financial statements included herein for information regarding recent accounting pronouncements.
27
ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Inflation Risk
The healthcare industry is labor intensive, and our largest expenses are labor related costs. Wage and other expenses increase during periods of inflation and when labor shortages occur in the marketplace. We have recently experienced higher labor costs related to the current inflationary environment and competitive labor market. In addition, suppliers have passed along rising costs to us in the form of higher prices. To help mitigate the inflationary pressures on our business, we have implemented compensation strategies, selective price increases in certain markets, supply chain optimization initiatives and carefully monitor labor costs in our day-to-day operations. However, if our costs continue to be subject to significant inflationary pressures, we may not be able to offset such higher costs through price increases, which could adversely affect our business, results of operations, or financial condition.
Interest Rate Risk
We are subject to interest rate risk in connection with our variable rate long-term indebtedness. As of June 30, 2024, our principal interest rate exposure related to the borrowings outstanding on our related party revolving promissory note, which bears interest at a rate indexed against Term SOFR. In connection with the separation in July 2024, as described in “Note 12. Subsequent Events”, the related party revolving promissory note was repaid. On July 26, 2024, the Company entered into Credit Facilities which consist of a term loan and revolving credit facility which bear interest rates that are indexed against Term SOFR.
Subsequent to the July 26, 2024 debt financing transactions discussed in “Note 12. Subsequent Events” above, each 0.25% increase in market interest rates will impact the annual interest expense on our variable rate debt by $2.1 million per year.
ITEM 4.  CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
We carried out an evaluation, under the supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered in this report. Based on this evaluation, as of June 30, 2024, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures, including the accumulation and communication of disclosure to our principal executive officer and principal financial officer as appropriate to allow timely decisions regarding disclosure, are effective to provide reasonable assurance that material information required to be included in our periodic SEC reports is recorded, processed, summarized, and reported within the time periods specified in the relevant SEC rules and forms.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) identified in connection with the evaluation required by Rule 13a-15(d) of the Securities Exchange Act of 1934 that occurred during the second quarter ended June 30, 2024, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Inherent Limitations on Effectiveness of Controls
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
28
PART II: OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Refer to the “Litigation” section contained within Note 11 – Commitments and Contingencies of the notes to our condensed consolidated financial statements included herein.
ITEM 1A. RISK FACTORS
There have been no material changes from our risk factors set forth in our Registration Statement.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Unregistered Sales of Equity Securities
None.
Use of Proceeds
On July 26, 2024, the Company completed the IPO, resulting in the issuance of 22,500,000 shares of its common stock at a price of $23.50 per share. In addition, the underwriters exercised the option to purchase an additional 750,000 shares of the Company’s common stock. The 23,250,000 shares of common stock sold in the IPO represent approximately 18.26% of the Company’s outstanding shares, of which Select owns 81.74%.
The shares sold in the offering were registered under the Securities Act pursuant to a registration statement on Form S-1 File No. 333-280242, which was declared effective by the SEC as of July 24, 2024. The aggregate offering price of common stock registered and sold under the registration statement was approximately $546.4 million (including shares issued pursuant to the underwriters’ option to purchase additional shares). Net proceeds from the IPO were approximately $516.3 million, after deducting underwriting discounts and commissions of $30.1 million. As contemplated by the Registration Statement, the Company used the net proceeds to repay the outstanding revolving promissory note with Select, as well as repay the promissory note issued to Select in contemplation of the IPO.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
Not applicable.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
Rule 10b5-1 Trading Plans
During the three months ended June 30, 2024, none of our directors or executive officers adopted or terminated any contract, instruction, or written plan for the purchase or sale of our securities to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any non-Rule 10b5-1 trading arrangement.
29
ITEM 6. EXHIBITS
NumberDescription
3.1
3.2
4.1
4.2
10.1
10.2
10.3
10.4
10.5
10.6
10.7
31.1
31.2
32.1
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document.
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.
104Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
30
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
 Concentra Group Holdings Parent, Inc.
  
  
 By:/s/ Matthew T. DiCanio
  Matthew T. DiCanio
  President and Principal Financial Officer
  (Duly Authorized Officer)
   
 By:/s/ Su Zan Nelson
  Su Zan Nelson
  Executive Vice President, Chief Accounting Officer
  (Principal Accounting Officer)
 
Dated:  August 27, 2024
31
 EX-31.1 2 cghp-630202410qxex311.htm EX-31.1 Document

EXHIBIT 31.1
 
CONCENTRA GROUP HOLDINGS PARENT
CERTIFICATIONS PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
 
I, William K. Newton, certify that:
 
1.    I have reviewed this quarterly report on Form 10-Q of Concentra Group Holdings Parent;
 
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date: August 27, 2024/s/ William K. Newton
 William K. Newton
 President and Chief Executive Officer

 EX-31.2 3 cghp-630202410qxex312.htm EX-31.2 Document

EXHIBIT 31.2
 
CONCENTRA GROUP HOLDINGS PARENT
CERTIFICATIONS PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
 
I, Matthew T. DiCanio, certify that:
 
1.    I have reviewed this quarterly report on Form 10-Q of Concentra Group Holdings Parent;
 
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date: August 27, 2024/s/ Matthew T. DiCanio
 Matthew T. DiCanio
 President and Chief Financial Officer

 EX-32.1 4 cghp-630202410qxex321.htm EX-32.1 Document

EXHIBIT 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q of Concentra Group Holdings Parent (the “Company”) for the period ended June 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, William K.. Newton and Matthew T. DiCanio, Chief Executive Officer and Chief Financial Officer, respectively, of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to our knowledge:
 
(1)    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.
 
August 27, 2024

/s/ William K. Newton 
William K. Newton
President and Chief Executive Officer
 
 
/s/ Matthew T. DiCanio 
Matthew T. DiCanio
President and Chief Financial Officer

 EX-101.SCH 5 cghp-20240630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 9952151 - Statement - Condensed Consolidated Balance Sheets (unaudited) link:presentationLink link:calculationLink link:definitionLink 9952152 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952153 - Statement - Condensed Consolidated Statements of Operations (unaudited) link:presentationLink link:calculationLink link:definitionLink 9952154 - Statement - Condensed Consolidated Statements of Operations (unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952155 - Statement - Condensed Consolidated Statements of Changes in Stockholders’/Members’ Equity (unaudited) link:presentationLink link:calculationLink link:definitionLink 9952156 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited) link:presentationLink link:calculationLink link:definitionLink 9952157 - Disclosure - Organization link:presentationLink link:calculationLink link:definitionLink 9952158 - Disclosure - Accounting Policies link:presentationLink link:calculationLink link:definitionLink 9952159 - Disclosure - Redeemable Non-Controlling Interests link:presentationLink link:calculationLink link:definitionLink 9952160 - Disclosure - Variable Interest Entities link:presentationLink link:calculationLink link:definitionLink 9952161 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 9952162 - Disclosure - Long-Term Debt and Notes Payable link:presentationLink link:calculationLink link:definitionLink 9952163 - Disclosure - Accrued and Other Liabilities link:presentationLink link:calculationLink link:definitionLink 9952164 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 9952165 - Disclosure - Earnings per Share link:presentationLink link:calculationLink link:definitionLink 9952166 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 9952167 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 9952168 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Redeemable Non-Controlling Interests (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Long-Term Debt and Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Accrued and Other Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Earnings per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Organization (Details) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Redeemable Non-Controlling Interests - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Redeemable Non-Controlling Interests - Schedule of Redeemable Non-Controlling Interests (Details) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Variable Interest Entities (Details) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Long-Term Debt and Notes Payable - Carrying Value Of Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Long-Term Debt and Notes Payable - Principal Maturities Of Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Accrued and Other Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Earnings per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Earnings per Share - Computation of EPS (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Earnings per Share - Net Income Attributable to the Company, Units Outstanding, and Participating Units Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Earnings per Share - Computation of EPS Under the Two-Class Method (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 cghp-20240630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 cghp-20240630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 cghp-20240630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Prepaid income taxes Prepaid Taxes Members’ Contributed Capital Members Units, Contributed Capital [Member] Members Units, Contributed Capital Related Party Transactions Related Party Transactions Disclosure [Text Block] Schedule of lease cost Lease, Cost [Table Text Block] Cover [Abstract] Cover [Abstract] Net increase (decrease) in cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Obligations payable Other Liabilities, Current Trading Symbol Trading Symbol All Trading Arrangements All Trading Arrangements [Member] Long-term debt, net of current portion Long-Term Debt and Lease Obligation Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Non-NEOs Non-NEOs [Member] Schedule of computation of basic and diluted earnings per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Variable Interest Entity, Primary Beneficiary Variable Interest Entity, Primary Beneficiary [Member] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Cash paid for taxes Income Taxes Paid, Net Class A Units Voting Common Class A [Member] Distributions to and purchases of non-controlling interests Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Pay vs Performance Disclosure [Line Items] Redeemable non-controlling interests Balance, beginning Balance, ending Redeemable Noncontrolling Interest, Equity, Carrying Amount Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Accounts receivable Increase (Decrease) in Accounts Receivable Organization Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Award Timing Disclosures [Line Items] Other Performance Measure, Amount Other Performance Measure, Amount Leases Lessee, Operating Leases [Text Block] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Operating lease cost Operating Lease, Cost Lease, Cost [Abstract] Lease, Cost [Abstract] Non-current operating lease liabilities Operating Lease, Liability, Noncurrent Interest on lease liabilities Finance Lease, Interest Expense Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Other occupational health center revenue Occupational Health Center, Other [Member] Occupational Health Center, Other Sale of stock, price per share (in dollars per share) Sale of Stock, Price Per Share Other assets Other Assets, Noncurrent Entity Tax Identification Number Entity Tax Identification Number Leases [Abstract] Leases [Abstract] Schedule of long-term debt and notes payable Schedule of Long-Term Debt Instruments [Table Text Block] Variable Interest Entities Variable Interest Entity Disclosure [Text Block] Operating Segments Operating Segments [Member] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Contribution from Parent Adjustments To Member's Contributed Capital, Contributions From Parent Adjustments To Member's Contributed Capital, Contributions From Parent Net proceeds received Sale of Stock, Consideration Received on Transaction Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Income taxes payable Taxes Payable, Current Term loan Secured Debt [Member] Equity Components [Axis] Equity Components [Axis] Other current assets Other Assets, Current Award Timing Method Award Timing Method [Text Block] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Distributions to Parent Payments of Capital Distribution Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Insider Trading Policies and Procedures [Line Items] Total annual aggregate limit of insurance coverage Malpractice Insurance, Annual Coverage Limit Use of Estimates Use of Estimates, Policy [Policy Text Block] Accrued payroll Accrued Salaries, Accrued Bonuses, And Accrued Payroll Taxes, Current Accrued Salaries, Accrued Bonuses, And Accrued Payroll Taxes, Current Total costs and expenses Costs and Expenses Insurance Type and Tier Identifier [Axis] Insurance Type and Tier Identifier [Axis] Adjustment to Compensation, Amount Adjustment to Compensation Amount Capital in excess of par Additional Paid in Capital, Common Stock Payables and Accruals [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Diluted EPS Earnings Per Share, Diluted [Abstract] Number of states in which entity operates Number of States in which Entity Operates Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Company Selected Measure Amount Company Selected Measure Amount Senior Secured Credit Facilities Senior Secured Credit Facilities [Member] Senior Secured Credit Facilities Tabular List, Table Tabular List [Table Text Block] Shared service fee from related party Contractually Specified Servicing Fees, Amount Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Class C Units Non-Voting Common Class C [Member] Credit Facility [Domain] Credit Facility [Domain] Cash at beginning of period Cash at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Current Assets: Assets, Current [Abstract] Goodwill Goodwill Consolidation Items [Axis] Consolidation Items [Axis] Professional liability claims Professional Malpractice Liability Insurance [Member] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Product and Service [Domain] Product and Service [Domain] Employee Stock Option Share-Based Payment Arrangement, Option [Member] Security Exchange Name Security Exchange Name Credit spread adjustment Debt Instrument, Basis Spread on Variable Rate Award Type Award Type [Axis] Basic EPS Earnings Per Share, Basic [Abstract] Number of occupational health centers operated by entity Number of Occupational Health Centers Operated by Entity Number of Occupational Health Centers Operated by Entity Property and equipment, net Property, Plant and Equipment, Net Repayments of debt Repayments of Debt Total Liabilities Liabilities Liabilities Non-controlling interests Equity, Attributable to Noncontrolling Interest Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Distributions to and purchases of redeemable non-controlling interests Noncontrolling Interest, Distributions to Redeemable Noncontrolling Interests Noncontrolling Interest, Distributions to Redeemable Noncontrolling Interests Revolving Credit Facility Revolving Credit Facility [Member] Expiration Date Trading Arrangement Expiration Date Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Current operating lease liabilities Operating Lease, Liability, Current Total Shareholder Return Amount Total Shareholder Return Amount Finance lease cost: Lessee, Finance Lease, Description [Abstract] Common stock, shares issued (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Issued Entity [Domain] Entity [Domain] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity 2024 Long-Term Debt And Finance Lease Obligation, Repayments Of Principal, Remainder Of Fiscal Year Long-Term Debt And Finance Lease Obligation, Repayments Of Principal, Remainder Of Fiscal Year Principal payments on other debt Repayments of Debt and Lease Obligation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Subsequent Event [Line Items] Subsequent Event [Line Items] General Liability General Liability [Member] Members’ contributed capital Members' unit, beginning balance Members' unit, ending balance Members' Capital Debt Instrument [Line Items] Debt Instrument [Line Items] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Vesting of restricted interests Partners' Capital Account, Unit-Based Payment Arrangement, Amount Business combinations, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Basis of Presentation and Consolidation Basis of Accounting, Policy [Policy Text Block] Weighted average common shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Net Income Allocation Undistributed Earnings, Basic [Abstract] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Total Stockholders' Equity Equity, Attributable to Parent Select Medical Revolving Promissory Note Select Medical Revolving Promissory Note [Member] Select Medical Revolving Promissory Note Related Party Related Party [Member] Deferred income taxes Deferred Income Tax Expense (Benefit) Number of onsite clinics Number of Onsite Clinics Operated by Entity Number of Onsite Clinics Operated by Entity Borrowings of other debt Proceeds from Other Debt Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Outstanding member interest Subsidiary, Ownership Percentage, Parent Sale of Stock [Domain] Sale of Stock [Domain] Long-term debt with related party Long-term revolving promissory note with related party Long-Term Debt Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Document Fiscal Period Focus Document Fiscal Period Focus Participating shares outstanding (in shares) Weighted average participating shares outstanding (in shares) Incremental Common Shares Attributable to Participating Nonvested Shares with Non-forfeitable Dividend Rights 2028 Long-Term Debt, Maturity, Year Four All Executive Categories All Executive Categories [Member] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] ASSETS Assets [Abstract] Document Type Document Type Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Nonrelated Party Nonrelated Party [Member] Total Stockholders’ Equity Parent [Member] Subsequent Event [Table] Subsequent Event [Table] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Accounts payable and Due to related party Accounts Payable, Current Accounting Policies [Abstract] Accounting Policies [Abstract] 2026 Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Two Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Two Net income attributable to redeemable non-controlling interests Net Income (Loss) Attributable to Redeemable Noncontrolling Interest Current Fiscal Year End Date Current Fiscal Year End Date Total lease cost Lease, Cost Accrued and other liabilities Accrued and other liabilities Accounts Payable and Other Accrued Liabilities, Current Thereafter Long-term Debt, Maturities, Repayments Of Principal After Year Four Long-term Debt, Maturities, Repayments Of Principal After Year Four PEO Name PEO Name Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Number of less than wholly owned subsidiaries Number Of Less Than Wholly Owned Subsidiaries Number Of Less Than Wholly Owned Subsidiaries All Award Types Award Type [Domain] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Name Outstanding Recovery, Individual Name Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Variable lease cost Variable Lease, Cost Conversion of LLC to Corporation and Impact of Reverse Stock Split Conversion of LLC to Corporation and Impact of Reverse Stock Split Stock Issued During Period, Value, Conversion of Units Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Non-PEO NEO Non-PEO NEO [Member] Capital in excess of par Additional Paid-in Capital [Member] Award Timing Predetermined Award Timing Predetermined [Flag] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Recent Accounting Guidance Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Class of Stock [Axis] Class of Stock [Axis] Diluted (in dollars per share) Diluted EPS (in dollars per share) Earnings Per Share, Diluted Name Measure Name Entity Interactive Data Current Entity Interactive Data Current Accrued vacation Accrued Vacation, Current Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Member Units Member Units [Member] Customer relationships Finite-Lived Customer Relationships, Gross Ownership [Axis] Ownership [Axis] Less: Distributed and undistributed income attributable to participating shares - basic EPS Participating shares - basic Participating Securities, Distributed and Undistributed Earnings (Loss), Basic Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Stock compensation expense Share-Based Payment Arrangement, Noncash Expense Net income Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Equity in losses of unconsolidated subsidiaries Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal Workers’ compensation Occupational Health Center, Workers Compensation [Member] Occupational Health Center, Workers Compensation Income tax expense Income Tax Expense (Benefit) Other income and expense: Nonoperating Income (Expense) [Abstract] Interest rate of debt (as a percent) Debt Instrument, Interest Rate, Stated Percentage Supplemental information Supplemental Cash Flow Information [Abstract] Net income allocated to common shares - diluted Distributed and undistributed income attributable to outstanding shares Net Income (Loss) Available to Common Stockholders, Diluted Revenue Revenue from Contract with Customer, Excluding Assessed Tax Purchase of customer relationships Payments to Acquire Intangible Assets Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Income from operations Operating Income (Loss) Total Liabilities and Equity Liabilities and Equity Subsequent Events Subsequent Events [Text Block] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] All Adjustments to Compensation All Adjustments to Compensation [Member] Other identifiable intangible assets, net Other Intangible Assets, Net Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Legal Entity [Axis] Legal Entity [Axis] Interest income (expense) Interest Income (Expense), Nonoperating Current portion of long-term debt and notes payable Long-Term Debt and Lease Obligation, Current Member interests converted to common shares Member Interest, Convertible, Conversion Ratio Member Interest, Convertible, Conversion Ratio Schedule of principal maturities of long-term debt and notes payable Schedule of Maturities of Long-Term Debt [Table Text Block] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Individual: Individual [Axis] Net proceeds of IPO and debt financing transactions, excluding amounts repaid for debt Proceeds From Issuance Initial Public Offering, Amount Not Distributed To Parent Proceeds From Issuance Initial Public Offering, Amount Not Distributed To Parent Loss contingency, number of patients Loss Contingency, Number Of Patients Loss Contingency, Number Of Patients Product and Service [Axis] Product and Service [Axis] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity Address, State or Province Entity Address, State or Province Redemption value adjustment on non-controlling interests Redemption value adjustment on non-controlling interests Redemption value adjustment on redeemable non-controlling interests Noncontrolling Interest, Change in Redemption Value Statement [Line Items] Statement [Line Items] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] IPO IPO [Member] LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Loss contingency, new claims filed, number Loss Contingency, New Claims Filed, Number Employer services Occupational Health Center, Employer Services [Member] Occupational Health Center, Employer Services 2025 Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Next Twelve Months Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Next Twelve Months Restatement Determination Date Restatement Determination Date Adoption Date Trading Arrangement Adoption Date Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Related Party Transactions [Abstract] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Provision for expected credit losses Accounts Receivable, Credit Loss Expense (Reversal) Segments [Axis] Segments [Axis] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Total Principal outstanding Long-Term Debt, Gross Exercise Price Award Exercise Price Earnings per Share Earnings Per Share [Text Block] Arrangement Duration Trading Arrangement Duration Subsequent Event Subsequent Event [Member] Leases Lessee, Finance Leases [Text Block] Costs and expenses: Costs and Expenses [Abstract] Schedule of Variable Interest Entities [Table] Variable Interest Entity [Table] 2027 Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Three Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Three Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Segments [Domain] Segments [Domain] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] All Individuals All Individuals [Member] Borrowings from related party revolving promissory note Proceeds from Lines of Credit Concentra Health Services, Inc. ("CHSI") Concentra Health Services, Inc. ("CHSI") [Member] Concentra Health Services, Inc. ("CHSI") PEO PEO [Member] Name Trading Arrangement, Individual Name Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Other assets Increase (Decrease) in Other Noncurrent Assets Equity in losses of unconsolidated subsidiaries Income (Loss) from Equity Method Investments 2024 Long-Term Debt, Maturity, Remainder of Fiscal Year Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Related Party [Domain] Related and Nonrelated Parties [Domain] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Local Phone Number Local Phone Number Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Non-current deferred tax liability Deferred Income Tax Liabilities, Net Conversion of LLC to Corporation and Impact of Reverse Stock Split (in shares) Conversion of LLC to Corporation and Impact of Reverse Stock Split (in shares) Conversion of units (in shares) Stock Issued During Period, Shares, Conversion of Units Total debt Total Long-Term Debt, Gross And Finance Lease Obligation Long-Term Debt, Gross And Finance Lease Obligation Changes in operating assets and liabilities, net of effects of business combinations: Increase (Decrease) in Operating Capital [Abstract] PEO Total Compensation Amount PEO Total Compensation Amount Underwriting discounts and commissions Payments of Stock Issuance Costs Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Common Stock Common Stock [Member] Measure: Measure [Axis] Stock split conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Line of Credit Line of Credit [Member] Entity Emerging Growth Company Entity Emerging Growth Company Total Members' Equity Members' Equity Onsite clinics Onsite Clinics [Member] Onsite Clinics Entity Central Index Key Entity Central Index Key Consumer health Occupational Health Center, Consumer Health [Member] Occupational Health Center, Consumer Health 6.875 Senior Notes Due 2032 6.875 Senior Notes Due 2032 [Member] 6.875 Senior Notes Due 2032 Accrued and Other Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Components of accrued and other liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Equity Component [Domain] Equity Component [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Increase (Decrease) in Partners' Capital [Roll Forward] Increase (Decrease) in Partners' Capital [Roll Forward] Class B Units Non-Voting Common Class B [Member] Title Trading Arrangement, Individual Title Consolidated Entities [Axis] Consolidated Entities [Axis] Statement [Table] Statement [Table] Concentra Group Holdings Parent Concentra Group Holdings Parent [Member] Interest expense on related party debt Interest Expense, Debt Accounting Policies Significant Accounting Policies [Text Block] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Consolidation Items [Domain] Consolidation Items [Domain] Variable Interest Entities Consolidation, Variable Interest Entity, Policy [Policy Text Block] City Area Code City Area Code Current Liabilities: Liabilities, Current [Abstract] Members' unit, beginning balance (in shares) Members' unit, ending balance (in shares) Common unit, outstanding (in shares) Common Unit, Outstanding Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] (Gain) loss on sale or disposal of assets Gain (Loss) on Disposition of Assets Total Current Assets Assets, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Senior notes Senior Notes [Member] Distribution to Parent Distributions to Parent Distribution Made To Parent Distribution Made To Parent 2028 Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Four Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Four 2027 Long-Term Debt, Maturity, Year Three Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Redemption value adjustment on redeemable non-controlling interests Noncontrolling Interest, Change In Redemption Value, Net Noncontrolling Interest, Change In Redemption Value, Net Subsequent Event Type [Axis] Subsequent Event Type [Axis] Repurchase of common shares Stock Repurchased and Retired During Period, Value Earnings per common share (Note 9): Earnings Per Share [Abstract] Retained earnings Retained Earnings (Accumulated Deficit) Class of Stock [Domain] Class of Stock [Domain] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Payments on related party revolving promissory note Repayments of Long-Term Lines of Credit General and administrative, exclusive of depreciation and amortization General and Administrative Expense 2026 Long-Term Debt, Maturity, Year Two Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Underlying Securities Award Underlying Securities Amount Credit Facility [Axis] Credit Facility [Axis] Amendment Flag Amendment Flag Entity Registrant Name Entity Registrant Name Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Net income attributable to non-controlling interests Net income attributable to non-controlling interests Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest Fair Value as of Grant Date Award Grant Date Fair Value Amortization of right-of-use assets Finance Lease, Right-of-Use Asset, Amortization Subsequent Events [Abstract] Subsequent Events [Abstract] Number of shares issued in initial public offering (in shares) Sale of Stock, Number of Shares Issued in Transaction Long-Term Debt and Notes Payable Debt Disclosure [Text Block] Total occupational health center revenue Occupational Health Center [Member] Occupational Health Center Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Schedule of disaggregation of revenue Disaggregation of Revenue [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Basis of Presentation and Consolidation Consolidation, Policy [Policy Text Block] Distributions to and purchases of non-controlling interests Payments of Ordinary Dividends, Noncontrolling Interest Restatement Determination Date: Restatement Determination Date [Axis] Other debt, including finance leases Notes Payable, Other Payables [Member] Title of 12(b) Security Title of 12(b) Security Common stock, $0.01 par value, 447,081 shares authorized, 104,094 shares issued and outstanding at June 30, 2024 Common Stock, Value, Issued Cash Cash and Cash Equivalents, at Carrying Value Vesting of restricted interests (in shares) Partners' Capital Account, Unit-Based Payment Arrangement, Number of Units Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Redeemable Non-Controlling Interests Noncontrolling Interest Disclosure [Text Block] Depreciation and amortization Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Basic (in dollars per share) Basic EPS (in dollars per share) Earnings Per Share, Basic Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Ownership [Domain] Ownership [Domain] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Net income allocated to common shares - basic Distributed and undistributed income attributable to outstanding shares Net Income (Loss) Available to Common Stockholders, Basic Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Total Current Liabilities Liabilities, Current Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Total Assets Assets Assets Over-Allotment Option Over-Allotment Option [Member] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Thereafter Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal After Year Four Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal After Year Four Other non-current liabilities Other Liabilities, Noncurrent Cost of services, exclusive of depreciation and amortization Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Commitments and contingencies (Note 11) Commitments and Contingencies Termination Date Trading Arrangement Termination Date Related Party Transaction [Table] Related Party Transaction [Table] 2025 Long-Term Debt, Maturity, Year One Entity Address, City or Town Entity Address, City or Town Debt Instrument [Axis] Debt Instrument [Axis] Noncontrolling Interest [Abstract] Noncontrolling Interest [Abstract] Select Medical Corporation Select Medical Corporation [Member] Select Medical Corporation [Member] Net income attributable to the Company Net income attributable to the Company Net Income (Loss) Attributable to Parent Other operating income Other Operating Income (Expense), Net Trading Arrangement: Trading Arrangement [Axis] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Loss Contingencies [Table] Loss Contingencies [Table] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Entity File Number Entity File Number Consolidated Entities [Domain] Consolidated Entities [Domain] Revenue Revenue from Contract with Customer [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Non-controlling Interests Noncontrolling Interest [Member] Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Accrued other Other Accrued Liabilities, Current Name Forgone Recovery, Individual Name Document Period End Date Document Period End Date Sale of Stock [Axis] Sale of Stock [Axis] Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Insider Trading Arrangements [Line Items] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Other current assets Increase (Decrease) in Other Current Assets PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Adjustment to Compensation: Adjustment to Compensation [Axis] Less: Net income attributable to non-controlling interests Net Income (Loss) Attributable to Noncontrolling Interest Document Transition Report Document Transition Report Document Quarterly Report Document Quarterly Report Type and Tier Identifier [Domain] Type and Tier Identifier [Domain] Schedule of redeemable non-controlling interests Redeemable Noncontrolling Interest [Table Text Block] Entity Current Reporting Status Entity Current Reporting Status Retained Earnings Retained Earnings Retained Earnings [Member] Proceeds from initial public offering Proceeds from Issuance Initial Public Offering Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Weighted average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Related Party [Axis] Related and Nonrelated Parties [Axis] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Proceeds from sale of assets Proceeds from Sale of Productive Assets Total Equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Redeemable Non-Controlling Interests Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Executive Category: Executive Category [Axis] Name Awards Close in Time to MNPI Disclosures, Individual Name Less: Distributed and undistributed income attributable to participating shares - diluted EPS Participating shares - diluted Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted Entity Filer Category Entity Filer Category Other Other Businesses [Member] Other Businesses Commitments and Contingencies Loss Contingencies [Line Items] Company Selected Measure Name Company Selected Measure Name EX-101.PRE 9 cghp-20240630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Cover - shares
 6 Months Ended
Jun. 30, 2024
Jul. 31, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2024  
Document Transition Report false  
Entity File Number 001-42188  
Entity Registrant Name CONCENTRA GROUP HOLDINGS PARENT, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 30-1006613  
Entity Address, Address Line One 4714 Gettysburg Road  
Entity Address, Address Line Two P.O. Box 2034  
Entity Address, City or Town Mechanicsburg  
Entity Address, State or Province PA  
Entity Address, Postal Zip Code 17055  
City Area Code 717  
Local Phone Number 972-1100  
Title of 12(b) Security Common Stock, par value $0.01 per share  
Trading Symbol CON  
Security Exchange Name NYSE  
Entity Current Reporting Status No  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   126,593,503
Entity Central Index Key 0002014596  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q2  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current Assets:    
Cash $ 50,669 $ 31,374
Accounts receivable 228,964 216,194
Prepaid income taxes 2,010 7,979
Other current assets 38,663 38,871
Total Current Assets 320,306 294,418
Operating lease right-of-use assets 399,464 397,852
Property and equipment, net 186,879 178,370
Goodwill 1,233,406 1,229,745
Customer relationships 105,459 117,259
Other identifiable intangible assets, net 107,409 107,510
Other assets 10,415 8,406
Total Assets 2,363,338 2,333,560
Current Liabilities:    
Current operating lease liabilities 73,517 72,946
Current portion of long-term debt and notes payable 4,682 1,455
Accrued and other liabilities 158,920 176,466
Total Current Liabilities 265,153 274,634
Non-current operating lease liabilities 359,736 357,310
Long-term debt, net of current portion 3,048 3,291
Non-current deferred tax liability 21,994 23,364
Other non-current liabilities 23,015 27,522
Total Liabilities 1,092,946 1,156,121
Commitments and contingencies (Note 11)
Redeemable non-controlling interests 18,410 16,477
Members’ contributed capital 0 470,303
Common stock, $0.01 par value, 447,081 shares authorized, 104,094 shares issued and outstanding at June 30, 2024 1,041 0
Capital in excess of par 461,520 0
Retained earnings 784,217 685,293
Total Stockholders' Equity 1,246,778  
Total Members' Equity   1,155,596
Non-controlling interests 5,204 5,366
Total Equity 1,251,982 1,160,962
Total Liabilities and Equity 2,363,338 2,333,560
Nonrelated Party    
Current Liabilities:    
Accounts payable and Due to related party 23,674 20,413
Related Party    
Current Liabilities:    
Accounts payable and Due to related party 4,360 3,354
Long-term debt with related party $ 420,000 $ 470,000
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)
shares in Thousands
Jun. 30, 2024
$ / shares
shares
Statement of Financial Position [Abstract]  
Common stock, par value (in dollars per share) | $ / shares $ 0.01
Common stock, shares authorized (in shares) 447,081
Common stock, shares issued (in shares) 104,094
Common stock, shares outstanding (in shares) 104,094
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations (unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenue $ 477,915 $ 467,079 $ 945,513 $ 923,377
Costs and expenses:        
Cost of services, exclusive of depreciation and amortization 339,273 329,836 676,263 657,914
General and administrative, exclusive of depreciation and amortization [1] 36,828 37,003 73,737 71,653
Depreciation and amortization 17,870 18,283 36,355 36,593
Total costs and expenses 393,971 385,122 786,355 766,160
Other operating income 0 151 284 151
Income from operations 83,944 82,108 159,442 157,368
Other income and expense:        
Equity in losses of unconsolidated subsidiaries (3,676) 0 (3,676) (526)
Interest income (expense) 205 17 94 (44)
Income before income taxes 71,155 70,625 136,571 134,222
Income tax expense 18,096 16,593 33,233 32,759
Net income 53,059 54,032 103,338 101,463
Less: Net income attributable to non-controlling interests 1,322 1,290 2,645 2,457
Net income attributable to the Company $ 51,737 $ 52,742 $ 100,693 $ 99,006
Earnings per common share (Note 9):        
Basic (in dollars per share) $ 0.50 $ 0.51 $ 0.97 $ 0.95
Diluted (in dollars per share) $ 0.50 $ 0.51 $ 0.97 $ 0.95
Related Party        
Other income and expense:        
Interest expense on related party debt $ (9,318) $ (11,500) $ (19,289) $ (22,576)
[1] Includes the shared service fee from related party of $3.8 million and $3.7 million for the three months ended June 30, 2024 and 2023, respectively, and $7.7 million and $7.3 million for the six months ended June 30, 2024 and 2023, respectively. See Note 10, Related Party Transactions, for additional information.
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations (unaudited) (Parenthetical) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Related Party        
Shared service fee from related party $ 3.8 $ 3.7 $ 7.7 $ 7.3
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Changes in Stockholders’/Members’ Equity (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Class A Units Voting
Class B Units Non-Voting
Class C Units Non-Voting
Member Units
Members’ Contributed Capital
Total Stockholders’ Equity
Common Stock
Capital in excess of par
Retained Earnings
Non-controlling Interests
Members' unit, beginning balance (in shares) at Dec. 31, 2022   435,000 8,498 2,770              
Members' unit, beginning balance at Dec. 31, 2022 $ 979,343       $ 973,317 $ 464,725       $ 508,592 $ 6,026
Increase (Decrease) in Partners' Capital [Roll Forward]                      
Net income attributable to the Company 46,264       46,264         46,264  
Net income attributable to non-controlling interests 253       0           253
Contribution from Parent 2,797       2,797 2,797          
Vesting of restricted interests (in shares)       248              
Vesting of restricted interests 178       178 178          
Distributions to and purchases of non-controlling interests (221)       0           (221)
Redemption value adjustment on non-controlling interests (435)       (435)         (435)  
Members' unit, ending balance (in shares) at Mar. 31, 2023   435,000 8,498 3,018              
Members' unit, ending balance at Mar. 31, 2023 1,028,179       1,022,121 467,700       554,421 6,058
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income attributable to the Company 46,264       46,264         46,264  
Net income attributable to non-controlling interests 253       0           253
Distributions to and purchases of non-controlling interests (221)       0           (221)
Redemption value adjustment on non-controlling interests (435)       (435)         (435)  
Members' unit, beginning balance (in shares) at Dec. 31, 2022   435,000 8,498 2,770              
Members' unit, beginning balance at Dec. 31, 2022 979,343       973,317 464,725       508,592 6,026
Increase (Decrease) in Partners' Capital [Roll Forward]                      
Net income attributable to the Company 99,006                    
Members' unit, ending balance (in shares) at Jun. 30, 2023   435,000 8,498 3,018              
Members' unit, ending balance at Jun. 30, 2023 1,077,220       1,071,703 464,543       607,160 5,517
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income attributable to the Company 99,006                    
Members' unit, beginning balance (in shares) at Mar. 31, 2023   435,000 8,498 3,018              
Members' unit, beginning balance at Mar. 31, 2023 1,028,179       1,022,121 467,700       554,421 6,058
Increase (Decrease) in Partners' Capital [Roll Forward]                      
Net income attributable to the Company 52,742       52,742         52,742  
Net income attributable to non-controlling interests 297       0           297
Distribution to Parent (3,352)       (3,352) (3,352)          
Repurchase of common shares (300)       195 195         (495)
Distributions to and purchases of non-controlling interests (343)       0           (343)
Redemption value adjustment on non-controlling interests (3)       (3)         (3)  
Members' unit, ending balance (in shares) at Jun. 30, 2023   435,000 8,498 3,018              
Members' unit, ending balance at Jun. 30, 2023 1,077,220       1,071,703 464,543       607,160 5,517
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income attributable to the Company 52,742       52,742         52,742  
Net income attributable to non-controlling interests 297       0           297
Distributions to Parent (3,352)       (3,352) (3,352)          
Distributions to and purchases of non-controlling interests (343)       0           (343)
Redemption value adjustment on non-controlling interests (3)       $ (3)         (3)  
Members' unit, beginning balance (in shares) at Dec. 31, 2023   435,000 8,498 3,583 447,081            
Members' unit, beginning balance at Dec. 31, 2023 470,303         470,303          
Increase (Decrease) in Partners' Capital [Roll Forward]                      
Net income attributable to the Company 48,956           $ 48,956     48,956  
Net income attributable to non-controlling interests 270           0       270
Distribution to Parent (6,891)         (6,891) (6,891)        
Distributions to and purchases of non-controlling interests (369)           0       (369)
Conversion of LLC to Corporation and Impact of Reverse Stock Split (in shares)         (447,081)     104,094      
Conversion of LLC to Corporation and Impact of Reverse Stock Split 0         (463,412) 0 $ 1,041 $ 462,371    
Redemption value adjustment on non-controlling interests (1,901)           (1,901)     (1,901)  
Members' unit, ending balance (in shares) at Mar. 31, 2024         0            
Members' unit, ending balance at Mar. 31, 2024           0          
Beginning balance (in shares) at Dec. 31, 2023               0      
Beginning balance at Dec. 31, 2023 1,160,962           1,155,596 $ 0 0 685,293 5,366
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income attributable to the Company 48,956           48,956     48,956  
Net income attributable to non-controlling interests 270           0       270
Distributions to Parent (6,891)         (6,891) (6,891)        
Distributions to and purchases of non-controlling interests (369)           0       (369)
Redemption value adjustment on non-controlling interests (1,901)           (1,901)     (1,901)  
Conversion of LLC to Corporation and Impact of Reverse Stock Split (in shares)         (447,081)     104,094      
Conversion of LLC to Corporation and Impact of Reverse Stock Split 0         (463,412) 0 $ 1,041 462,371    
Ending balance (in shares) at Mar. 31, 2024               104,094      
Ending balance at Mar. 31, 2024 1,201,027           1,195,760 $ 1,041 462,371 732,348 5,267
Members' unit, beginning balance (in shares) at Dec. 31, 2023   435,000 8,498 3,583 447,081            
Members' unit, beginning balance at Dec. 31, 2023 470,303         470,303          
Increase (Decrease) in Partners' Capital [Roll Forward]                      
Net income attributable to the Company 100,693                    
Members' unit, ending balance (in shares) at Jun. 30, 2024         0            
Members' unit, ending balance at Jun. 30, 2024 0         0          
Beginning balance (in shares) at Dec. 31, 2023               0      
Beginning balance at Dec. 31, 2023 1,160,962           1,155,596 $ 0 0 685,293 5,366
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income attributable to the Company $ 100,693                    
Ending balance (in shares) at Jun. 30, 2024 104,094             104,094      
Ending balance at Jun. 30, 2024 $ 1,251,982           1,246,778 $ 1,041 461,520 784,217 5,204
Members' unit, beginning balance (in shares) at Mar. 31, 2024         0            
Members' unit, beginning balance at Mar. 31, 2024           0          
Increase (Decrease) in Partners' Capital [Roll Forward]                      
Net income attributable to the Company 51,737           51,737     51,737  
Net income attributable to non-controlling interests 244           0       244
Distribution to Parent (851)           (851)   (851)    
Distributions to and purchases of non-controlling interests (307)           0       (307)
Redemption value adjustment on non-controlling interests 132           132     132  
Members' unit, ending balance (in shares) at Jun. 30, 2024         0            
Members' unit, ending balance at Jun. 30, 2024 0         $ 0          
Beginning balance (in shares) at Mar. 31, 2024               104,094      
Beginning balance at Mar. 31, 2024 1,201,027           1,195,760 $ 1,041 462,371 732,348 5,267
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income attributable to the Company 51,737           51,737     51,737  
Net income attributable to non-controlling interests 244           0       244
Distributions to Parent (851)           (851)   (851)    
Distributions to and purchases of non-controlling interests (307)           0       (307)
Redemption value adjustment on non-controlling interests $ 132           132     132  
Ending balance (in shares) at Jun. 30, 2024 104,094             104,094      
Ending balance at Jun. 30, 2024 $ 1,251,982           $ 1,246,778 $ 1,041 $ 461,520 $ 784,217 $ 5,204
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities    
Net income $ 103,338 $ 101,463
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 36,355 36,593
Provision for expected credit losses 59 185
Equity in losses of unconsolidated subsidiaries 3,676 526
(Gain) loss on sale or disposal of assets 42 (14)
Stock compensation expense 332 178
Deferred income taxes (1,618) (3,265)
Changes in operating assets and liabilities, net of effects of business combinations:    
Accounts receivable (12,829) (27,011)
Other current assets 1,224 (9,944)
Other assets (4,217) 1,796
Accounts payable and accrued liabilities (11,307) (966)
Net cash provided by operating activities 115,055 99,541
Investing activities    
Business combinations, net of cash acquired (5,144) (1,446)
Purchase of customer relationships 0 (4,382)
Purchases of property and equipment (32,494) (25,864)
Proceeds from sale of assets 23 20
Net cash used in investing activities (37,615) (31,672)
Financing activities    
Borrowings from related party revolving promissory note 10,000 0
Payments on related party revolving promissory note (60,000) (70,000)
Borrowings of other debt 6,618 5,471
Principal payments on other debt (4,378) (4,074)
Distributions to and purchases of non-controlling interests (2,643) (3,130)
Distributions to Parent (7,742) (555)
Net cash used in financing activities (58,145) (72,288)
Net increase (decrease) in cash 19,295 (4,419)
Cash at beginning of period 31,374 37,657
Cash at end of period 50,669 33,238
Supplemental information    
Cash paid for interest 19,512 22,784
Cash paid for taxes $ 34,009 $ 32,445
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Organization
 6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization Organization
Concentra Group Holdings Parent, LLC (“Concentra Group Holdings Parent”) was formed in October 2017 and converted to a Delaware corporation, Concentra Group Holdings Parent, Inc., on March 4, 2024. At the time of formation, Concentra Group Holdings Parent elected to be taxed as a corporation. The Company conducts substantially all of its business through Concentra Inc. and its subsidiaries. Concentra Group Holdings Parent and its subsidiaries are collectively referred to as the “Company.”
The Company is the largest provider of occupational health services in the United States based on number of facilities. As of June 30, 2024, the Company operated 547 occupational health centers and 154 onsite clinics at employer worksites in 42 states. The Company provides a diverse and comprehensive array of occupational health services, including workers’ compensation and employers services, and consumer health services.
The Company currently operates as an operating segment of Select Medical Corporation (“Select” or the “Parent”). As of June 30, 2024, Select Medical Corporation (“Select” or the “Parent”) owns 100.0% of the outstanding common shares of the Company on a fully diluted basis.
On January 3, 2024, Select announced its intention to separate the Company into a new, publicly traded company through a spin-off distribution in 2024. On February 27, 2024, Select received a private letter ruling from the U.S. Internal Revenue Service to the effect that the distribution of Concentra’s common stock to Select and its stockholders will be tax-free for U.S. federal income tax purposes. On March 4, 2024, the member interests of the Company converted to common shares on a one-for-one basis. On June 24, 2024, the Company’s Board of Directors approved a reverse stock split at a ratio of one share of common stock for every 4.295 shares of common stock, which was effectuated on June 25, 2024. In accordance with ASC 260, Earnings Per Share, the recapitalization of the Company into a stock corporation and the reverse stock split have been retrospectively reflected in the Company’s earnings per unit calculation for all periods presented, see Note 9, Earning per Share.
On July 26, 2024, Concentra completed an initial public offering (“IPO”) of 22,500,000 shares of its common stock, par value $0.01 per share, at an initial public offering price of $23.50 per share for the net proceeds of $499.7 million after deducting underwriting discounts and commission of $29.1 million. See Note 12, Subsequent Events for additional information on the IPO and the related debt transactions.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Accounting Policies
 6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Accounting Policies Accounting Policies
Basis of Presentation and Consolidation
The Company has historically operated as part of Select. The unaudited condensed consolidated financial statements of the Company have been prepared from Select’s historical accounting records and are derived from the condensed consolidated financial statements of Select to present Concentra as if it had been operating on a standalone basis. The unaudited condensed consolidated financial statements of the Company as of June 30, 2024, and for the three and six month periods ended June 30, 2024 and 2023, have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim reporting and the accounting principles generally accepted in the United States of America (“U.S. GAAP”). Accordingly, certain information and disclosures required by GAAP, which are normally included in the notes to the consolidated financial statements, have been condensed or omitted pursuant to those rules and regulations, although the Company believes the disclosure is adequate to make the information presented not misleading. In the opinion of management, such information contains all adjustments, which are normal and recurring in nature, necessary for a fair statement of the financial position, results of operations and cash flow for such periods.

The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the full fiscal year ended December 31, 2024. These unaudited condensed consolidated financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes as contained in the Company’s registration statement on Form S-1, as amended (File No. 333-280242) (the “Registration Statement”).

The condensed consolidated financial statements include the assets, liabilities, revenue, and expenses based on our legal entity structure as well as direct and indirect costs that are attributable to our operations. Indirect costs are the costs of support functions that are partially provided on a centralized basis by Select and its affiliates, which include finance, human resources, benefits administration, procurement support, information technology, legal, corporate governance and other professional
services. Indirect costs have been allocated to us for the purposes of preparing the condensed consolidated financial statements based on a specific identification basis or, when specific identification is not practicable, a proportional cost allocation method, primarily based on headcount or other allocation methodologies that are considered to be a reasonable reflection of the utilization of services provided or the benefit received by us during the periods presented, depending on the nature of the services received.

The income tax amounts in these condensed consolidated financial statements have been calculated based on a separate return methodology and are presented as if our income gave rise to separate federal and state consolidated income tax return filing obligations in the respective jurisdictions in which we operate. Adjustments to income tax expense resulting from the application of the separate return methodology, as compared to tax obligations determined by the Company’s inclusion in the Parent’s consolidated income tax provision, were assumed to be immediately settled with the Parent through Contributed Capital/Capital in Excess of Par as reflected on the Condensed Consolidated Balance Sheets, and reflected as a (Distribution)/Contribution to Parent on the Condensed Consolidated Statements of Changes in Stockholders’/Members’ Equity and the Condensed Consolidated Statements of Cash Flows within financing activities.
The condensed consolidated financial statements include the accounts of Concentra and the subsidiaries and variable interest entities in which Concentra has a controlling financial interest. All intercompany balances and transactions within the Company are eliminated in consolidation. Transactions between the Company and Select have been included in these consolidated financial statements. The transfers with Select are expected to be settled in cash, other than the assumed income tax settlement noted above, and are reflected within the consolidated statement of cash flows as an operating or financing activity determined by the nature of the transaction. Select’s third-party debt and related interest expense have not been attributed to the Company because the Company is not the primary legal obligor of the debt and the borrowings are not specifically identifiable to the Company. However, the Company was a guarantor for Select’s senior notes and credit facilities until the guarantee was released at the closing of the IPO. The Company maintains its own cash management system and does not participate in a centralized cash management arrangement with Select.
Recent Accounting Guidance Not Yet Adopted
Segment Reporting
In November 2023, FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which is intended to improve disclosure of segment information so that investors can better understand an entity’s overall performance. The ASU requires entities to quantitatively disclose significant segment expenses that are regularly provided to the chief operating decision maker for each reportable segment, as well as the amount of other segment items for each reportable segment and a description of what the other segment items are comprised. Disclosure of multiple measures of profit or loss will be permitted by the ASU.
The ASU is effective for annual reporting periods beginning on or after December 15, 2023, and interim periods with fiscal years beginning after December 15, 2024; however, early adoption is permitted. The ASU is required to be applied retrospectively to all periods presented in the financial statements. The Company is currently reviewing the impact that ASU 2023-07 will have on the disclosures in our consolidated financial statements.
Income Taxes
In December 2023, FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which is intended to improve the transparency and decision usefulness of income tax disclosures. The ASU includes enhanced requirements on the rate reconciliation, including specific categories that must be disclosed, and provides a threshold over which reconciling items must be disclosed. The amendments in the update also require annual disclosure of income taxes paid, disaggregated by federal, state, and foreign taxes, as well as any individual jurisdictions in which income taxes paid is greater than 5% of total income taxes paid.
The ASU is effective for annual periods beginning after December 15, 2024; however early adoption is permitted. The ASU can be applied either prospectively or retrospectively. The Company is currently reviewing the impact that ASU 2023-09 will have on the disclosures in our consolidated financial statements.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Actual results could differ from those estimates.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Redeemable Non-Controlling Interests
 6 Months Ended
Jun. 30, 2024
Noncontrolling Interest [Abstract]  
Redeemable Non-Controlling Interests Redeemable Non-Controlling Interests
The Company’s redeemable non-controlling interests are comprised of membership interests held by equity holders other than the Company in five less than wholly-owned subsidiaries. These interests are subject to redemption rights. The changes in redeemable non-controlling interests are as follows:
20242023
(in thousands)
Balance as of January 1$16,477 $16,772 
Net income attributable to redeemable non-controlling interests1,053 914 
Distributions to and purchases of redeemable non-controlling interests(1,174)(1,656)
Redemption value adjustment on redeemable non-controlling interests1,901 436 
Balance as of March 31$18,257 $16,466 
Net income attributable to redeemable non-controlling interests1,078 993 
Distributions to and purchases of redeemable non-controlling interests(793)(610)
Redemption value adjustment on redeemable non-controlling interests(132)3 
Balance as of June 30$18,410 $16,852 
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Variable Interest Entities
 6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Variable Interest Entities Variable Interest Entities
Certain states prohibit the “corporate practice of medicine,” which restricts the Company from owning medical practices that directly employ physicians and from exercising control over medical decisions by physicians. In these states, the Company enters into long-term management agreements with affiliated professional medical groups (referred to as “Managed PCs”) that are owned by licensed physicians which, in turn, employ or contract with physicians who provide professional medical services in its occupational health centers. The Company also enters into a stock transfer restriction agreement with the respective equity holders, which provide for the Company to direct the transfer of ownership of the Managed PCs to other licensed physicians at any time. The long-term management agreements provide for various administrative and management services to be provided by the Company to the Managed PCs, including, but not limited to, billing and collections, accounting, non-physician personnel, supplies, security and maintenance, and insurance. The Company has the right to receive income as an ongoing management fee, and effectively absorbs all of the residual interests of the Managed PCs. Based on the provisions of the management and stock transfer agreements, the Managed PCs are variable interest entities for which the Company is the primary beneficiary and consolidates the Managed PCs under the VIE model. There are no restrictions on the use of the assets of the Managed PCs or on the settlement of its liabilities. Additionally, the Company fully indemnifies the licensed physician owners from all claims, demands, costs, damages, losses, liabilities, and other amounts arising from the ownership and operation of the medical practices, excluding gross negligence.
As of June 30, 2024, and December 31, 2023, the total assets of the Company’s variable interest entities were $224.8 million and $212.3 million, respectively, and are principally comprised of accounts receivable. As of June 30, 2024, and December 31, 2023, the total liabilities of the Company’s variable interest entities were $53.7 million and $56.4 million, respectively, and are principally comprised of accounts payable and accrued expenses. These variable interest entities have obligations payable for services received under their management agreements with the Company of $171.7 million and $156.2 million as of June 30, 2024, and December 31, 2023, respectively. These intercompany balances are eliminated in consolidation.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Leases
 6 Months Ended
Jun. 30, 2024
Leases [Abstract]  
Leases Leases
The Company’s total lease cost is as follows:
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
(in thousands)
Operating lease cost
$25,077 $24,296 $49,867 $48,424 
Finance lease cost:
Amortization of right-of-use assets
109 261 320 512 
Interest on lease liabilities
77 100 132 203 
Variable lease cost5,293 4,920 10,549 10,034 
Total lease cost$30,556 $29,577 $60,868 $59,173 
Leases Leases
The Company’s total lease cost is as follows:
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
(in thousands)
Operating lease cost
$25,077 $24,296 $49,867 $48,424 
Finance lease cost:
Amortization of right-of-use assets
109 261 320 512 
Interest on lease liabilities
77 100 132 203 
Variable lease cost5,293 4,920 10,549 10,034 
Total lease cost$30,556 $29,577 $60,868 $59,173 
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Long-Term Debt and Notes Payable
 6 Months Ended
Jun. 30, 2024
Debt Disclosure [Abstract]  
Long-Term Debt and Notes Payable Long-Term Debt and Notes Payable
The carrying values of the Company’s long-term debt are as follows:
 June 30, 2024December 31, 2023
(in thousands)
Long-term revolving promissory note with related party$420,000 $470,000 
Other debt (1)
7,730 4,746 
Total debt$427,730 $474,746 
_______________________________________________________________________________
(1)        Other debt is primarily comprised of insurance financing arrangements, promissory notes executed in connection with business combinations, and finance leases.
As of June 30, 2024, principal maturities of the Company’s long-term debt were as follows:
 20242025202620272028ThereafterTotal
(in thousands)
Revolving promissory note with related party$— $— $— $— $— $420,000 $420,000 
Other debt, including finance leases3,819 1,024 351 397 447 1,692 7,730 
Total debt$3,819 $1,024 $351 $397 $447 $421,692 $427,730 
See Note 12, Subsequent Events, for a description of the debt financing transactions which occurred in connection with the IPO on July 26, 2024.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Accrued and Other Liabilities
 6 Months Ended
Jun. 30, 2024
Payables and Accruals [Abstract]  
Accrued and Other Liabilities Accrued and Other Liabilities
The following table sets forth the components of accrued and other liabilities:
June 30, 2024December 31, 2023
(in thousands)
Accrued payroll$57,439 $62,824 
Accrued vacation42,983 41,488 
Accrued other55,484 71,755 
Income taxes payable3,014 399 
Accrued and other liabilities$158,920 $176,466 
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue
 6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
The following table disaggregates the Company’s revenue for the three and six months ended June 30, 2024 and 2023:
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
(in thousands)
Occupational health centers:
Workers’ compensation$288,405 $278,554 $568,271 $546,894 
Employer services153,305 153,164 304,040 305,337 
Consumer health7,669 7,802 15,995 15,987 
Other occupational health center revenue1,861 2,254 4,006 4,672 
Total occupational health center revenue451,240 441,774 892,312 872,890 
Onsite clinics15,539 14,705 31,396 29,250 
Other11,136 10,600 21,805 21,237 
Total revenue$477,915 $467,079 $945,513 $923,377 
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Earnings per Share
 6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Earnings per Share Earnings per Share
At December 31, 2023, there were 435,000 Class A units, 8,498 Class B units, and 3,583 Class C units (in thousands) outstanding which converted to common shares on a one-for-one basis effective March 4, 2024. On June 25, 2024, the Company effectuated a reverse stock split at a ratio of one share of common stock for every 4.295 shares of common stock and resulted in 104,094 shares (in thousands) outstanding. There were no participating shares or securities outstanding during the three and six months ended June 30, 2024.
The following table sets forth the computation of earnings per share (EPS) in 2024:
Three Months Ended June 30, 2024Six Months Ended June 30, 2024
Net Income Attributable to the Company
Shares(1)
Basic and Diluted EPSNet Income Attributable to the Company
Shares(1)
Basic and Diluted EPS
(in thousands, except for per share amounts)
Common shares$51,737 104,094 $0.50 $100,693 104,094 $0.97 
At June 30, 2023, Concentra’s capital structure included Class A, B and C units outstanding and unvested restricted interests and outstanding options. To calculate EPS for the three and six months ended June 30, 2023, Concentra applied the two-class method because its unvested restricted interests and outstanding options were participating securities.
The following table sets forth the net income attributable to the Company, its units outstanding, and its participating units outstanding:
Three Months Ended
June 30, 2023		Six Months Ended
June 30, 2023
(in thousands)
Net income$54,032 $101,463 
Less: net income attributable to non-controlling interests1,290 2,457 
Net income attributable to the Company52,742 99,006 
Less: Distributed and undistributed income attributable to participating shares148 287 
Distributed and undistributed income attributable to outstanding shares$52,594 $98,719 
The following table sets forth the computation of EPS in 2023, under the two-class method:
Three Months Ended June 30, 2023Six Months Ended June 30, 2023
Net Income Allocation
Shares(1)(2)
Basic and Diluted EPSNet Income Allocation
Shares(1)(2)
Basic and Diluted EPS
(in thousands, except for per share amounts)
Outstanding Class A, Class B, and Class C shares$52,594 103,962 $0.51 $98,719 103,952 $0.95 
Participating shares148 292 $0.51 287 302 $0.95 
Total Company$52,742 $99,006 
_______________________________________________________________________________
(1)    The recapitalization of the members units into common shares has been treated as such for earnings per share purposes and has been reflected retrospectively for all periods, along with the one for 4.295 reverse stock split, as described in Note 1, Organization.
(2)    Represents the weighted average units outstanding during the period.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Related Party Transactions
 6 Months Ended
Jun. 30, 2024
Related Party Transactions [Abstract]  
Related Party Transactions Related Party Transactions
Shared Services Agreement - cost allocations from Select
The Company pays Select a fee for the shared support functions provided on a centralized basis by Select and its affiliates. The shared services fee is reassessed and adjusted annually. For the three months ended June 30, 2024 and 2023, the shared service fees were $3.8 million and $3.7 million, respectively. For the six months ended June 30, 2024 and 2023, the shared service fees were $7.7 million and $7.3 million, respectively. These cost allocations reasonably reflect the services and the benefits derived for the periods presented. These allocations may not be indicative of the actual expenses that would have been incurred as a stand-alone entity.
In connection with the IPO, and described in the Registration Statement, Select and Concentra entered into a separation agreement, a transition services agreement, a tax matters agreement, and an employee matters agreement on July 26, 2024, which effects the separation of the Company’s business from Select and provides a framework for the Company’s relationship with Select after the separation.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Commitments and Contingencies
 6 Months Ended
Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Litigation
The Company is a party to various legal actions, proceedings, and claims, and regulatory and other governmental audits and investigations in the ordinary course of its business, including, but not limited to, legal actions and claims alleging professional malpractice, general liability for property damage, personal and bodily injury, violations of federal and state employment laws, often in the form of wage and hour class action lawsuits, and liability for data breaches. Many of these actions involve large claims and significant defense costs and sometimes, as in the case of wage and hour class actions, are not covered by insurance. The Company cannot predict the ultimate outcome of pending litigation, proceedings, and regulatory and other governmental audits and investigations. These matters could potentially subject the Company to sanctions, damages, recoupments, fines, and other penalties.
To address claims arising out of the Company’s operations, the Company maintains professional malpractice liability insurance and general liability insurance coverages through a number of different programs that are dependent upon such factors as the state where the Company is operating. The Company currently maintains insurance coverages under a combination of policies with a total annual aggregate limit of up to $29.0 million for professional malpractice liability insurance and $29.0 million for general liability insurance. The Company’s insurance for the professional liability coverage is written on a “claims-made” basis, and its commercial general liability coverage is maintained on an “occurrence” basis. These coverages apply after a self-insured retention limit is exceeded. Each of these programs has either a deductible or self-insured retention limit. The Company also maintains additional types of liability insurance covering claims which, due to their nature or amount, are not covered by or not fully covered by the applicable professional malpractice and general liability insurance policies, including workers compensation, property and casualty, directors and officers, cyber liability, and employment practices liability insurance coverages. Our insurance policies generally are silent with respect to punitive damages so coverage is available to the extent insurable under the law of any applicable jurisdiction, and are subject to various deductibles and policy limits. The Company reviews its insurance program annually and may make adjustments to the amount of insurance coverage and self-insured retentions in future years. Significant legal actions, as well as the cost and possible lack of available insurance, could subject the Company to substantial uninsured liabilities.
Physical Therapy Billing. On October 7, 2021, Select received a letter from a Trial Attorney at the U.S. Department of Justice, Civil Division, Commercial Litigation Branch, Fraud Section (“DOJ”) stating that the DOJ, in conjunction with the U.S. Department of Health and Human Services (“HHS”), is investigating Select in connection with potential violations of the False Claims Act, 31 U.S.C. § 3729, et seq. The letter specified that the investigation relates to Select’s billing for physical therapy services, and indicated that the DOJ would be requesting certain records from Select. In October and December 2021, the DOJ requested, and Select furnished, records relating to six of Select’s outpatient therapy clinics in Florida. In 2022 and 2023, the DOJ requested certain data relating to all of Select’s outpatient therapy clinics nationwide, and sought information about the Company’s ability to produce additional data relating to the physical therapy services furnished by Select’s outpatient therapy clinics and the Company. The Company has produced data and other documents requested by the DOJ and is fully cooperating on this investigation. In May 2024, by order of the U.S. District Court for the Middle District of Florida, a qui tam lawsuit that is related to the DOJ’s investigation was unsealed after the U.S. filed a notice declining to intervene in the case, but stating that its investigation is continuing and reserving its right to intervene at a later date. The lawsuit, filed in May 2021 and amended in October 2021 and July 2024, was brought by Kathleen Kane, a physical therapist formerly employed in Select’s outpatient division, against Select Medical Corporation, Select Physical Therapy Holdings, Inc. and Select Employment Services, Inc. The amended complaint alleges that the defendants billed federally funded health programs for one-on-one therapy services when group therapy was performed or overbilled for one-on-one therapy services, and billed for
unreimbursable unskilled physical therapy services. At this time, the Company is unable to predict the timing and outcome of this matter.
California Department of Insurance Investigation. On February 5, 2024, the Company received a subpoena from the California Department of Insurance relating to an investigation under the California Insurance Frauds Prevention Act, Cal. Ins. Code § 1871.7 et seq., which allows a whistleblower to file a false claims lawsuit based on the submission of false or fraudulent claims to insurance companies. The subpoena seeks documentation relating mainly to the Company’s billing and coding for physical therapy claims submitted to commercial insurers and workers compensation carriers located or doing business in California. The Company has produced data and other documents requested by the California Department of Insurance and intends to fully cooperate on this investigation. At this time, the Company is unable to predict the timing and outcome of this matter.
Perry Johnson & Associates, Inc. Data Breach. On November 10, 2023, Perry Johnson & Associates, Inc., a third-party vendor of health information technology solutions that provides medical transcription services (“PJ&A”), notified Concentra Health Services, Inc. (“Concentra”) that certain information related to particular Concentra patients was potentially affected by a cybersecurity event. In February 2024, Concentra sent notices to almost four million patients who may have been impacted by the data breach. During the first quarter of 2024, Concentra became aware of six putative class action lawsuits filed against PJ&A and Concentra related to the data breach. The first was filed in the U.S. District Court for the Eastern District of Michigan on February 19, 2024 by Elliot Curry, individually and on behalf of all others similarly situated. Plaintiff alleged, among other things, that he became the victim of identity theft as a result of the PJ&A data breach and that Concentra had lax data security policies. The second was filed in the U.S. District Court for the Eastern District of New York on February 21, 2024 by Tiffany Williams and Jo Joaquim, individually and on behalf of all others similarly situated. Plaintiffs alleged, among other things, that they face an immediate and heightened risk of identity theft as a result of the data breach and that the defendants failed to take measures to properly safeguard their private information. The third was filed in the U.S. District Court for the Eastern District of Missouri on February 26, 2024 by Stephen Tate, a.k.a. Steven Tate, individually and on behalf of all others similarly situated. Plaintiff alleged, among other things, that he faces a heightened and imminent risk of identity theft as a result of the data breach and that the defendants failed to take measures to properly safeguard his private information. The fourth was filed in the U.S. District Court for the Eastern District of Michigan on February 26, 2024 by Eric Franczak, individually and on behalf of all others similarly situated. Plaintiff alleged, among other things, that he faces a substantially increased risk of fraud and identity theft as a result of the data breach and that the defendants failed to take measures to properly safeguard his private information. The fifth was filed in the U.S. District Court for the Eastern District of Michigan on March 6, 2024 by Lazema Johnson, individually and on behalf of all others similarly situated. Plaintiff alleged, among other things, that she faces a substantially increased risk of fraud and identity theft as a result of the data breach and that the defendants failed to take measures to properly safeguard her private information. The sixth was filed in the Superior Court of California, County of Los Angeles, on April 8, 2024 by Robert Valencia, individually and on behalf of all others similarly situated. Plaintiff alleged, among other things, that he faces a substantially increased risk of fraud and identity theft as a result of the data breach and that the defendants failed to take measures to properly safeguard his private information. Concentra is working with its cybersecurity risk insurance policy carrier and does not believe that the data breach or the lawsuits will have a material impact on its operations or financial performance. However, at this time, Concentra is unable to predict the timing and outcome of these matters.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Subsequent Events
 6 Months Ended
Jun. 30, 2024
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
On July 26, 2024, the Company completed an IPO of 22,500,000 shares of its common stock, par value $0.01 per share, at an initial public offering price of $23.50 per share for the net proceeds of $499.7 million after deducting underwriting discounts and commission of $29.1 million. In addition, the underwriters exercised the option to purchase an additional 750,000 shares of the Company’s common stock for net proceeds of $16.7 million after deducting underwriting discounts and commission of $1.0 million. The Company’s shares began trading on the New York Stock Exchange under the symbol “CON” on July 25, 2024. In connection with the IPO, Concentra Health Services, Inc. (“CHSI”), a wholly-owned subsidiary of the Company, entered into certain financing arrangements which include senior secured credit facilities of $1,250.0 million (the “Credit Facilities”) and a private offering of $650.0 million aggregate principal amount of 6.875% Senior Notes due 2032 (the “Notes”). The Notes are unconditionally guaranteed, jointly and severally, on a senior unsecured basis by Concentra and certain of its wholly-owned subsidiaries. The Credit Facilities consist of an $850.0 million Term Loan and a $400.0 million Revolving Credit Facility. The Revolving Credit Facility was undrawn at the closing of the IPO. The Term Loan matures on July 26, 2031, and has an interest rate of Term SOFR plus 2.25%, subject to a leverage-based pricing grid. The Revolving Credit Facility matures on July 26, 2029, and has an interest rate of Term SOFR plus 2.50%, subject to a leverage-based pricing grid.
The net proceeds of the IPO and the debt financing transactions, except for $34.7 million, were paid to Select through the issuance of a dividend, the repayment of the $420.0 million revolving promissory note outstanding, and the repayment of a new promissory note issued subsequent to June 30, 2024 in contemplation of the IPO.
After the closing of the IPO, and the exercise of the underwriters’ option to purchase additional shares, Select owns 81.74% of the total outstanding shares of the Company’s common stock. Select intends to make a distribution, which is intended to be tax-free for U.S. federal income tax purposes, to its stockholders of all of its remaining equity interest in the Company within twelve months of the IPO.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Pay vs Performance Disclosure            
Net income attributable to the Company $ 51,737 $ 48,956 $ 52,742 $ 46,264 $ 100,693 $ 99,006
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Accounting Policies (Policies)
 6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Basis of Presentation and Consolidation
Basis of Presentation and Consolidation
The Company has historically operated as part of Select. The unaudited condensed consolidated financial statements of the Company have been prepared from Select’s historical accounting records and are derived from the condensed consolidated financial statements of Select to present Concentra as if it had been operating on a standalone basis. The unaudited condensed consolidated financial statements of the Company as of June 30, 2024, and for the three and six month periods ended June 30, 2024 and 2023, have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim reporting and the accounting principles generally accepted in the United States of America (“U.S. GAAP”). Accordingly, certain information and disclosures required by GAAP, which are normally included in the notes to the consolidated financial statements, have been condensed or omitted pursuant to those rules and regulations, although the Company believes the disclosure is adequate to make the information presented not misleading. In the opinion of management, such information contains all adjustments, which are normal and recurring in nature, necessary for a fair statement of the financial position, results of operations and cash flow for such periods.

The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the full fiscal year ended December 31, 2024. These unaudited condensed consolidated financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes as contained in the Company’s registration statement on Form S-1, as amended (File No. 333-280242) (the “Registration Statement”).

The condensed consolidated financial statements include the assets, liabilities, revenue, and expenses based on our legal entity structure as well as direct and indirect costs that are attributable to our operations. Indirect costs are the costs of support functions that are partially provided on a centralized basis by Select and its affiliates, which include finance, human resources, benefits administration, procurement support, information technology, legal, corporate governance and other professional
services. Indirect costs have been allocated to us for the purposes of preparing the condensed consolidated financial statements based on a specific identification basis or, when specific identification is not practicable, a proportional cost allocation method, primarily based on headcount or other allocation methodologies that are considered to be a reasonable reflection of the utilization of services provided or the benefit received by us during the periods presented, depending on the nature of the services received.

The income tax amounts in these condensed consolidated financial statements have been calculated based on a separate return methodology and are presented as if our income gave rise to separate federal and state consolidated income tax return filing obligations in the respective jurisdictions in which we operate. Adjustments to income tax expense resulting from the application of the separate return methodology, as compared to tax obligations determined by the Company’s inclusion in the Parent’s consolidated income tax provision, were assumed to be immediately settled with the Parent through Contributed Capital/Capital in Excess of Par as reflected on the Condensed Consolidated Balance Sheets, and reflected as a (Distribution)/Contribution to Parent on the Condensed Consolidated Statements of Changes in Stockholders’/Members’ Equity and the Condensed Consolidated Statements of Cash Flows within financing activities.
The condensed consolidated financial statements include the accounts of Concentra and the subsidiaries and variable interest entities in which Concentra has a controlling financial interest. All intercompany balances and transactions within the Company are eliminated in consolidation. Transactions between the Company and Select have been included in these consolidated financial statements. The transfers with Select are expected to be settled in cash, other than the assumed income tax settlement noted above, and are reflected within the consolidated statement of cash flows as an operating or financing activity determined by the nature of the transaction. Select’s third-party debt and related interest expense have not been attributed to the Company because the Company is not the primary legal obligor of the debt and the borrowings are not specifically identifiable to the Company. However, the Company was a guarantor for Select’s senior notes and credit facilities until the guarantee was released at the closing of the IPO. The Company maintains its own cash management system and does not participate in a centralized cash management arrangement with Select.
Basis of Presentation and Consolidation
Basis of Presentation and Consolidation
The Company has historically operated as part of Select. The unaudited condensed consolidated financial statements of the Company have been prepared from Select’s historical accounting records and are derived from the condensed consolidated financial statements of Select to present Concentra as if it had been operating on a standalone basis. The unaudited condensed consolidated financial statements of the Company as of June 30, 2024, and for the three and six month periods ended June 30, 2024 and 2023, have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim reporting and the accounting principles generally accepted in the United States of America (“U.S. GAAP”). Accordingly, certain information and disclosures required by GAAP, which are normally included in the notes to the consolidated financial statements, have been condensed or omitted pursuant to those rules and regulations, although the Company believes the disclosure is adequate to make the information presented not misleading. In the opinion of management, such information contains all adjustments, which are normal and recurring in nature, necessary for a fair statement of the financial position, results of operations and cash flow for such periods.

The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the full fiscal year ended December 31, 2024. These unaudited condensed consolidated financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes as contained in the Company’s registration statement on Form S-1, as amended (File No. 333-280242) (the “Registration Statement”).

The condensed consolidated financial statements include the assets, liabilities, revenue, and expenses based on our legal entity structure as well as direct and indirect costs that are attributable to our operations. Indirect costs are the costs of support functions that are partially provided on a centralized basis by Select and its affiliates, which include finance, human resources, benefits administration, procurement support, information technology, legal, corporate governance and other professional
services. Indirect costs have been allocated to us for the purposes of preparing the condensed consolidated financial statements based on a specific identification basis or, when specific identification is not practicable, a proportional cost allocation method, primarily based on headcount or other allocation methodologies that are considered to be a reasonable reflection of the utilization of services provided or the benefit received by us during the periods presented, depending on the nature of the services received.

The income tax amounts in these condensed consolidated financial statements have been calculated based on a separate return methodology and are presented as if our income gave rise to separate federal and state consolidated income tax return filing obligations in the respective jurisdictions in which we operate. Adjustments to income tax expense resulting from the application of the separate return methodology, as compared to tax obligations determined by the Company’s inclusion in the Parent’s consolidated income tax provision, were assumed to be immediately settled with the Parent through Contributed Capital/Capital in Excess of Par as reflected on the Condensed Consolidated Balance Sheets, and reflected as a (Distribution)/Contribution to Parent on the Condensed Consolidated Statements of Changes in Stockholders’/Members’ Equity and the Condensed Consolidated Statements of Cash Flows within financing activities.
The condensed consolidated financial statements include the accounts of Concentra and the subsidiaries and variable interest entities in which Concentra has a controlling financial interest. All intercompany balances and transactions within the Company are eliminated in consolidation. Transactions between the Company and Select have been included in these consolidated financial statements. The transfers with Select are expected to be settled in cash, other than the assumed income tax settlement noted above, and are reflected within the consolidated statement of cash flows as an operating or financing activity determined by the nature of the transaction. Select’s third-party debt and related interest expense have not been attributed to the Company because the Company is not the primary legal obligor of the debt and the borrowings are not specifically identifiable to the Company. However, the Company was a guarantor for Select’s senior notes and credit facilities until the guarantee was released at the closing of the IPO. The Company maintains its own cash management system and does not participate in a centralized cash management arrangement with Select.
Recent Accounting Guidance Not Yet Adopted
Recent Accounting Guidance Not Yet Adopted
Segment Reporting
In November 2023, FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which is intended to improve disclosure of segment information so that investors can better understand an entity’s overall performance. The ASU requires entities to quantitatively disclose significant segment expenses that are regularly provided to the chief operating decision maker for each reportable segment, as well as the amount of other segment items for each reportable segment and a description of what the other segment items are comprised. Disclosure of multiple measures of profit or loss will be permitted by the ASU.
The ASU is effective for annual reporting periods beginning on or after December 15, 2023, and interim periods with fiscal years beginning after December 15, 2024; however, early adoption is permitted. The ASU is required to be applied retrospectively to all periods presented in the financial statements. The Company is currently reviewing the impact that ASU 2023-07 will have on the disclosures in our consolidated financial statements.
Income Taxes
In December 2023, FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which is intended to improve the transparency and decision usefulness of income tax disclosures. The ASU includes enhanced requirements on the rate reconciliation, including specific categories that must be disclosed, and provides a threshold over which reconciling items must be disclosed. The amendments in the update also require annual disclosure of income taxes paid, disaggregated by federal, state, and foreign taxes, as well as any individual jurisdictions in which income taxes paid is greater than 5% of total income taxes paid.
The ASU is effective for annual periods beginning after December 15, 2024; however early adoption is permitted. The ASU can be applied either prospectively or retrospectively. The Company is currently reviewing the impact that ASU 2023-09 will have on the disclosures in our consolidated financial statements.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Actual results could differ from those estimates.
Redeemable Non-Controlling Interests Redeemable Non-Controlling InterestsThe Company’s redeemable non-controlling interests are comprised of membership interests held by equity holders other than the Company in five less than wholly-owned subsidiaries. These interests are subject to redemption rights.
Variable Interest Entities Variable Interest Entities
Certain states prohibit the “corporate practice of medicine,” which restricts the Company from owning medical practices that directly employ physicians and from exercising control over medical decisions by physicians. In these states, the Company enters into long-term management agreements with affiliated professional medical groups (referred to as “Managed PCs”) that are owned by licensed physicians which, in turn, employ or contract with physicians who provide professional medical services in its occupational health centers. The Company also enters into a stock transfer restriction agreement with the respective equity holders, which provide for the Company to direct the transfer of ownership of the Managed PCs to other licensed physicians at any time. The long-term management agreements provide for various administrative and management services to be provided by the Company to the Managed PCs, including, but not limited to, billing and collections, accounting, non-physician personnel, supplies, security and maintenance, and insurance. The Company has the right to receive income as an ongoing management fee, and effectively absorbs all of the residual interests of the Managed PCs. Based on the provisions of the management and stock transfer agreements, the Managed PCs are variable interest entities for which the Company is the primary beneficiary and consolidates the Managed PCs under the VIE model. There are no restrictions on the use of the assets of the Managed PCs or on the settlement of its liabilities. Additionally, the Company fully indemnifies the licensed physician owners from all claims, demands, costs, damages, losses, liabilities, and other amounts arising from the ownership and operation of the medical practices, excluding gross negligence.
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Redeemable Non-Controlling Interests (Tables)
 6 Months Ended
Jun. 30, 2024
Noncontrolling Interest [Abstract]  
Schedule of redeemable non-controlling interests The changes in redeemable non-controlling interests are as follows:
20242023
(in thousands)
Balance as of January 1$16,477 $16,772 
Net income attributable to redeemable non-controlling interests1,053 914 
Distributions to and purchases of redeemable non-controlling interests(1,174)(1,656)
Redemption value adjustment on redeemable non-controlling interests1,901 436 
Balance as of March 31$18,257 $16,466 
Net income attributable to redeemable non-controlling interests1,078 993 
Distributions to and purchases of redeemable non-controlling interests(793)(610)
Redemption value adjustment on redeemable non-controlling interests(132)3 
Balance as of June 30$18,410 $16,852 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Leases (Tables)
 6 Months Ended
Jun. 30, 2024
Leases [Abstract]  
Schedule of lease cost
The Company’s total lease cost is as follows:
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
(in thousands)
Operating lease cost
$25,077 $24,296 $49,867 $48,424 
Finance lease cost:
Amortization of right-of-use assets
109 261 320 512 
Interest on lease liabilities
77 100 132 203 
Variable lease cost5,293 4,920 10,549 10,034 
Total lease cost$30,556 $29,577 $60,868 $59,173 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Long-Term Debt and Notes Payable (Tables)
 6 Months Ended
Jun. 30, 2024
Debt Disclosure [Abstract]  
Schedule of long-term debt and notes payable
The carrying values of the Company’s long-term debt are as follows:
 June 30, 2024December 31, 2023
(in thousands)
Long-term revolving promissory note with related party$420,000 $470,000 
Other debt (1)
7,730 4,746 
Total debt$427,730 $474,746 
_______________________________________________________________________________
(1)        Other debt is primarily comprised of insurance financing arrangements, promissory notes executed in connection with business combinations, and finance leases.
Schedule of principal maturities of long-term debt and notes payable
As of June 30, 2024, principal maturities of the Company’s long-term debt were as follows:
 20242025202620272028ThereafterTotal
(in thousands)
Revolving promissory note with related party$— $— $— $— $— $420,000 $420,000 
Other debt, including finance leases3,819 1,024 351 397 447 1,692 7,730 
Total debt$3,819 $1,024 $351 $397 $447 $421,692 $427,730 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Accrued and Other Liabilities (Tables)
 6 Months Ended
Jun. 30, 2024
Payables and Accruals [Abstract]  
Components of accrued and other liabilities
The following table sets forth the components of accrued and other liabilities:
June 30, 2024December 31, 2023
(in thousands)
Accrued payroll$57,439 $62,824 
Accrued vacation42,983 41,488 
Accrued other55,484 71,755 
Income taxes payable3,014 399 
Accrued and other liabilities$158,920 $176,466 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue (Tables)
 6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of disaggregation of revenue
The following table disaggregates the Company’s revenue for the three and six months ended June 30, 2024 and 2023:
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
(in thousands)
Occupational health centers:
Workers’ compensation$288,405 $278,554 $568,271 $546,894 
Employer services153,305 153,164 304,040 305,337 
Consumer health7,669 7,802 15,995 15,987 
Other occupational health center revenue1,861 2,254 4,006 4,672 
Total occupational health center revenue451,240 441,774 892,312 872,890 
Onsite clinics15,539 14,705 31,396 29,250 
Other11,136 10,600 21,805 21,237 
Total revenue$477,915 $467,079 $945,513 $923,377 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Earnings per Share (Tables)
 6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Schedule of computation of basic and diluted earnings per share
The following table sets forth the computation of earnings per share (EPS) in 2024:
Three Months Ended June 30, 2024Six Months Ended June 30, 2024
Net Income Attributable to the Company
Shares(1)
Basic and Diluted EPSNet Income Attributable to the Company
Shares(1)
Basic and Diluted EPS
(in thousands, except for per share amounts)
Common shares$51,737 104,094 $0.50 $100,693 104,094 $0.97 
The following table sets forth the net income attributable to the Company, its units outstanding, and its participating units outstanding:
Three Months Ended
June 30, 2023		Six Months Ended
June 30, 2023
(in thousands)
Net income$54,032 $101,463 
Less: net income attributable to non-controlling interests1,290 2,457 
Net income attributable to the Company52,742 99,006 
Less: Distributed and undistributed income attributable to participating shares148 287 
Distributed and undistributed income attributable to outstanding shares$52,594 $98,719 
The following table sets forth the computation of EPS in 2023, under the two-class method:
Three Months Ended June 30, 2023Six Months Ended June 30, 2023
Net Income Allocation
Shares(1)(2)
Basic and Diluted EPSNet Income Allocation
Shares(1)(2)
Basic and Diluted EPS
(in thousands, except for per share amounts)
Outstanding Class A, Class B, and Class C shares$52,594 103,962 $0.51 $98,719 103,952 $0.95 
Participating shares148 292 $0.51 287 302 $0.95 
Total Company$52,742 $99,006 
_______________________________________________________________________________
(1)    The recapitalization of the members units into common shares has been treated as such for earnings per share purposes and has been reflected retrospectively for all periods, along with the one for 4.295 reverse stock split, as described in Note 1, Organization.
(2)    Represents the weighted average units outstanding during the period.
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Organization (Details)
$ / shares in Units, $ in Millions
 6 Months Ended
Jul. 26, 2024
USD ($)
$ / shares
shares
Jun. 25, 2024
Mar. 04, 2024
Jun. 30, 2024
clinic
state
health_center
$ / shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Number of occupational health centers operated by entity | health_center       547
Number of onsite clinics | clinic       154
Number of states in which entity operates | state       42
Member interests converted to common shares     1  
Stock split conversion ratio   0.233    
Common stock, par value (in dollars per share)       $ 0.01
Select Medical Corporation | Concentra Group Holdings Parent        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Outstanding member interest       100.00%
Subsequent Event | IPO        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Number of shares issued in initial public offering (in shares) | shares 22,500,000      
Common stock, par value (in dollars per share) $ 0.01      
Sale of stock, price per share (in dollars per share) $ 23.50      
Proceeds from initial public offering | $ $ 499.7      
Underwriting discounts and commissions | $ $ 29.1      
Subsequent Event | IPO | Select Medical Corporation | Concentra Group Holdings Parent        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Outstanding member interest 81.74%      
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Redeemable Non-Controlling Interests - Narrative (Details)
Jun. 30, 2024
less_than_wholly_owned_subsidiary
Noncontrolling Interest [Abstract]  
Number of less than wholly owned subsidiaries 5
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Redeemable Non-Controlling Interests - Schedule of Redeemable Non-Controlling Interests (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Increase (Decrease) in Temporary Equity [Roll Forward]        
Balance, beginning $ 18,257 $ 16,477 $ 16,466 $ 16,772
Net income attributable to redeemable non-controlling interests 1,078 1,053 993 914
Distributions to and purchases of redeemable non-controlling interests (793) (1,174) (610) (1,656)
Redemption value adjustment on redeemable non-controlling interests (132) 1,901 3 435
Redemption value adjustment on redeemable non-controlling interests       436
Balance, ending $ 18,410 $ 18,257 $ 16,852 $ 16,466
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Variable Interest Entities (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Variable Interest Entity [Line Items]    
Assets $ 2,363,338 $ 2,333,560
Liabilities 1,092,946 1,156,121
Variable Interest Entity, Primary Beneficiary    
Variable Interest Entity [Line Items]    
Assets 224,800 212,300
Liabilities 53,700 56,400
Variable Interest Entity, Primary Beneficiary | Related Party    
Variable Interest Entity [Line Items]    
Obligations payable $ 171,700 $ 156,200
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Leases (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Lease, Cost [Abstract]        
Operating lease cost $ 25,077 $ 24,296 $ 49,867 $ 48,424
Finance lease cost:        
Amortization of right-of-use assets 109 261 320 512
Interest on lease liabilities 77 100 132 203
Variable lease cost 5,293 4,920 10,549 10,034
Total lease cost $ 30,556 $ 29,577 $ 60,868 $ 59,173
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Long-Term Debt and Notes Payable - Carrying Value Of Long-Term Debt (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Total debt $ 427,730 $ 474,746
Related Party    
Debt Instrument [Line Items]    
Long-term revolving promissory note with related party 420,000 470,000
Nonrelated Party    
Debt Instrument [Line Items]    
Total debt $ 7,730 $ 4,746
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Long-Term Debt and Notes Payable - Principal Maturities Of Long-Term Debt (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
2024 $ 3,819  
2025 1,024  
2026 351  
2027 397  
2028 447  
Thereafter 421,692  
Total 427,730 $ 474,746
Other debt, including finance leases    
Debt Instrument [Line Items]    
2024 3,819  
2025 1,024  
2026 351  
2027 397  
2028 447  
Thereafter 1,692  
Total 7,730  
Related Party    
Debt Instrument [Line Items]    
2024 0  
2025 0  
2026 0  
2027 0  
2028 0  
Thereafter 420,000  
Total $ 420,000  
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Accrued and Other Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Payables and Accruals [Abstract]    
Accrued payroll $ 57,439 $ 62,824
Accrued vacation 42,983 41,488
Accrued other 55,484 71,755
Income taxes payable 3,014 399
Accrued and other liabilities $ 158,920 $ 176,466
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Disaggregation of Revenue [Line Items]        
Revenue $ 477,915 $ 467,079 $ 945,513 $ 923,377
Operating Segments | Total occupational health center revenue        
Disaggregation of Revenue [Line Items]        
Revenue 451,240 441,774 892,312 872,890
Operating Segments | Onsite clinics        
Disaggregation of Revenue [Line Items]        
Revenue 15,539 14,705 31,396 29,250
Operating Segments | Other        
Disaggregation of Revenue [Line Items]        
Revenue 11,136 10,600 21,805 21,237
Workers’ compensation        
Disaggregation of Revenue [Line Items]        
Revenue 288,405 278,554 568,271 546,894
Employer services        
Disaggregation of Revenue [Line Items]        
Revenue 153,305 153,164 304,040 305,337
Consumer health        
Disaggregation of Revenue [Line Items]        
Revenue 7,669 7,802 15,995 15,987
Other occupational health center revenue        
Disaggregation of Revenue [Line Items]        
Revenue $ 1,861 $ 2,254 $ 4,006 $ 4,672
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Earnings per Share - Narrative (Details)
shares in Thousands
 3 Months Ended 6 Months Ended
Jun. 25, 2024
shares
Mar. 04, 2024
Jun. 30, 2024
shares
Jun. 30, 2023
shares
Jun. 30, 2024
shares
Jun. 30, 2023
shares
Dec. 31, 2023
shares
Mar. 31, 2023
shares
Dec. 31, 2022
shares
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]                  
Member interests converted to common shares   1              
Stock split conversion ratio 0.233                
Conversion of units (in shares) 104,094                
Participating shares outstanding (in shares)     0 292 0 302      
Class A Units Voting                  
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]                  
Common unit, outstanding (in shares)       435,000   435,000 435,000 435,000 435,000
Class B Units Non-Voting                  
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]                  
Common unit, outstanding (in shares)       8,498   8,498 8,498 8,498 8,498
Class C Units Non-Voting                  
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]                  
Common unit, outstanding (in shares)       3,018   3,018 3,583 3,018 2,770
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Earnings per Share - Computation of EPS (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Earnings Per Share [Abstract]        
Net income allocated to common shares - basic $ 51,737 $ 52,594 $ 100,693 $ 98,719
Net income allocated to common shares - diluted $ 51,737 $ 52,594 $ 100,693 $ 98,719
Weighted average common shares outstanding, basic (in shares) 104,094 103,962 104,094 103,952
Weighted average common shares outstanding, diluted (in shares) 104,094 103,962 104,094 103,952
Basic (in dollars per share) $ 0.50 $ 0.51 $ 0.97 $ 0.95
Diluted (in dollars per share) $ 0.50 $ 0.51 $ 0.97 $ 0.95
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Earnings per Share - Net Income Attributable to the Company, Units Outstanding, and Participating Units Outstanding (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Earnings Per Share [Abstract]            
Net income $ 53,059   $ 54,032   $ 103,338 $ 101,463
Less: Net income attributable to non-controlling interests 1,322   1,290   2,645 2,457
Net income attributable to the Company 51,737 $ 48,956 52,742 $ 46,264 100,693 99,006
Basic EPS            
Less: Distributed and undistributed income attributable to participating shares - basic EPS     148     287
Distributed and undistributed income attributable to outstanding shares 51,737   52,594   100,693 98,719
Diluted EPS            
Less: Distributed and undistributed income attributable to participating shares - diluted EPS     148     287
Distributed and undistributed income attributable to outstanding shares $ 51,737   $ 52,594   $ 100,693 $ 98,719
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Earnings per Share - Computation of EPS Under the Two-Class Method (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Net Income Allocation            
Net income allocated to common shares - basic $ 51,737   $ 52,594   $ 100,693 $ 98,719
Participating shares - basic     148     287
Net income allocated to common shares - diluted 51,737   52,594   100,693 98,719
Participating shares - diluted     148     287
Net income attributable to the Company $ 51,737 $ 48,956 $ 52,742 $ 46,264 $ 100,693 $ 99,006
Weighted average common shares outstanding, basic (in shares) 104,094   103,962   104,094 103,952
Weighted average common shares outstanding, diluted (in shares) 104,094   103,962   104,094 103,952
Weighted average participating shares outstanding (in shares) 0   292   0 302
Basic EPS            
Basic EPS (in dollars per share) $ 0.50   $ 0.51   $ 0.97 $ 0.95
Diluted EPS            
Diluted EPS (in dollars per share) $ 0.50   $ 0.51   $ 0.97 $ 0.95
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Related Party Transactions (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Related Party        
Related Party Transaction [Line Items]        
Shared service fee from related party $ 3.8 $ 3.7 $ 7.7 $ 7.3
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Commitments and Contingencies (Details)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 31, 2024
class_action_lawsuit
Jun. 30, 2024
USD ($)
Feb. 29, 2024
patient
Commitments and Contingencies      
Loss contingency, number of patients | patient     4,000,000
Loss contingency, new claims filed, number | class_action_lawsuit 6    
Professional liability claims      
Commitments and Contingencies      
Total annual aggregate limit of insurance coverage   $ 29.0  
General Liability      
Commitments and Contingencies      
Total annual aggregate limit of insurance coverage   $ 29.0  
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Subsequent Events (Details) - USD ($)
$ / shares in Units, $ in Millions
Jul. 26, 2024
Jun. 30, 2024
Subsequent Event [Line Items]    
Common stock, par value (in dollars per share)   $ 0.01
Select Medical Corporation | Concentra Group Holdings Parent    
Subsequent Event [Line Items]    
Outstanding member interest   100.00%
Subsequent Event | IPO    
Subsequent Event [Line Items]    
Number of shares issued in initial public offering (in shares) 22,500,000  
Common stock, par value (in dollars per share) $ 0.01  
Sale of stock, price per share (in dollars per share) $ 23.50  
Proceeds from initial public offering $ 499.7  
Underwriting discounts and commissions 29.1  
Net proceeds of IPO and debt financing transactions, excluding amounts repaid for debt $ 34.7  
Subsequent Event | IPO | Select Medical Corporation | Concentra Group Holdings Parent    
Subsequent Event [Line Items]    
Outstanding member interest 81.74%  
Subsequent Event | IPO | Senior Secured Credit Facilities | Concentra Health Services, Inc. ("CHSI")    
Subsequent Event [Line Items]    
Maximum borrowing capacity $ 1,250.0  
Subsequent Event | IPO | Term loan | Concentra Health Services, Inc. ("CHSI")    
Subsequent Event [Line Items]    
Maximum borrowing capacity $ 850.0  
Credit spread adjustment 2.25%  
Subsequent Event | IPO | Line of Credit | Concentra Health Services, Inc. ("CHSI") | Revolving Credit Facility    
Subsequent Event [Line Items]    
Maximum borrowing capacity $ 400.0  
Credit spread adjustment 2.50%  
Subsequent Event | IPO | 6.875 Senior Notes Due 2032 | Senior notes | Concentra Health Services, Inc. ("CHSI")    
Subsequent Event [Line Items]    
Principal outstanding $ 650.0  
Interest rate of debt (as a percent) 6.875%  
Subsequent Event | IPO | Select Medical Revolving Promissory Note    
Subsequent Event [Line Items]    
Repayments of debt $ 420.0  
Subsequent Event | Over-Allotment Option    
Subsequent Event [Line Items]    
Number of shares issued in initial public offering (in shares) 750,000  
Underwriting discounts and commissions $ 1.0  
Net proceeds received $ 16.7  
EXCEL 55 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 57 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2.u1 html 136 207 1 true 37 0 false 10 false false R1.htm 0000001 - Document - Cover Sheet http://www.concentra.com/role/Cover Cover Cover 1 false false R2.htm 9952151 - Statement - Condensed Consolidated Balance Sheets (unaudited) Sheet http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited Condensed Consolidated Balance Sheets (unaudited) Statements 2 false false R3.htm 9952152 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) Sheet http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) Statements 3 false false R4.htm 9952153 - Statement - Condensed Consolidated Statements of Operations (unaudited) Sheet http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited Condensed Consolidated Statements of Operations (unaudited) Statements 4 false false R5.htm 9952154 - Statement - Condensed Consolidated Statements of Operations (unaudited) (Parenthetical) Sheet http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunauditedParenthetical Condensed Consolidated Statements of Operations (unaudited) (Parenthetical) Statements 5 false false R6.htm 9952155 - Statement - Condensed Consolidated Statements of Changes in Stockholders???/Members??? Equity (unaudited) Sheet http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited Condensed Consolidated Statements of Changes in Stockholders???/Members??? Equity (unaudited) Statements 6 false false R7.htm 9952156 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited) Sheet http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited Condensed Consolidated Statements of Cash Flows (unaudited) Statements 7 false false R8.htm 9952157 - Disclosure - Organization Sheet http://www.concentra.com/role/Organization Organization Notes 8 false false R9.htm 9952158 - Disclosure - Accounting Policies Sheet http://www.concentra.com/role/AccountingPolicies Accounting Policies Notes 9 false false R10.htm 9952159 - Disclosure - Redeemable Non-Controlling Interests Sheet http://www.concentra.com/role/RedeemableNonControllingInterests Redeemable Non-Controlling Interests Notes 10 false false R11.htm 9952160 - Disclosure - Variable Interest Entities Sheet http://www.concentra.com/role/VariableInterestEntities Variable Interest Entities Notes 11 false false R12.htm 9952161 - Disclosure - Leases Sheet http://www.concentra.com/role/Leases Leases Notes 12 false false R13.htm 9952162 - Disclosure - Long-Term Debt and Notes Payable Notes http://www.concentra.com/role/LongTermDebtandNotesPayable Long-Term Debt and Notes Payable Notes 13 false false R14.htm 9952163 - Disclosure - Accrued and Other Liabilities Sheet http://www.concentra.com/role/AccruedandOtherLiabilities Accrued and Other Liabilities Notes 14 false false R15.htm 9952164 - Disclosure - Revenue Sheet http://www.concentra.com/role/Revenue Revenue Notes 15 false false R16.htm 9952165 - Disclosure - Earnings per Share Sheet http://www.concentra.com/role/EarningsperShare Earnings per Share Notes 16 false false R17.htm 9952166 - Disclosure - Related Party Transactions Sheet http://www.concentra.com/role/RelatedPartyTransactions Related Party Transactions Notes 17 false false R18.htm 9952167 - Disclosure - Commitments and Contingencies Sheet http://www.concentra.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 18 false false R19.htm 9952168 - Disclosure - Subsequent Events Sheet http://www.concentra.com/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 20 false false R21.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 21 false false R22.htm 9954471 - Disclosure - Accounting Policies (Policies) Sheet http://www.concentra.com/role/AccountingPoliciesPolicies Accounting Policies (Policies) Policies http://www.concentra.com/role/AccountingPolicies 22 false false R23.htm 9954472 - Disclosure - Redeemable Non-Controlling Interests (Tables) Sheet http://www.concentra.com/role/RedeemableNonControllingInterestsTables Redeemable Non-Controlling Interests (Tables) Tables http://www.concentra.com/role/RedeemableNonControllingInterests 23 false false R24.htm 9954473 - Disclosure - Leases (Tables) Sheet http://www.concentra.com/role/LeasesTables Leases (Tables) Tables http://www.concentra.com/role/Leases 24 false false R25.htm 9954474 - Disclosure - Long-Term Debt and Notes Payable (Tables) Notes http://www.concentra.com/role/LongTermDebtandNotesPayableTables Long-Term Debt and Notes Payable (Tables) Tables http://www.concentra.com/role/LongTermDebtandNotesPayable 25 false false R26.htm 9954475 - Disclosure - Accrued and Other Liabilities (Tables) Sheet http://www.concentra.com/role/AccruedandOtherLiabilitiesTables Accrued and Other Liabilities (Tables) Tables http://www.concentra.com/role/AccruedandOtherLiabilities 26 false false R27.htm 9954476 - Disclosure - Revenue (Tables) Sheet http://www.concentra.com/role/RevenueTables Revenue (Tables) Tables http://www.concentra.com/role/Revenue 27 false false R28.htm 9954477 - Disclosure - Earnings per Share (Tables) Sheet http://www.concentra.com/role/EarningsperShareTables Earnings per Share (Tables) Tables http://www.concentra.com/role/EarningsperShare 28 false false R29.htm 9954478 - Disclosure - Organization (Details) Sheet http://www.concentra.com/role/OrganizationDetails Organization (Details) Details http://www.concentra.com/role/Organization 29 false false R30.htm 9954479 - Disclosure - Redeemable Non-Controlling Interests - Narrative (Details) Sheet http://www.concentra.com/role/RedeemableNonControllingInterestsNarrativeDetails Redeemable Non-Controlling Interests - Narrative (Details) Details 30 false false R31.htm 9954480 - Disclosure - Redeemable Non-Controlling Interests - Schedule of Redeemable Non-Controlling Interests (Details) Sheet http://www.concentra.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails Redeemable Non-Controlling Interests - Schedule of Redeemable Non-Controlling Interests (Details) Details 31 false false R32.htm 9954481 - Disclosure - Variable Interest Entities (Details) Sheet http://www.concentra.com/role/VariableInterestEntitiesDetails Variable Interest Entities (Details) Details http://www.concentra.com/role/VariableInterestEntities 32 false false R33.htm 9954482 - Disclosure - Leases (Details) Sheet http://www.concentra.com/role/LeasesDetails Leases (Details) Details http://www.concentra.com/role/LeasesTables 33 false false R34.htm 9954483 - Disclosure - Long-Term Debt and Notes Payable - Carrying Value Of Long-Term Debt (Details) Notes http://www.concentra.com/role/LongTermDebtandNotesPayableCarryingValueOfLongTermDebtDetails Long-Term Debt and Notes Payable - Carrying Value Of Long-Term Debt (Details) Details 34 false false R35.htm 9954484 - Disclosure - Long-Term Debt and Notes Payable - Principal Maturities Of Long-Term Debt (Details) Notes http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails Long-Term Debt and Notes Payable - Principal Maturities Of Long-Term Debt (Details) Details 35 false false R36.htm 9954485 - Disclosure - Accrued and Other Liabilities (Details) Sheet http://www.concentra.com/role/AccruedandOtherLiabilitiesDetails Accrued and Other Liabilities (Details) Details http://www.concentra.com/role/AccruedandOtherLiabilitiesTables 36 false false R37.htm 9954486 - Disclosure - Revenue (Details) Sheet http://www.concentra.com/role/RevenueDetails Revenue (Details) Details http://www.concentra.com/role/RevenueTables 37 false false R38.htm 9954487 - Disclosure - Earnings per Share - Narrative (Details) Sheet http://www.concentra.com/role/EarningsperShareNarrativeDetails Earnings per Share - Narrative (Details) Details 38 false false R39.htm 9954488 - Disclosure - Earnings per Share - Computation of EPS (Details) Sheet http://www.concentra.com/role/EarningsperShareComputationofEPSDetails Earnings per Share - Computation of EPS (Details) Details 39 false false R40.htm 9954489 - Disclosure - Earnings per Share - Net Income Attributable to the Company, Units Outstanding, and Participating Units Outstanding (Details) Sheet http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails Earnings per Share - Net Income Attributable to the Company, Units Outstanding, and Participating Units Outstanding (Details) Details 40 false false R41.htm 9954490 - Disclosure - Earnings per Share - Computation of EPS Under the Two-Class Method (Details) Sheet http://www.concentra.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails Earnings per Share - Computation of EPS Under the Two-Class Method (Details) Details 41 false false R42.htm 9954491 - Disclosure - Related Party Transactions (Details) Sheet http://www.concentra.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.concentra.com/role/RelatedPartyTransactions 42 false false R43.htm 9954492 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.concentra.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.concentra.com/role/CommitmentsandContingencies 43 false false R44.htm 9954493 - Disclosure - Subsequent Events (Details) Sheet http://www.concentra.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.concentra.com/role/SubsequentEvents 44 false false All Reports Book All Reports cghp-20240630.htm cghp-20240630.xsd cghp-20240630_cal.xml cghp-20240630_def.xml cghp-20240630_lab.xml cghp-20240630_pre.xml http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true JSON 62 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "cghp-20240630.htm": { "nsprefix": "cghp", "nsuri": "http://www.concentra.com/20240630", "dts": { "inline": { "local": [ "cghp-20240630.htm" ] }, "schema": { "local": [ "cghp-20240630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "cghp-20240630_cal.xml" ] }, "definitionLink": { "local": [ "cghp-20240630_def.xml" ] }, "labelLink": { "local": [ "cghp-20240630_lab.xml" ] }, "presentationLink": { "local": [ "cghp-20240630_pre.xml" ] } }, "keyStandard": 188, "keyCustom": 19, "axisStandard": 15, "axisCustom": 0, "memberStandard": 23, "memberCustom": 14, "hidden": { "total": 7, "http://xbrl.sec.gov/dei/2024": 5, "http://fasb.org/us-gaap/2024": 2 }, "contextCount": 136, "entityCount": 1, "segmentCount": 37, "elementCount": 432, "unitCount": 10, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 518, "http://xbrl.sec.gov/dei/2024": 30, "http://xbrl.sec.gov/ecd/2024": 4 }, "report": { "R1": { "role": "http://www.concentra.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited", "longName": "9952151 - Statement - Condensed Consolidated Balance Sheets (unaudited)", "shortName": "Condensed Consolidated Balance Sheets (unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical", "longName": "9952152 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "unique": true } }, "R4": { "role": "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited", "longName": "9952153 - Statement - Condensed Consolidated Statements of Operations (unaudited)", "shortName": "Condensed Consolidated Statements of Operations (unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-9", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-9", "name": "us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "unique": true } }, "R5": { "role": "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunauditedParenthetical", "longName": "9952154 - Statement - Condensed Consolidated Statements of Operations (unaudited) (Parenthetical)", "shortName": "Condensed Consolidated Statements of Operations (unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-12", "name": "us-gaap:ContractuallySpecifiedServicingFeesAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "link:footnote", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": null }, "R6": { "role": "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited", "longName": "9952155 - Statement - Condensed Consolidated Statements of Changes in Stockholders\u2019/Members\u2019 Equity (unaudited)", "shortName": "Condensed Consolidated Statements of Changes in Stockholders\u2019/Members\u2019 Equity (unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-50", "name": "us-gaap:CommonUnitOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-60", "name": "cghp:AdjustmentsToMembersContributedCapitalContributionsFromParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "unique": true } }, "R7": { "role": "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited", "longName": "9952156 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ProvisionForDoubtfulAccounts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "unique": true } }, "R8": { "role": "http://www.concentra.com/role/Organization", "longName": "9952157 - Disclosure - Organization", "shortName": "Organization", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.concentra.com/role/AccountingPolicies", "longName": "9952158 - Disclosure - Accounting Policies", "shortName": "Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.concentra.com/role/RedeemableNonControllingInterests", "longName": "9952159 - Disclosure - Redeemable Non-Controlling Interests", "shortName": "Redeemable Non-Controlling Interests", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.concentra.com/role/VariableInterestEntities", "longName": "9952160 - Disclosure - Variable Interest Entities", "shortName": "Variable Interest Entities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConsolidationVariableInterestEntityPolicy", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConsolidationVariableInterestEntityPolicy", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.concentra.com/role/Leases", "longName": "9952161 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.concentra.com/role/LongTermDebtandNotesPayable", "longName": "9952162 - Disclosure - Long-Term Debt and Notes Payable", "shortName": "Long-Term Debt and Notes Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.concentra.com/role/AccruedandOtherLiabilities", "longName": "9952163 - Disclosure - Accrued and Other Liabilities", "shortName": "Accrued and Other Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.concentra.com/role/Revenue", "longName": "9952164 - Disclosure - Revenue", "shortName": "Revenue", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.concentra.com/role/EarningsperShare", "longName": "9952165 - Disclosure - Earnings per Share", "shortName": "Earnings per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.concentra.com/role/RelatedPartyTransactions", "longName": "9952166 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.concentra.com/role/CommitmentsandContingencies", "longName": "9952167 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.concentra.com/role/SubsequentEvents", "longName": "9952168 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R20": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-9", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": null }, "R21": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-9", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-9", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.concentra.com/role/AccountingPoliciesPolicies", "longName": "9954471 - Disclosure - Accounting Policies (Policies)", "shortName": "Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConsolidationPolicyTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConsolidationPolicyTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.concentra.com/role/RedeemableNonControllingInterestsTables", "longName": "9954472 - Disclosure - Redeemable Non-Controlling Interests (Tables)", "shortName": "Redeemable Non-Controlling Interests (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.concentra.com/role/LeasesTables", "longName": "9954473 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.concentra.com/role/LongTermDebtandNotesPayableTables", "longName": "9954474 - Disclosure - Long-Term Debt and Notes Payable (Tables)", "shortName": "Long-Term Debt and Notes Payable (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.concentra.com/role/AccruedandOtherLiabilitiesTables", "longName": "9954475 - Disclosure - Accrued and Other Liabilities (Tables)", "shortName": "Accrued and Other Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.concentra.com/role/RevenueTables", "longName": "9954476 - Disclosure - Revenue (Tables)", "shortName": "Revenue (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.concentra.com/role/EarningsperShareTables", "longName": "9954477 - Disclosure - Earnings per Share (Tables)", "shortName": "Earnings per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.concentra.com/role/OrganizationDetails", "longName": "9954478 - Disclosure - Organization (Details)", "shortName": "Organization (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "cghp:NumberOfOccupationalHealthCentersOperatedByEntity", "unitRef": "health_center", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "cghp:NumberOfOccupationalHealthCentersOperatedByEntity", "unitRef": "health_center", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.concentra.com/role/RedeemableNonControllingInterestsNarrativeDetails", "longName": "9954479 - Disclosure - Redeemable Non-Controlling Interests - Narrative (Details)", "shortName": "Redeemable Non-Controlling Interests - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "c-3", "name": "cghp:NumberOfLessThanWhollyOwnedSubsidiaries", "unitRef": "less_than_wholly_owned_subsidiary", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "cghp:NumberOfLessThanWhollyOwnedSubsidiaries", "unitRef": "less_than_wholly_owned_subsidiary", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.concentra.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails", "longName": "9954480 - Disclosure - Redeemable Non-Controlling Interests - Schedule of Redeemable Non-Controlling Interests (Details)", "shortName": "Redeemable Non-Controlling Interests - Schedule of Redeemable Non-Controlling Interests (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "c-38", "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-57", "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "unique": true } }, "R32": { "role": "http://www.concentra.com/role/VariableInterestEntitiesDetails", "longName": "9954481 - Disclosure - Variable Interest Entities (Details)", "shortName": "Variable Interest Entities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:Assets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-89", "name": "us-gaap:Assets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "unique": true } }, "R33": { "role": "http://www.concentra.com/role/LeasesDetails", "longName": "9954482 - Disclosure - Leases (Details)", "shortName": "Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "c-9", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "us-gaap:LeaseCostTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-9", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "us-gaap:LeaseCostTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.concentra.com/role/LongTermDebtandNotesPayableCarryingValueOfLongTermDebtDetails", "longName": "9954483 - Disclosure - Long-Term Debt and Notes Payable - Carrying Value Of Long-Term Debt (Details)", "shortName": "Long-Term Debt and Notes Payable - Carrying Value Of Long-Term Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-3", "name": "cghp:LongTermDebtGrossAndFinanceLeaseObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "cghp:LongTermDebtGrossAndFinanceLeaseObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "unique": true } }, "R35": { "role": "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "longName": "9954484 - Disclosure - Long-Term Debt and Notes Payable - Principal Maturities Of Long-Term Debt (Details)", "shortName": "Long-Term Debt and Notes Payable - Principal Maturities Of Long-Term Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-3", "name": "cghp:LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "cghp:LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.concentra.com/role/AccruedandOtherLiabilitiesDetails", "longName": "9954485 - Disclosure - Accrued and Other Liabilities (Details)", "shortName": "Accrued and Other Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-3", "name": "cghp:AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "cghp:AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.concentra.com/role/RevenueDetails", "longName": "9954486 - Disclosure - Revenue (Details)", "shortName": "Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-9", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-110", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "unique": true } }, "R38": { "role": "http://www.concentra.com/role/EarningsperShareNarrativeDetails", "longName": "9954487 - Disclosure - Earnings per Share - Narrative (Details)", "shortName": "Earnings per Share - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-85", "name": "cghp:MemberInterestConvertibleConversionRatio", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-88", "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "unique": true } }, "R39": { "role": "http://www.concentra.com/role/EarningsperShareComputationofEPSDetails", "longName": "9954488 - Disclosure - Earnings per Share - Computation of EPS (Details)", "shortName": "Earnings per Share - Computation of EPS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-9", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": null }, "R40": { "role": "http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails", "longName": "9954489 - Disclosure - Earnings per Share - Net Income Attributable to the Company, Units Outstanding, and Participating Units Outstanding (Details)", "shortName": "Earnings per Share - Net Income Attributable to the Company, Units Outstanding, and Participating Units Outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-9", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": null }, "R41": { "role": "http://www.concentra.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails", "longName": "9954490 - Disclosure - Earnings per Share - Computation of EPS Under the Two-Class Method (Details)", "shortName": "Earnings per Share - Computation of EPS Under the Two-Class Method (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-9", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": null }, "R42": { "role": "http://www.concentra.com/role/RelatedPartyTransactionsDetails", "longName": "9954491 - Disclosure - Related Party Transactions (Details)", "shortName": "Related Party Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-12", "name": "us-gaap:ContractuallySpecifiedServicingFeesAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "link:footnote", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": null }, "R43": { "role": "http://www.concentra.com/role/CommitmentsandContingenciesDetails", "longName": "9954492 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-127", "name": "cghp:LossContingencyNumberOfPatients", "unitRef": "patient", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-127", "name": "cghp:LossContingencyNumberOfPatients", "unitRef": "patient", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.concentra.com/role/SubsequentEventsDetails", "longName": "9954493 - Disclosure - Subsequent Events (Details)", "shortName": "Subsequent Events (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-86", "name": "cghp:ProceedsFromIssuanceInitialPublicOfferingAmountNotDistributedToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cghp-20240630.htm", "unique": true } } }, "tag": { "cghp_A6.875SeniorNotesDue2032Member": { "xbrltype": "domainItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "A6.875SeniorNotesDue2032Member", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "6.875 Senior Notes Due 2032", "label": "6.875 Senior Notes Due 2032 [Member]", "documentation": "6.875 Senior Notes Due 2032" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "presentation": [ "http://www.concentra.com/role/AccruedandOtherLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued and Other Liabilities", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period." } } }, "auth_ref": [ "r336" ] }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 }, "http://www.concentra.com/role/AccruedandOtherLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.concentra.com/role/AccruedandOtherLiabilitiesDetails", "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued and other liabilities", "totalLabel": "Accrued and other liabilities", "label": "Accounts Payable and Other Accrued Liabilities, Current", "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and Due to related party", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r44", "r576" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts receivable", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r708" ] }, "cghp_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent", "crdr": "credit", "calculation": { "http://www.concentra.com/role/AccruedandOtherLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/AccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued payroll", "label": "Accrued Salaries, Accrued Bonuses, And Accrued Payroll Taxes, Current", "documentation": "Accrued Salaries, Accrued Bonuses, And Accrued Payroll Taxes, Current" } } }, "auth_ref": [] }, "us-gaap_AccruedVacationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedVacationCurrent", "crdr": "credit", "calculation": { "http://www.concentra.com/role/AccruedandOtherLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.concentra.com/role/AccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued vacation", "label": "Accrued Vacation, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r26", "r47" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r630" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_MembersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Capital in excess of par", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r57" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Capital in excess of par", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r468", "r697", "r698", "r699", "r700", "r732", "r771" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r643" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r643" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r643" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r643" ] }, "cghp_AdjustmentsToMembersContributedCapitalContributionsFromParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "AdjustmentsToMembersContributedCapitalContributionsFromParent", "crdr": "credit", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Contribution from Parent", "label": "Adjustments To Member's Contributed Capital, Contributions From Parent", "documentation": "Adjustments To Member's Contributed Capital, Contributions From Parent" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table", "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r676" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r602", "r612", "r622", "r654" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r605", "r615", "r625", "r657" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Pension Adjustments Service Cost", "label": "Aggregate Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r677" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r643" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r650" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r606", "r616", "r626", "r650", "r658", "r662", "r670" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r668" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited", "http://www.concentra.com/role/VariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "verboseLabel": "Assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r89", "r102", "r122", "r145", "r182", "r189", "r206", "r209", "r217", "r250", "r251", "r253", "r254", "r255", "r256", "r257", "r259", "r260", "r355", "r359", "r370", "r413", "r500", "r553", "r554", "r576", "r593", "r727", "r728", "r738" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r117", "r127", "r145", "r217", "r250", "r251", "r253", "r254", "r255", "r256", "r257", "r259", "r260", "r355", "r359", "r370", "r576", "r727", "r728", "r738" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Current Assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r665" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r666" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r661" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r661" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r661" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r661" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r661" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r661" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r664" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r663" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r662" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r662" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.concentra.com/role/AccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation and Consolidation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r11", "r119", "r546" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash at beginning of period", "periodEndLabel": "Cash at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r11", "r73", "r142" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r73" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r641" ] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year", "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]" } } }, "auth_ref": [ "r638" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested", "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r636" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited", "http://www.concentra.com/role/EarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r112", "r123", "r124", "r125", "r145", "r167", "r168", "r175", "r177", "r186", "r187", "r217", "r250", "r253", "r254", "r255", "r259", "r260", "r291", "r292", "r293", "r294", "r295", "r370", "r458", "r459", "r460", "r461", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r488", "r509", "r531", "r537", "r538", "r539", "r540", "r541", "r681", "r690", "r701" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r642" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r642" ] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://www.concentra.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r353" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (Note 11)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r53", "r92", "r417", "r487" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.concentra.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r78", "r242", "r243", "r543", "r715", "r719" ] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonClassAMember", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited", "http://www.concentra.com/role/EarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class A Units Voting", "label": "Common Class A [Member]", "documentation": "Classification of common stock representing ownership interest in a corporation." } } }, "auth_ref": [ "r771" ] }, "us-gaap_CommonClassBMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonClassBMember", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited", "http://www.concentra.com/role/EarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class B Units Non-Voting", "label": "Common Class B [Member]", "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation." } } }, "auth_ref": [ "r771" ] }, "us-gaap_CommonClassCMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonClassCMember", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited", "http://www.concentra.com/role/EarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class C Units Non-Voting", "label": "Common Class C [Member]", "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation." } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r583", "r584", "r585", "r587", "r588", "r589", "r590", "r697", "r698", "r700", "r732", "r770", "r771" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical", "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r56" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r56", "r488" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical", "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r56" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r6", "r56", "r488", "r506", "r771", "r772" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_MembersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock, $0.01 par value, 447,081 shares authorized, 104,094 shares issued and outstanding at June\u00a030, 2024", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r56", "r418", "r576" ] }, "us-gaap_CommonUnitOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonUnitOutstanding", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited", "http://www.concentra.com/role/EarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Members' unit, beginning balance (in shares)", "periodEndLabel": "Members' unit, ending balance (in shares)", "terseLabel": "Common unit, outstanding (in shares)", "label": "Common Unit, Outstanding", "documentation": "Number of common units of ownership outstanding of a limited liability company (LLC)." } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r647" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r646" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r648" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r645" ] }, "cghp_ConcentraGroupHoldingsParentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "ConcentraGroupHoldingsParentMember", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentra Group Holdings Parent", "label": "Concentra Group Holdings Parent [Member]", "documentation": "" } } }, "auth_ref": [] }, "cghp_ConcentraHealthServicesInc.CHSIMember": { "xbrltype": "domainItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "ConcentraHealthServicesInc.CHSIMember", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentra Health Services, Inc. (\"CHSI\")", "label": "Concentra Health Services, Inc. (\"CHSI\") [Member]", "documentation": "Concentra Health Services, Inc. (\"CHSI\")" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.concentra.com/role/VariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Axis]", "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r148", "r355", "r356", "r359", "r360", "r400", "r544", "r726", "r729", "r730" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.concentra.com/role/VariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Domain]", "label": "Consolidated Entities [Domain]" } } }, "auth_ref": [ "r148", "r355", "r356", "r359", "r360", "r400", "r544", "r726", "r729", "r730" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r100", "r148", "r182", "r191", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r250", "r251", "r252", "r253", "r255", "r256", "r257", "r258", "r259", "r553", "r554", "r727", "r728" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r100", "r148", "r182", "r191", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r250", "r251", "r252", "r253", "r255", "r256", "r257", "r258", "r259", "r553", "r554", "r727", "r728" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://www.concentra.com/role/AccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation and Consolidation", "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r30", "r548" ] }, "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy", "presentation": [ "http://www.concentra.com/role/AccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable Non-Controlling Interests", "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest." } } }, "auth_ref": [ "r104" ] }, "us-gaap_ConsolidationVariableInterestEntityPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConsolidationVariableInterestEntityPolicy", "presentation": [ "http://www.concentra.com/role/AccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Interest Entities", "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined)." } } }, "auth_ref": [ "r27", "r33", "r35" ] }, "us-gaap_ContractuallySpecifiedServicingFeesAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractuallySpecifiedServicingFeesAmount", "crdr": "credit", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunauditedParenthetical", "http://www.concentra.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shared service fee from related party", "label": "Contractually Specified Servicing Fees, Amount", "documentation": "All amounts that, per contract, are due to the servicer in exchange for servicing the financial asset and would no longer be received by a servicer if the beneficial owners of the serviced assets (or their trustees or agents) were to exercise their actual or potential authority under the contract to shift the servicing to another servicer. Depending on the servicing contract, those fees may include some or all of the difference between the interest rate collected on the asset being serviced and the rate to be paid to the beneficial owners of the asset." } } }, "auth_ref": [ "r407" ] }, "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of services, exclusive of depreciation and amortization", "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization", "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization." } } }, "auth_ref": [ "r682", "r683" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total costs and expenses", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r68" ] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Costs and expenses:", "label": "Costs and Expenses [Abstract]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditFacilityAxis", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r249", "r724" ] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditFacilityDomain", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r249", "r724", "r725" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayable" ], "lang": { "en-us": { "role": { "verboseLabel": "Long-Term Debt and Notes Payable", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r79", "r144", "r235", "r236", "r237", "r238", "r239", "r248", "r249", "r261", "r267", "r268", "r269", "r270", "r271", "r272", "r277", "r284", "r285", "r287", "r378" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r7", "r46", "r47", "r90", "r91", "r148", "r262", "r263", "r264", "r265", "r266", "r268", "r273", "r274", "r275", "r276", "r278", "r279", "r280", "r281", "r282", "r283", "r558", "r559", "r560", "r561", "r562", "r574", "r691", "r716", "r717", "r718", "r734", "r735" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit spread adjustment", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "verboseLabel": "Principal outstanding", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r7", "r91", "r288" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate of debt (as a percent)", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r49", "r263" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayableCarryingValueOfLongTermDebtDetails", "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r148", "r262", "r263", "r264", "r265", "r266", "r268", "r273", "r274", "r275", "r276", "r278", "r279", "r280", "r281", "r282", "r283", "r286", "r558", "r559", "r560", "r561", "r562", "r574", "r691", "r734", "r735" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r7", "r148", "r262", "r263", "r264", "r265", "r266", "r268", "r273", "r274", "r275", "r276", "r278", "r279", "r280", "r281", "r282", "r283", "r558", "r559", "r560", "r561", "r562", "r574", "r691", "r716", "r717", "r718", "r734", "r735" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentTable", "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayableCarryingValueOfLongTermDebtDetails", "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "Disclosure of information about long-term debt instrument or arrangement." } } }, "auth_ref": [ "r7", "r23", "r24", "r42", "r82", "r83", "r148", "r262", "r263", "r264", "r265", "r266", "r268", "r273", "r274", "r275", "r276", "r278", "r279", "r280", "r281", "r282", "r283", "r286", "r558", "r559", "r560", "r561", "r562", "r574", "r691", "r734", "r735" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r3", "r109", "r693" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current deferred tax liability", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r337", "r338", "r414" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 }, "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "verboseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization, Nonproduction", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r3", "r19" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r306", "r563", "r564", "r565", "r566", "r567", "r568", "r569" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r306", "r563", "r564", "r565", "r566", "r567", "r568", "r569" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.concentra.com/role/RevenueTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of disaggregation of revenue", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r731" ] }, "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Equity in losses of unconsolidated subsidiaries", "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal", "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations." } } }, "auth_ref": [ "r233", "r689", "r714" ] }, "cghp_DistributionMadeToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "DistributionMadeToParent", "crdr": "credit", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Distribution to Parent", "terseLabel": "Distributions to Parent", "label": "Distribution Made To Parent", "documentation": "Distribution Made To Parent" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r597" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r629" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year", "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]" } } }, "auth_ref": [ "r640" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per common share (Note 9):", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited", "http://www.concentra.com/role/EarningsperShareComputationofEPSDetails", "http://www.concentra.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in dollars per share)", "verboseLabel": "Basic EPS (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r133", "r154", "r155", "r156", "r157", "r158", "r159", "r164", "r167", "r175", "r176", "r177", "r181", "r349", "r352", "r368", "r369", "r410", "r430", "r549" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.concentra.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails", "http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic EPS", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasicLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasicLineItems", "presentation": [ "http://www.concentra.com/role/EarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]", "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r167", "r168", "r175" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited", "http://www.concentra.com/role/EarningsperShareComputationofEPSDetails", "http://www.concentra.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Diluted EPS (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r133", "r154", "r155", "r156", "r157", "r158", "r159", "r167", "r175", "r176", "r177", "r181", "r349", "r352", "r368", "r369", "r410", "r430", "r549" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://www.concentra.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails", "http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted EPS", "label": "Earnings Per Share, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.concentra.com/role/EarningsperShare" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r163", "r178", "r179", "r180" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r595" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityDomain", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Entity [Domain]", "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r595" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r595" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r679" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r595" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r595" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r595" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r595" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Footnote", "label": "Equity Awards Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r634" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table", "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]" } } }, "auth_ref": [ "r675" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments", "label": "Equity Awards Adjustments [Member]" } } }, "auth_ref": [ "r675" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table", "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r675" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r6", "r113", "r130", "r131", "r132", "r149", "r150", "r151", "r153", "r158", "r160", "r162", "r183", "r218", "r219", "r232", "r296", "r343", "r344", "r346", "r347", "r348", "r350", "r351", "r352", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r371", "r372", "r373", "r374", "r375", "r376", "r379", "r382", "r391", "r429", "r450", "r451", "r452", "r468", "r531" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r644" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r602", "r612", "r622", "r654" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r599", "r609", "r619", "r651" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r650" ] }, "us-gaap_FinanceLeaseInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseInterestExpense", "crdr": "debit", "calculation": { "http://www.concentra.com/role/LeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest on lease liabilities", "label": "Finance Lease, Interest Expense", "documentation": "Amount of interest expense on finance lease liability." } } }, "auth_ref": [ "r385", "r387", "r575" ] }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseRightOfUseAssetAmortization", "crdr": "debit", "calculation": { "http://www.concentra.com/role/LeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of right-of-use assets", "label": "Finance Lease, Right-of-Use Asset, Amortization", "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease." } } }, "auth_ref": [ "r385", "r387", "r575" ] }, "us-gaap_FiniteLivedCustomerRelationshipsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedCustomerRelationshipsGross", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Customer relationships", "label": "Finite-Lived Customer Relationships, Gross", "documentation": "Amount, before amortization, of finite-lived asset representing customer relationship acquired in business combination, asset acquisition, and from joint venture formation." } } }, "auth_ref": [ "r684", "r713" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r606", "r616", "r626", "r658" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r606", "r616", "r626", "r658" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r606", "r616", "r626", "r658" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r606", "r616", "r626", "r658" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r606", "r616", "r626", "r658" ] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year", "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]" } } }, "auth_ref": [ "r639" ] }, "us-gaap_GainLossOnDispositionOfAssets1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnDispositionOfAssets1", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "(Gain) loss on sale or disposal of assets", "label": "Gain (Loss) on Disposition of Assets", "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee." } } }, "auth_ref": [ "r689" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative, exclusive of depreciation and amortization", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r66", "r511" ] }, "us-gaap_GeneralLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralLiabilityMember", "presentation": [ "http://www.concentra.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General Liability", "label": "General Liability [Member]", "documentation": "Type of business insurance which provides insurance coverage for a wide variety of liability exposures including, but not limited to, contractual liability, product liability and personal injury liability." } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r120", "r221", "r409", "r554", "r556", "r573", "r576", "r711", "r712" ] }, "us-gaap_IPOMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IPOMember", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "IPO", "label": "IPO [Member]", "documentation": "First sale of stock by a private company to the public." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Income before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r62", "r96", "r101", "r411", "r425", "r551", "r553", "r703", "r704", "r705", "r706", "r707" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Equity in losses of unconsolidated subsidiaries", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r3", "r63", "r95", "r182", "r196", "r209", "r216", "r424" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax expense", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r103", "r110", "r161", "r162", "r182", "r197", "r209", "r339", "r340", "r345", "r431", "r570" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for taxes", "label": "Income Taxes Paid, Net", "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax." } } }, "auth_ref": [ "r12", "r141", "r341", "r342" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued liabilities", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities, net of effects of business combinations:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherCurrentAssets", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Other current assets", "label": "Increase (Decrease) in Other Current Assets", "documentation": "Amount of increase (decrease) in current assets classified as other." } } }, "auth_ref": [ "r688" ] }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Other assets", "label": "Increase (Decrease) in Other Noncurrent Assets", "documentation": "Amount of increase (decrease) in noncurrent assets classified as other." } } }, "auth_ref": [ "r688" ] }, "us-gaap_IncreaseDecreaseInPartnersCapitalRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPartnersCapitalRollForward", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Partners' Capital [Roll Forward]", "label": "Increase (Decrease) in Partners' Capital [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInTemporaryEquityRollForward", "presentation": [ "http://www.concentra.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]", "label": "Increase (Decrease) in Temporary Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights", "presentation": [ "http://www.concentra.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails", "http://www.concentra.com/role/EarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Participating shares outstanding (in shares)", "terseLabel": "Weighted average participating shares outstanding (in shares)", "label": "Incremental Common Shares Attributable to Participating Nonvested Shares with Non-forfeitable Dividend Rights", "documentation": "This element represents nonvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents (whether paid or unpaid). Basic and dilutive earnings per share are generally disclosed for such shares using the two-class method." } } }, "auth_ref": [ "r13" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r606", "r616", "r626", "r650", "r658", "r662", "r670" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r668" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r598", "r674" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r598", "r674" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r598", "r674" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseDebt", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest expense on related party debt", "label": "Interest Expense, Debt", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r67", "r281", "r290", "r561", "r562" ] }, "us-gaap_InterestIncomeExpenseNonoperatingNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestIncomeExpenseNonoperatingNet", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income (expense)", "label": "Interest Income (Expense), Nonoperating", "documentation": "Amount of interest income (expense) classified as nonoperating." } } }, "auth_ref": [ "r553", "r686", "r704" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for interest", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r136", "r139", "r140" ] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://www.concentra.com/role/LeasesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.concentra.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease cost", "label": "Lease, Cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r386", "r575" ] }, "us-gaap_LeaseCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseCostAbstract", "presentation": [ "http://www.concentra.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease, Cost [Abstract]", "label": "Lease, Cost [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.concentra.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of lease cost", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r736" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Leases [Abstract]", "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LegalEntityAxis", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal Entity [Axis]", "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeFinanceLeaseDescriptionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeFinanceLeaseDescriptionAbstract", "presentation": [ "http://www.concentra.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance lease cost:", "label": "Lessee, Finance Lease, Description [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LesseeFinanceLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeFinanceLeasesTextBlock", "presentation": [ "http://www.concentra.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Finance Leases [Text Block]", "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability." } } }, "auth_ref": [ "r381" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.concentra.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r381" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited", "http://www.concentra.com/role/VariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities", "terseLabel": "Liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r7", "r46", "r47", "r48", "r51", "r52", "r53", "r54", "r145", "r217", "r250", "r251", "r253", "r254", "r255", "r256", "r257", "r259", "r260", "r356", "r359", "r360", "r370", "r486", "r550", "r593", "r727", "r738", "r739" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities and Equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r61", "r94", "r421", "r576", "r692", "r709", "r733" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r48", "r118", "r145", "r217", "r250", "r251", "r253", "r254", "r255", "r256", "r257", "r259", "r260", "r356", "r359", "r360", "r370", "r576", "r727", "r738", "r739" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Current Liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r45", "r50" ] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditMember", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Line of Credit", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited", "http://www.concentra.com/role/LongTermDebtandNotesPayableCarryingValueOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Long-term debt with related party", "terseLabel": "Long-term revolving promissory note with related party", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r7", "r91", "r274", "r289", "r559", "r560", "r574", "r740" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtAndCapitalLeaseObligations", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt, net of current portion", "label": "Long-Term Debt and Lease Obligation", "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent." } } }, "auth_ref": [ "r7", "r415" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of long-term debt and notes payable", "label": "Long-Term Debt and Lease Obligation, Current", "documentation": "Amount of long-term debt and lease obligation, classified as current." } } }, "auth_ref": [ "r47" ] }, "cghp_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour", "crdr": "credit", "calculation": { "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "parentTag": "cghp_LongTermDebtGrossAndFinanceLeaseObligation", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal After Year Four", "documentation": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal After Year Four" } } }, "auth_ref": [] }, "cghp_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "parentTag": "cghp_LongTermDebtGrossAndFinanceLeaseObligation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Next Twelve Months", "documentation": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Next Twelve Months" } } }, "auth_ref": [] }, "cghp_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "parentTag": "cghp_LongTermDebtGrossAndFinanceLeaseObligation", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Four", "documentation": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Four" } } }, "auth_ref": [] }, "cghp_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "parentTag": "cghp_LongTermDebtGrossAndFinanceLeaseObligation", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Three", "documentation": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Three" } } }, "auth_ref": [] }, "cghp_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "parentTag": "cghp_LongTermDebtGrossAndFinanceLeaseObligation", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Two", "documentation": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Two" } } }, "auth_ref": [] }, "cghp_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "parentTag": "cghp_LongTermDebtGrossAndFinanceLeaseObligation", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Long-Term Debt And Finance Lease Obligation, Repayments Of Principal, Remainder Of Fiscal Year", "documentation": "Long-Term Debt And Finance Lease Obligation, Repayments Of Principal, Remainder Of Fiscal Year" } } }, "auth_ref": [] }, "cghp_LongTermDebtGrossAndFinanceLeaseObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "LongTermDebtGrossAndFinanceLeaseObligation", "crdr": "credit", "calculation": { "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayableCarryingValueOfLongTermDebtDetails", "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total debt", "totalLabel": "Total", "label": "Long-Term Debt, Gross And Finance Lease Obligation", "documentation": "Long-Term Debt, Gross And Finance Lease Obligation" } } }, "auth_ref": [] }, "cghp_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour", "crdr": "credit", "calculation": { "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Long-term Debt, Maturities, Repayments Of Principal After Year Four", "documentation": "Long-term Debt, Maturities, Repayments Of Principal After Year Four" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Long-Term Debt, Maturity, Year One", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r5", "r148", "r279" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Long-Term Debt, Maturity, Year Four", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r5", "r148", "r279" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Long-Term Debt, Maturity, Year Three", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r5", "r148", "r279" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Long-Term Debt, Maturity, Year Two", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r5", "r148", "r279" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year." } } }, "auth_ref": [ "r696" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r7", "r716", "r717", "r718" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r7", "r20", "r716", "r717", "r718" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.concentra.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r244", "r245", "r246", "r247", "r335", "r557", "r720", "r721" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesTable", "presentation": [ "http://www.concentra.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation." } } }, "auth_ref": [ "r244", "r245", "r246", "r247", "r335", "r557", "r720", "r721" ] }, "us-gaap_LossContingencyNewClaimsFiledNumber": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingencyNewClaimsFiledNumber", "presentation": [ "http://www.concentra.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss contingency, new claims filed, number", "label": "Loss Contingency, New Claims Filed, Number", "documentation": "The total number of new claims filed pertaining to a loss contingency during the period." } } }, "auth_ref": [ "r720", "r721" ] }, "cghp_LossContingencyNumberOfPatients": { "xbrltype": "integerItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "LossContingencyNumberOfPatients", "presentation": [ "http://www.concentra.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss contingency, number of patients", "label": "Loss Contingency, Number Of Patients", "documentation": "Loss Contingency, Number Of Patients" } } }, "auth_ref": [] }, "us-gaap_MalpracticeInsuranceAnnualCoverageLimit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MalpracticeInsuranceAnnualCoverageLimit", "crdr": "debit", "presentation": [ "http://www.concentra.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total annual aggregate limit of insurance coverage", "label": "Malpractice Insurance, Annual Coverage Limit", "documentation": "Annual coverage limit provided by the insurance arrangement for malpractice claims." } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r642" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r642" ] }, "cghp_MemberInterestConvertibleConversionRatio": { "xbrltype": "pureItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "MemberInterestConvertibleConversionRatio", "presentation": [ "http://www.concentra.com/role/EarningsperShareNarrativeDetails", "http://www.concentra.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Member interests converted to common shares", "label": "Member Interest, Convertible, Conversion Ratio", "documentation": "Member Interest, Convertible, Conversion Ratio" } } }, "auth_ref": [] }, "us-gaap_MemberUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MemberUnitsMember", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Member Units", "label": "Member Units [Member]", "documentation": "Ownership interest in limited liability company (LLC)." } } }, "auth_ref": [] }, "us-gaap_MembersCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MembersCapital", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_MembersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Members\u2019 contributed capital", "periodStartLabel": "Members' unit, beginning balance", "periodEndLabel": "Members' unit, ending balance", "label": "Members' Capital", "documentation": "Amount of member capital in limited liability company (LLC)." } } }, "auth_ref": [ "r84" ] }, "us-gaap_MembersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MembersEquity", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total Members' Equity", "label": "Members' Equity", "documentation": "Amount of ownership interest in limited liability company (LLC), attributable to the parent entity." } } }, "auth_ref": [ "r84", "r184", "r185", "r186", "r187" ] }, "cghp_MembersUnitsContributedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "MembersUnitsContributedCapitalMember", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Members\u2019 Contributed Capital", "label": "Members Units, Contributed Capital [Member]", "documentation": "Members Units, Contributed Capital" } } }, "auth_ref": [] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Non-controlling interests", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r60", "r93", "r145", "r217", "r250", "r253", "r254", "r255", "r259", "r260", "r370", "r420", "r490" ] }, "us-gaap_MinorityInterestChangeInRedemptionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterestChangeInRedemptionValue", "crdr": "credit", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited", "http://www.concentra.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Redemption value adjustment on non-controlling interests", "terseLabel": "Redemption value adjustment on non-controlling interests", "negatedTerseLabel": "Redemption value adjustment on redeemable non-controlling interests", "label": "Noncontrolling Interest, Change in Redemption Value", "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest." } } }, "auth_ref": [ "r22", "r25", "r80", "r81" ] }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "crdr": "debit", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Distributions to and purchases of non-controlling interests", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders." } } }, "auth_ref": [ "r84" ] }, "us-gaap_MinorityInterestDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterestDisclosureTextBlock", "presentation": [ "http://www.concentra.com/role/RedeemableNonControllingInterests" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable Non-Controlling Interests", "label": "Noncontrolling Interest Disclosure [Text Block]", "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock." } } }, "auth_ref": [ "r87" ] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding member interest", "label": "Subsidiary, Ownership Percentage, Parent", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r661" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r669" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r643" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r138" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Financing activities", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r138" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Investing activities", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r73", "r74", "r75" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Operating activities", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0, "order": 1.0 }, "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited", "http://www.concentra.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails", "http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net income attributable to the Company", "terseLabel": "Net income attributable to the Company", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r65", "r75", "r97", "r116", "r128", "r129", "r132", "r145", "r152", "r154", "r155", "r156", "r157", "r158", "r161", "r162", "r173", "r217", "r250", "r251", "r253", "r254", "r255", "r256", "r257", "r259", "r260", "r349", "r352", "r369", "r370", "r428", "r508", "r529", "r530", "r591", "r727" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited", "http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Net income attributable to non-controlling interests", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r39", "r88", "r128", "r129", "r158", "r161", "r162", "r427", "r685" ] }, "us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAttributableToNonredeemableNoncontrollingInterest", "crdr": "debit", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Net income attributable to non-controlling interests", "negatedTerseLabel": "Net income attributable to non-controlling interests", "label": "Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest", "documentation": "Portion of net income (loss) attributable to nonredeemable noncontrolling interest." } } }, "auth_ref": [ "r64" ] }, "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest", "crdr": "debit", "presentation": [ "http://www.concentra.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net income attributable to redeemable non-controlling interests", "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest." } } }, "auth_ref": [ "r64" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.concentra.com/role/EarningsperShareComputationofEPSDetails", "http://www.concentra.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails", "http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Net income allocated to common shares - basic", "totalLabel": "Distributed and undistributed income attributable to outstanding shares", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r135", "r154", "r155", "r156", "r157", "r164", "r165", "r174", "r177", "r352" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "crdr": "credit", "calculation": { "http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.concentra.com/role/EarningsperShareComputationofEPSDetails", "http://www.concentra.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails", "http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net income allocated to common shares - diluted", "totalLabel": "Distributed and undistributed income attributable to outstanding shares", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r135", "r166", "r169", "r170", "r171", "r172", "r174", "r177" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.concentra.com/role/AccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recent Accounting Guidance Not Yet Adopted", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r642" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r606", "r616", "r626", "r650", "r658" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r633" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r632" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r650" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r669" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r669" ] }, "us-gaap_NoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncontrollingInterestAbstract", "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling Interest [Abstract]", "label": "Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "cghp_NoncontrollingInterestChangeInRedemptionValueNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "NoncontrollingInterestChangeInRedemptionValueNet", "crdr": "credit", "presentation": [ "http://www.concentra.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Redemption value adjustment on redeemable non-controlling interests", "label": "Noncontrolling Interest, Change In Redemption Value, Net", "documentation": "Noncontrolling Interest, Change In Redemption Value, Net" } } }, "auth_ref": [] }, "cghp_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests", "crdr": "debit", "presentation": [ "http://www.concentra.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Distributions to and purchases of redeemable non-controlling interests", "label": "Noncontrolling Interest, Distributions to Redeemable Noncontrolling Interests", "documentation": "Noncontrolling Interest, Distributions to Redeemable Noncontrolling Interests" } } }, "auth_ref": [] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Non-controlling Interests", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r28", "r296", "r697", "r698", "r699", "r700", "r771" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other income and expense:", "label": "Nonoperating Income (Expense) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NonrelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonrelatedPartyMember", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited", "http://www.concentra.com/role/LongTermDebtandNotesPayableCarryingValueOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Nonrelated Party", "label": "Nonrelated Party [Member]", "documentation": "Party not related to reporting entity." } } }, "auth_ref": [ "r694", "r695" ] }, "us-gaap_NotesPayableOtherPayablesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NotesPayableOtherPayablesMember", "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other debt, including finance leases", "label": "Notes Payable, Other Payables [Member]", "documentation": "A written promise to pay a note to a third party." } } }, "auth_ref": [] }, "cghp_NumberOfLessThanWhollyOwnedSubsidiaries": { "xbrltype": "integerItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "NumberOfLessThanWhollyOwnedSubsidiaries", "presentation": [ "http://www.concentra.com/role/RedeemableNonControllingInterestsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of less than wholly owned subsidiaries", "label": "Number Of Less Than Wholly Owned Subsidiaries", "documentation": "Number Of Less Than Wholly Owned Subsidiaries" } } }, "auth_ref": [] }, "cghp_NumberOfOccupationalHealthCentersOperatedByEntity": { "xbrltype": "integerItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "NumberOfOccupationalHealthCentersOperatedByEntity", "presentation": [ "http://www.concentra.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of occupational health centers operated by entity", "label": "Number of Occupational Health Centers Operated by Entity", "documentation": "Number of Occupational Health Centers Operated by Entity" } } }, "auth_ref": [] }, "cghp_NumberOfOnsiteClinicsOperatedByEntity": { "xbrltype": "integerItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "NumberOfOnsiteClinicsOperatedByEntity", "presentation": [ "http://www.concentra.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of onsite clinics", "label": "Number of Onsite Clinics Operated by Entity", "documentation": "Number of Onsite Clinics Operated by Entity" } } }, "auth_ref": [] }, "us-gaap_NumberOfStatesInWhichEntityOperates": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NumberOfStatesInWhichEntityOperates", "presentation": [ "http://www.concentra.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of states in which entity operates", "label": "Number of States in which Entity Operates", "documentation": "The number of states the entity operates in as of the balance sheet date." } } }, "auth_ref": [] }, "cghp_OccupationalHealthCenterConsumerHealthMember": { "xbrltype": "domainItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "OccupationalHealthCenterConsumerHealthMember", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consumer health", "label": "Occupational Health Center, Consumer Health [Member]", "documentation": "Occupational Health Center, Consumer Health" } } }, "auth_ref": [] }, "cghp_OccupationalHealthCenterEmployerServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "OccupationalHealthCenterEmployerServicesMember", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employer services", "label": "Occupational Health Center, Employer Services [Member]", "documentation": "Occupational Health Center, Employer Services" } } }, "auth_ref": [] }, "cghp_OccupationalHealthCenterMember": { "xbrltype": "domainItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "OccupationalHealthCenterMember", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total occupational health center revenue", "label": "Occupational Health Center [Member]", "documentation": "Occupational Health Center" } } }, "auth_ref": [] }, "cghp_OccupationalHealthCenterOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "OccupationalHealthCenterOtherMember", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other occupational health center revenue", "label": "Occupational Health Center, Other [Member]", "documentation": "Occupational Health Center, Other" } } }, "auth_ref": [] }, "cghp_OccupationalHealthCenterWorkersCompensationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "OccupationalHealthCenterWorkersCompensationMember", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Workers\u2019 compensation", "label": "Occupational Health Center, Workers Compensation [Member]", "documentation": "Occupational Health Center, Workers Compensation" } } }, "auth_ref": [] }, "cghp_OnsiteClinicsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "OnsiteClinicsMember", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Onsite clinics", "label": "Onsite Clinics [Member]", "documentation": "Onsite Clinics" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Income from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r101", "r551", "r703", "r704", "r705", "r706", "r707" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://www.concentra.com/role/LeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease cost", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r388", "r575" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Current operating lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r384" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current operating lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r384" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r383" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r204", "r205", "r206", "r207", "r208", "r210", "r553", "r554" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.concentra.com/role/Organization" ], "lang": { "en-us": { "role": { "terseLabel": "Organization", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r43", "r87", "r455", "r456" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.concentra.com/role/AccruedandOtherLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/AccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued other", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r47" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r126", "r576" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r121" ] }, "cghp_OtherBusinessesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "OtherBusinessesMember", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Businesses [Member]", "documentation": "Other Businesses" } } }, "auth_ref": [] }, "us-gaap_OtherIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other identifiable intangible assets, net", "label": "Other Intangible Assets, Net", "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://www.concentra.com/role/VariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Obligations payable", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r47", "r576" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r52" ] }, "us-gaap_OtherOperatingIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherOperatingIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other operating income", "label": "Other Operating Income (Expense), Net", "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r642" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r604", "r614", "r624", "r656" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r607", "r617", "r627", "r659" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r607", "r617", "r627", "r659" ] }, "us-gaap_OverAllotmentOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OverAllotmentOptionMember", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Over-Allotment Option", "label": "Over-Allotment Option [Member]", "documentation": "Right given to the underwriter to sell additional shares over the initial allotment." } } }, "auth_ref": [] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "OwnershipAxis", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership [Axis]", "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "OwnershipDomain", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership [Domain]", "label": "Ownership [Domain]" } } }, "auth_ref": [] }, "us-gaap_ParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ParentMember", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Total Stockholders\u2019 Equity", "label": "Parent [Member]", "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests." } } }, "auth_ref": [] }, "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic", "crdr": "debit", "calculation": { "http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails", "http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Distributed and undistributed income attributable to participating shares - basic EPS", "verboseLabel": "Participating shares - basic", "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic", "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method." } } }, "auth_ref": [ "r174", "r680" ] }, "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted", "crdr": "debit", "calculation": { "http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails", "http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Distributed and undistributed income attributable to participating shares - diluted EPS", "verboseLabel": "Participating shares - diluted", "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted", "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method." } } }, "auth_ref": [ "r174" ] }, "us-gaap_PartnersCapitalAccountUnitBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PartnersCapitalAccountUnitBasedCompensation", "crdr": "credit", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting of restricted interests", "label": "Partners' Capital Account, Unit-Based Payment Arrangement, Amount", "documentation": "Amount of increase (decrease) in partners' capital account for unit-based payment arrangement issued by partnership. Partner includes, but is not limited to, general, limited and preferred partners." } } }, "auth_ref": [ "r84", "r86" ] }, "us-gaap_PartnersCapitalAccountUnitsUnitbasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PartnersCapitalAccountUnitsUnitbasedCompensation", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting of restricted interests (in shares)", "label": "Partners' Capital Account, Unit-Based Payment Arrangement, Number of Units", "documentation": "Number of units issued for unit-based payment arrangement issued by partnership. Partner includes, but is not limited to, general, limited and preferred partners." } } }, "auth_ref": [ "r84" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r631" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsOfCapitalDistribution": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsOfCapitalDistribution", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Distributions to Parent", "label": "Payments of Capital Distribution", "documentation": "Cash outflow to owners or shareholders, excluding ordinary dividends. Includes special dividends." } } }, "auth_ref": [ "r71" ] }, "us-gaap_PaymentsOfDividendsMinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsOfDividendsMinorityInterest", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Distributions to and purchases of non-controlling interests", "label": "Payments of Ordinary Dividends, Noncontrolling Interest", "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests." } } }, "auth_ref": [ "r71" ] }, "us-gaap_PaymentsOfStockIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsOfStockIssuanceCosts", "crdr": "credit", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Underwriting discounts and commissions", "label": "Payments of Stock Issuance Costs", "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security." } } }, "auth_ref": [ "r10" ] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Business combinations, net of cash acquired", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r8" ] }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireIntangibleAssets", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchase of customer relationships", "label": "Payments to Acquire Intangible Assets", "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r70" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r70" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r641" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r641" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r633" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r650" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r643" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r632" ] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Prior Service Cost", "label": "Pension Adjustments Prior Service Cost [Member]" } } }, "auth_ref": [ "r634" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Service Cost", "label": "Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r678" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Benefits Adjustments, Footnote", "label": "Pension Benefits Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r633" ] }, "us-gaap_PrepaidTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidTaxes", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid income taxes", "label": "Prepaid Taxes", "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r547", "r555", "r710" ] }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceInitialPublicOffering", "crdr": "debit", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from initial public offering", "label": "Proceeds from Issuance Initial Public Offering", "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public." } } }, "auth_ref": [ "r1" ] }, "cghp_ProceedsFromIssuanceInitialPublicOfferingAmountNotDistributedToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "ProceedsFromIssuanceInitialPublicOfferingAmountNotDistributedToParent", "crdr": "debit", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net proceeds of IPO and debt financing transactions, excluding amounts repaid for debt", "label": "Proceeds From Issuance Initial Public Offering, Amount Not Distributed To Parent", "documentation": "Proceeds From Issuance Initial Public Offering, Amount Not Distributed To Parent" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings from related party revolving promissory note", "label": "Proceeds from Lines of Credit", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r9", "r691" ] }, "us-gaap_ProceedsFromOtherDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromOtherDebt", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings of other debt", "label": "Proceeds from Other Debt", "documentation": "Amount of cash inflow from debt classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromSaleOfProductiveAssets", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of assets", "label": "Proceeds from Sale of Productive Assets", "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r69" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r212", "r408", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r545", "r563", "r577", "r578", "r579", "r581", "r582", "r722", "r723", "r731", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r212", "r408", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r545", "r563", "r577", "r578", "r579", "r581", "r582", "r722", "r723", "r731", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769" ] }, "us-gaap_ProfessionalMalpracticeLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfessionalMalpracticeLiabilityMember", "presentation": [ "http://www.concentra.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Professional liability claims", "label": "Professional Malpractice Liability Insurance [Member]", "documentation": "Business insurance coverage for professionals, such as doctors, lawyers, insurance agents, accountants, real estate agents, veterinarians, and others. This liability coverage insures losses for claims arising from mistakes and errors or omissions in the course of professional activities." } } }, "auth_ref": [] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited", "http://www.concentra.com/role/EarningsperShareNetIncomeAttributabletotheCompanyUnitsOutstandingandParticipatingUnitsOutstandingDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "terseLabel": "Net income", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r116", "r128", "r129", "r137", "r145", "r152", "r158", "r161", "r162", "r217", "r250", "r251", "r253", "r254", "r255", "r256", "r257", "r259", "r260", "r349", "r352", "r354", "r357", "r358", "r369", "r370", "r411", "r426", "r467", "r508", "r529", "r530", "r571", "r572", "r592", "r685", "r727" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r4", "r390", "r412", "r423", "r576" ] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Provision for expected credit losses", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r134", "r220" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r631" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r631" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r599", "r609", "r619", "r651" ] }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited", "http://www.concentra.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable non-controlling interests", "periodStartLabel": "Balance, beginning", "periodEndLabel": "Balance, ending", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity." } } }, "auth_ref": [ "r21", "r22", "r80", "r81" ] }, "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RedeemableNoncontrollingInterestTableTextBlock", "presentation": [ "http://www.concentra.com/role/RedeemableNonControllingInterestsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of redeemable non-controlling interests", "label": "Redeemable Noncontrolling Interest [Table Text Block]", "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyDomain", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunauditedParenthetical", "http://www.concentra.com/role/LongTermDebtandNotesPayableCarryingValueOfLongTermDebtDetails", "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.concentra.com/role/RelatedPartyTransactionsDetails", "http://www.concentra.com/role/VariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Domain]", "label": "Related and Nonrelated Parties [Domain]", "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r215", "r308", "r395", "r396", "r416", "r422", "r481", "r482", "r483", "r484", "r485", "r505", "r507", "r536" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyMember", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunauditedParenthetical", "http://www.concentra.com/role/LongTermDebtandNotesPayableCarryingValueOfLongTermDebtDetails", "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.concentra.com/role/RelatedPartyTransactionsDetails", "http://www.concentra.com/role/VariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party", "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r146", "r147", "r395", "r396", "r397", "r398", "r416", "r422", "r481", "r482", "r483", "r484", "r485", "r505", "r507", "r536" ] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://www.concentra.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Line Items]", "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r215", "r512", "r513", "r516" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunauditedParenthetical", "http://www.concentra.com/role/LongTermDebtandNotesPayableCarryingValueOfLongTermDebtDetails", "http://www.concentra.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails", "http://www.concentra.com/role/RelatedPartyTransactionsDetails", "http://www.concentra.com/role/VariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Axis]", "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r215", "r308", "r395", "r396", "r416", "r422", "r481", "r482", "r483", "r484", "r485", "r505", "r507", "r536", "r737" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.concentra.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transactions", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r392", "r393", "r394", "r396", "r399", "r463", "r464", "r465", "r514", "r515", "r516", "r534", "r535" ] }, "us-gaap_RepaymentsOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfDebt", "crdr": "credit", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments of debt", "label": "Repayments of Debt", "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation." } } }, "auth_ref": [ "r687" ] }, "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfDebtAndCapitalLeaseObligations", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Principal payments on other debt", "label": "Repayments of Debt and Lease Obligation", "documentation": "Amount of cash outflow for short-term and long-term debt and lease obligation." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLongTermLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfLongTermLinesOfCredit", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on related party revolving promissory note", "label": "Repayments of Long-Term Lines of Credit", "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer." } } }, "auth_ref": [ "r72" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r600", "r610", "r620", "r652" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r601", "r611", "r621", "r653" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r608", "r618", "r628", "r660" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r58", "r84", "r419", "r453", "r454", "r462", "r489", "r576" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Retained Earnings", "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r113", "r149", "r150", "r151", "r153", "r158", "r160", "r162", "r218", "r219", "r232", "r343", "r344", "r346", "r347", "r348", "r350", "r351", "r352", "r361", "r363", "r364", "r366", "r367", "r379", "r382", "r450", "r452", "r468", "r771" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "terseLabel": "Revenue from Contract with Customer [Abstract]", "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited", "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r99", "r100", "r182", "r190", "r191", "r204", "r209", "r212", "r213", "r214", "r305", "r306", "r408" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.concentra.com/role/Revenue" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r111", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r307" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Revolving Credit Facility", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r669" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r669" ] }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockConsiderationReceivedOnTransaction", "crdr": "debit", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net proceeds received", "label": "Sale of Stock, Consideration Received on Transaction", "documentation": "Cash received on stock transaction after deduction of issuance costs." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of Stock [Domain]", "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares issued in initial public offering (in shares)", "label": "Sale of Stock, Number of Shares Issued in Transaction", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockPricePerShare", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of stock, price per share (in dollars per share)", "label": "Sale of Stock, Price Per Share", "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.concentra.com/role/AccruedandOtherLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Components of accrued and other liabilities", "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://www.concentra.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r353" ] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayableTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of long-term debt and notes payable", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r7", "r23", "r24", "r42", "r82", "r83", "r559", "r561", "r696", "r734" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.concentra.com/role/EarningsperShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of computation of basic and diluted earnings per share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r702" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable", "presentation": [ "http://www.concentra.com/role/EarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]", "label": "Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]", "documentation": "Disclosure of information about basic earnings per share by class of stock. Includes, but is not limited to, two-class method." } } }, "auth_ref": [ "r14", "r15", "r167", "r168", "r175" ] }, "us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis", "presentation": [ "http://www.concentra.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Insurance Type and Tier Identifier [Axis]", "label": "Insurance Type and Tier Identifier [Axis]", "documentation": "Information by type of insurance coverage or layer of insurance that covers malpractice claims." } } }, "auth_ref": [ "r98" ] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://www.concentra.com/role/LongTermDebtandNotesPayableTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of principal maturities of long-term debt and notes payable", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://www.concentra.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Table]", "label": "Related Party Transaction [Table]", "documentation": "Disclosure of information about related party transaction." } } }, "auth_ref": [ "r40", "r41", "r512", "r513", "r516" ] }, "us-gaap_ScheduleOfVariableInterestEntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfVariableInterestEntitiesTable", "presentation": [ "http://www.concentra.com/role/VariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Variable Interest Entities [Table]", "label": "Variable Interest Entity [Table]", "documentation": "Disclosure of information about variable interest held, whether or not such variable interest entity (VIE) is included in consolidated financial statements." } } }, "auth_ref": [ "r31", "r32", "r34", "r36", "r37", "r355", "r356", "r359", "r360", "r404", "r405", "r406" ] }, "us-gaap_SecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SecuredDebtMember", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Term loan", "label": "Secured Debt [Member]", "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r594" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r596" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentDomain", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r99", "r100", "r101", "r102", "r182", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r214", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r240", "r241", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r552", "r553", "r554", "r556", "r580", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769" ] }, "cghp_SelectMedicalCorporationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "SelectMedicalCorporationMember", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Select Medical Corporation", "label": "Select Medical Corporation [Member]", "documentation": "Select Medical Corporation [Member]" } } }, "auth_ref": [] }, "cghp_SelectMedicalRevolvingPromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "SelectMedicalRevolvingPromissoryNoteMember", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Select Medical Revolving Promissory Note", "label": "Select Medical Revolving Promissory Note [Member]", "documentation": "Select Medical Revolving Promissory Note" } } }, "auth_ref": [] }, "us-gaap_SeniorNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeniorNotesMember", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior notes", "label": "Senior Notes [Member]", "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors." } } }, "auth_ref": [] }, "cghp_SeniorSecuredCreditFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.concentra.com/20240630", "localname": "SeniorSecuredCreditFacilitiesMember", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Secured Credit Facilities", "label": "Senior Secured Credit Facilities [Member]", "documentation": "Senior Secured Credit Facilities" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Stock compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r2" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Award Types", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.concentra.com/role/AccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r76", "r143" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.concentra.com/role/RevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r99", "r100", "r101", "r102", "r115", "r182", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r214", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r234", "r240", "r241", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r552", "r553", "r554", "r556", "r580", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited", "http://www.concentra.com/role/EarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r112", "r123", "r124", "r125", "r145", "r167", "r168", "r175", "r177", "r186", "r187", "r217", "r250", "r253", "r254", "r255", "r259", "r260", "r291", "r292", "r293", "r294", "r295", "r370", "r458", "r459", "r460", "r461", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r488", "r509", "r531", "r537", "r538", "r539", "r540", "r541", "r681", "r690", "r701" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r6", "r56", "r59", "r60", "r113", "r130", "r131", "r132", "r149", "r150", "r151", "r153", "r158", "r160", "r162", "r183", "r218", "r219", "r232", "r296", "r343", "r344", "r346", "r347", "r348", "r350", "r351", "r352", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r371", "r372", "r373", "r374", "r375", "r376", "r379", "r382", "r391", "r429", "r450", "r451", "r452", "r468", "r531" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r149", "r150", "r151", "r183", "r382", "r408", "r457", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r488", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r501", "r502", "r503", "r504", "r505", "r507", "r510", "r511", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r531", "r586" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofOperationsunauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r149", "r150", "r151", "r183", "r215", "r382", "r408", "r457", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r488", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r501", "r502", "r503", "r504", "r505", "r507", "r510", "r511", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r531", "r586" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r603", "r613", "r623", "r655" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited", "http://www.concentra.com/role/EarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Conversion of LLC to Corporation and Impact of Reverse Stock Split (in shares)", "terseLabel": "Conversion of LLC to Corporation and Impact of Reverse Stock Split (in shares)", "netLabel": "Conversion of units (in shares)", "label": "Stock Issued During Period, Shares, Conversion of Units", "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)." } } }, "auth_ref": [ "r6", "r23", "r55", "r56", "r84" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueConversionOfUnits", "crdr": "credit", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Conversion of LLC to Corporation and Impact of Reverse Stock Split", "terseLabel": "Conversion of LLC to Corporation and Impact of Reverse Stock Split", "label": "Stock Issued During Period, Value, Conversion of Units", "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)." } } }, "auth_ref": [ "r6", "r56", "r59", "r60", "r84" ] }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "crdr": "debit", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repurchase of common shares", "label": "Stock Repurchased and Retired During Period, Value", "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital)." } } }, "auth_ref": [ "r6", "r55", "r56", "r84" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total Stockholders' Equity", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r56", "r59", "r60", "r77", "r490", "r506", "r532", "r533", "r576", "r593", "r692", "r709", "r733", "r771" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedBalanceSheetsunaudited", "http://www.concentra.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquityunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total Equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r28", "r29", "r38", "r113", "r114", "r131", "r149", "r150", "r151", "r153", "r158", "r160", "r218", "r219", "r232", "r296", "r343", "r344", "r346", "r347", "r348", "r350", "r351", "r352", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r371", "r372", "r376", "r380", "r391", "r451", "r452", "r466", "r490", "r506", "r532", "r533", "r542", "r592", "r692", "r709", "r733", "r771" ] }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "presentation": [ "http://www.concentra.com/role/EarningsperShareNarrativeDetails", "http://www.concentra.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock split conversion ratio", "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio", "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one." } } }, "auth_ref": [ "r85" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventLineItems", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Line Items]", "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r377", "r402" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventMember", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r377", "r402" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTable", "presentation": [ "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Table]", "label": "Subsequent Event [Table]", "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued." } } }, "auth_ref": [ "r377", "r402" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Axis]", "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r377", "r402" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Domain]", "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r377", "r402" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events [Abstract]", "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.concentra.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r401", "r403" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://www.concentra.com/role/OrganizationDetails", "http://www.concentra.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of Stock [Axis]", "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.concentra.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental information", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r649" ] }, "us-gaap_TaxesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TaxesPayableCurrent", "crdr": "credit", "calculation": { "http://www.concentra.com/role/AccruedandOtherLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.concentra.com/role/AccruedandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes payable", "label": "Taxes Payable, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r46", "r47" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r641" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r648" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r668" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r670" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.concentra.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r671" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r672" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration Date", "label": "Trading Arrangement Expiration Date" } } }, "auth_ref": [ "r672" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r670" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r670" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r673" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r671" ] }, "us-gaap_TypeAndTierIdentifierDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TypeAndTierIdentifierDomain", "presentation": [ "http://www.concentra.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type and Tier Identifier [Domain]", "label": "Type and Tier Identifier [Domain]", "documentation": "Name of the type of insurance coverage or layer of insurance that covers malpractice claims." } } }, "auth_ref": [ "r98" ] }, "us-gaap_UndistributedEarningsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UndistributedEarningsAbstract", "presentation": [ "http://www.concentra.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Income Allocation", "label": "Undistributed Earnings, Basic [Abstract]" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r667" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://www.concentra.com/role/AccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r16", "r17", "r18", "r105", "r106", "r107", "r108" ] }, "us-gaap_VariableInterestEntityDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VariableInterestEntityDisclosureTextBlock", "presentation": [ "http://www.concentra.com/role/VariableInterestEntities" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Interest Entities", "label": "Variable Interest Entity Disclosure [Text Block]", "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss." } } }, "auth_ref": [ "r87" ] }, "us-gaap_VariableInterestEntityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VariableInterestEntityLineItems", "presentation": [ "http://www.concentra.com/role/VariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Interest Entity [Line Items]", "label": "Variable Interest Entity [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r355", "r356", "r359", "r360", "r404", "r405", "r406" ] }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "presentation": [ "http://www.concentra.com/role/VariableInterestEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Interest Entity, Primary Beneficiary", "label": "Variable Interest Entity, Primary Beneficiary [Member]", "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity." } } }, "auth_ref": [ "r31", "r355", "r356", "r359", "r360" ] }, "us-gaap_VariableLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VariableLeaseCost", "crdr": "debit", "calculation": { "http://www.concentra.com/role/LeasesDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.concentra.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable lease cost", "label": "Variable Lease, Cost", "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases." } } }, "auth_ref": [ "r389", "r575" ] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year", "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]" } } }, "auth_ref": [ "r637" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://www.concentra.com/role/EarningsperShareComputationofEPSDetails", "http://www.concentra.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average common shares outstanding, diluted (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r166", "r177" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://www.concentra.com/role/EarningsperShareComputationofEPSDetails", "http://www.concentra.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average common shares outstanding, basic (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r164", "r177" ] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested", "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r635" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "68B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-68B" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "(12)(c)", "Section": "S99", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "(16)(c)", "Paragraph": "3A", "Section": "S99", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "710", "SubTopic": "10", "Section": "25", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483070/710-10-25-3" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Paragraph": "2AA", "Subparagraph": "(a)", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-2AA" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-6" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-9" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205/tableOfContent" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(14)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(15)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 4.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "954", "SubTopic": "450", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477850/954-450-50-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/606/tableOfContent" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/260/tableOfContent" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-4" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/842-20/tableOfContent" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/850/tableOfContent" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r546": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r549": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r550": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r551": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r552": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r553": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r554": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r555": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5" }, "r556": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r557": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27" }, "r558": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r559": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r560": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r561": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r562": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r563": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r564": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r565": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r566": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r567": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r568": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r569": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r570": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r571": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r572": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r573": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r574": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r575": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53" }, "r576": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r577": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r578": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r579": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r580": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r581": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r582": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r583": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r585": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r589": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r590": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r591": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r592": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r593": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r594": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r595": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r596": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r598": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r599": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r600": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r601": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r602": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r603": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r604": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r605": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r606": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r607": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r608": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r609": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r610": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r611": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r612": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r613": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r614": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r615": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r616": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r617": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r618": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r619": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r620": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r621": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r622": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r623": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r624": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r625": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r626": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r627": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r628": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r629": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r631": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r632": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r633": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r634": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "ii" }, "r635": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "i" }, "r636": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "ii" }, "r637": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iii" }, "r638": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iv" }, "r639": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "v" }, "r640": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "vi" }, "r641": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r642": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r643": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r644": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r645": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r646": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r647": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r648": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r649": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r650": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r651": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r652": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r653": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r654": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r655": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r656": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r657": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r658": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r659": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r660": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r661": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r662": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r663": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r664": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r665": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r666": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r667": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r668": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r669": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r670": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r671": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r672": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r673": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r674": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r675": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Number": "229", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1" }, "r676": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "A", "Number": "229" }, "r677": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Number": "229" }, "r678": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "i", "Number": "229" }, "r679": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r680": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60" }, "r681": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r682": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r683": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r684": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r685": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r686": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r687": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r688": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r689": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r690": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r691": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r692": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r693": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r694": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r695": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r696": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r697": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r698": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r699": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r700": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r701": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r702": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r703": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r704": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r705": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r706": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r707": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r708": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r709": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r710": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1" }, "r711": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r712": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r713": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r714": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5" }, "r715": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r716": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r717": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r718": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r719": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r720": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r721": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r722": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r723": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r724": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r725": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r726": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r727": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r728": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r729": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r730": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r731": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r732": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r733": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r734": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r735": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r736": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r737": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r738": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r739": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r740": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r741": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r742": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r743": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r744": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r745": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r746": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r747": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r748": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r749": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r750": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r751": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r752": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r753": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r754": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r755": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r756": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r757": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r758": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r759": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r760": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r761": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r762": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r763": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r764": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r765": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r766": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r767": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r768": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r769": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r770": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r771": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r772": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } } ZIP 63 0001628280-24-038538-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-24-038538-xbrl.zip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�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end XML 64 cghp-20240630_htm.xml IDEA: XBRL DOCUMENT 0002014596 2024-01-01 2024-06-30 0002014596 2024-07-31 0002014596 2024-06-30 0002014596 2023-12-31 0002014596 us-gaap:NonrelatedPartyMember 2024-06-30 0002014596 us-gaap:NonrelatedPartyMember 2023-12-31 0002014596 us-gaap:RelatedPartyMember 2024-06-30 0002014596 us-gaap:RelatedPartyMember 2023-12-31 0002014596 2024-04-01 2024-06-30 0002014596 2023-04-01 2023-06-30 0002014596 2023-01-01 2023-06-30 0002014596 us-gaap:RelatedPartyMember 2024-04-01 2024-06-30 0002014596 us-gaap:RelatedPartyMember 2023-04-01 2023-06-30 0002014596 us-gaap:RelatedPartyMember 2024-01-01 2024-06-30 0002014596 us-gaap:RelatedPartyMember 2023-01-01 2023-06-30 0002014596 us-gaap:MemberUnitsMember 2023-12-31 0002014596 cghp:MembersUnitsContributedCapitalMember 2023-12-31 0002014596 us-gaap:CommonStockMember 2023-12-31 0002014596 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0002014596 us-gaap:RetainedEarningsMember 2023-12-31 0002014596 us-gaap:ParentMember 2023-12-31 0002014596 us-gaap:NoncontrollingInterestMember 2023-12-31 0002014596 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0002014596 us-gaap:ParentMember 2024-01-01 2024-03-31 0002014596 2024-01-01 2024-03-31 0002014596 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0002014596 cghp:MembersUnitsContributedCapitalMember 2024-01-01 2024-03-31 0002014596 us-gaap:MemberUnitsMember 2024-01-01 2024-03-31 0002014596 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0002014596 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0002014596 us-gaap:MemberUnitsMember 2024-03-31 0002014596 cghp:MembersUnitsContributedCapitalMember 2024-03-31 0002014596 us-gaap:CommonStockMember 2024-03-31 0002014596 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0002014596 us-gaap:RetainedEarningsMember 2024-03-31 0002014596 us-gaap:ParentMember 2024-03-31 0002014596 us-gaap:NoncontrollingInterestMember 2024-03-31 0002014596 2024-03-31 0002014596 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0002014596 us-gaap:ParentMember 2024-04-01 2024-06-30 0002014596 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0002014596 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0002014596 us-gaap:MemberUnitsMember 2024-06-30 0002014596 cghp:MembersUnitsContributedCapitalMember 2024-06-30 0002014596 us-gaap:CommonStockMember 2024-06-30 0002014596 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0002014596 us-gaap:RetainedEarningsMember 2024-06-30 0002014596 us-gaap:ParentMember 2024-06-30 0002014596 us-gaap:NoncontrollingInterestMember 2024-06-30 0002014596 us-gaap:CommonClassAMember 2022-12-31 0002014596 us-gaap:CommonClassBMember 2022-12-31 0002014596 us-gaap:CommonClassCMember 2022-12-31 0002014596 cghp:MembersUnitsContributedCapitalMember 2022-12-31 0002014596 us-gaap:RetainedEarningsMember 2022-12-31 0002014596 us-gaap:MemberUnitsMember 2022-12-31 0002014596 us-gaap:NoncontrollingInterestMember 2022-12-31 0002014596 2022-12-31 0002014596 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0002014596 us-gaap:MemberUnitsMember 2023-01-01 2023-03-31 0002014596 2023-01-01 2023-03-31 0002014596 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0002014596 cghp:MembersUnitsContributedCapitalMember 2023-01-01 2023-03-31 0002014596 us-gaap:CommonClassCMember 2023-01-01 2023-03-31 0002014596 us-gaap:CommonClassAMember 2023-03-31 0002014596 us-gaap:CommonClassBMember 2023-03-31 0002014596 us-gaap:CommonClassCMember 2023-03-31 0002014596 cghp:MembersUnitsContributedCapitalMember 2023-03-31 0002014596 us-gaap:RetainedEarningsMember 2023-03-31 0002014596 us-gaap:MemberUnitsMember 2023-03-31 0002014596 us-gaap:NoncontrollingInterestMember 2023-03-31 0002014596 2023-03-31 0002014596 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0002014596 us-gaap:MemberUnitsMember 2023-04-01 2023-06-30 0002014596 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0002014596 cghp:MembersUnitsContributedCapitalMember 2023-04-01 2023-06-30 0002014596 us-gaap:CommonClassAMember 2023-06-30 0002014596 us-gaap:CommonClassBMember 2023-06-30 0002014596 us-gaap:CommonClassCMember 2023-06-30 0002014596 cghp:MembersUnitsContributedCapitalMember 2023-06-30 0002014596 us-gaap:RetainedEarningsMember 2023-06-30 0002014596 us-gaap:MemberUnitsMember 2023-06-30 0002014596 us-gaap:NoncontrollingInterestMember 2023-06-30 0002014596 2023-06-30 0002014596 cghp:ConcentraGroupHoldingsParentMember cghp:SelectMedicalCorporationMember 2024-06-30 0002014596 2024-03-04 2024-03-04 0002014596 us-gaap:SubsequentEventMember us-gaap:IPOMember 2024-07-26 2024-07-26 0002014596 us-gaap:SubsequentEventMember us-gaap:IPOMember 2024-07-26 0002014596 2024-06-25 2024-06-25 0002014596 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2024-06-30 0002014596 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2023-12-31 0002014596 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:RelatedPartyMember 2024-06-30 0002014596 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:RelatedPartyMember 2023-12-31 0002014596 us-gaap:NotesPayableOtherPayablesMember 2024-06-30 0002014596 cghp:OccupationalHealthCenterWorkersCompensationMember 2024-04-01 2024-06-30 0002014596 cghp:OccupationalHealthCenterWorkersCompensationMember 2023-04-01 2023-06-30 0002014596 cghp:OccupationalHealthCenterWorkersCompensationMember 2024-01-01 2024-06-30 0002014596 cghp:OccupationalHealthCenterWorkersCompensationMember 2023-01-01 2023-06-30 0002014596 cghp:OccupationalHealthCenterEmployerServicesMember 2024-04-01 2024-06-30 0002014596 cghp:OccupationalHealthCenterEmployerServicesMember 2023-04-01 2023-06-30 0002014596 cghp:OccupationalHealthCenterEmployerServicesMember 2024-01-01 2024-06-30 0002014596 cghp:OccupationalHealthCenterEmployerServicesMember 2023-01-01 2023-06-30 0002014596 cghp:OccupationalHealthCenterConsumerHealthMember 2024-04-01 2024-06-30 0002014596 cghp:OccupationalHealthCenterConsumerHealthMember 2023-04-01 2023-06-30 0002014596 cghp:OccupationalHealthCenterConsumerHealthMember 2024-01-01 2024-06-30 0002014596 cghp:OccupationalHealthCenterConsumerHealthMember 2023-01-01 2023-06-30 0002014596 cghp:OccupationalHealthCenterOtherMember 2024-04-01 2024-06-30 0002014596 cghp:OccupationalHealthCenterOtherMember 2023-04-01 2023-06-30 0002014596 cghp:OccupationalHealthCenterOtherMember 2024-01-01 2024-06-30 0002014596 cghp:OccupationalHealthCenterOtherMember 2023-01-01 2023-06-30 0002014596 us-gaap:OperatingSegmentsMember cghp:OccupationalHealthCenterMember 2024-04-01 2024-06-30 0002014596 us-gaap:OperatingSegmentsMember cghp:OccupationalHealthCenterMember 2023-04-01 2023-06-30 0002014596 us-gaap:OperatingSegmentsMember cghp:OccupationalHealthCenterMember 2024-01-01 2024-06-30 0002014596 us-gaap:OperatingSegmentsMember cghp:OccupationalHealthCenterMember 2023-01-01 2023-06-30 0002014596 us-gaap:OperatingSegmentsMember cghp:OnsiteClinicsMember 2024-04-01 2024-06-30 0002014596 us-gaap:OperatingSegmentsMember cghp:OnsiteClinicsMember 2023-04-01 2023-06-30 0002014596 us-gaap:OperatingSegmentsMember cghp:OnsiteClinicsMember 2024-01-01 2024-06-30 0002014596 us-gaap:OperatingSegmentsMember cghp:OnsiteClinicsMember 2023-01-01 2023-06-30 0002014596 us-gaap:OperatingSegmentsMember cghp:OtherBusinessesMember 2024-04-01 2024-06-30 0002014596 us-gaap:OperatingSegmentsMember cghp:OtherBusinessesMember 2023-04-01 2023-06-30 0002014596 us-gaap:OperatingSegmentsMember cghp:OtherBusinessesMember 2024-01-01 2024-06-30 0002014596 us-gaap:OperatingSegmentsMember cghp:OtherBusinessesMember 2023-01-01 2023-06-30 0002014596 us-gaap:CommonClassAMember 2023-12-31 0002014596 us-gaap:CommonClassBMember 2023-12-31 0002014596 us-gaap:CommonClassCMember 2023-12-31 0002014596 us-gaap:ProfessionalMalpracticeLiabilityMember 2024-01-01 2024-06-30 0002014596 us-gaap:GeneralLiabilityMember 2024-01-01 2024-06-30 0002014596 2024-02-29 0002014596 us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2024-07-26 2024-07-26 0002014596 cghp:SeniorSecuredCreditFacilitiesMember us-gaap:SubsequentEventMember us-gaap:IPOMember cghp:ConcentraHealthServicesInc.CHSIMember 2024-07-26 0002014596 cghp:A6.875SeniorNotesDue2032Member us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember us-gaap:IPOMember cghp:ConcentraHealthServicesInc.CHSIMember 2024-07-26 0002014596 us-gaap:SecuredDebtMember us-gaap:SubsequentEventMember us-gaap:IPOMember cghp:ConcentraHealthServicesInc.CHSIMember 2024-07-26 0002014596 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:SubsequentEventMember us-gaap:IPOMember cghp:ConcentraHealthServicesInc.CHSIMember 2024-07-26 0002014596 us-gaap:SecuredDebtMember us-gaap:SubsequentEventMember us-gaap:IPOMember cghp:ConcentraHealthServicesInc.CHSIMember 2024-07-26 2024-07-26 0002014596 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:SubsequentEventMember us-gaap:IPOMember cghp:ConcentraHealthServicesInc.CHSIMember 2024-07-26 2024-07-26 0002014596 cghp:SelectMedicalRevolvingPromissoryNoteMember us-gaap:SubsequentEventMember us-gaap:IPOMember 2024-07-26 2024-07-26 0002014596 cghp:ConcentraGroupHoldingsParentMember us-gaap:SubsequentEventMember us-gaap:IPOMember cghp:SelectMedicalCorporationMember 2024-07-26 shares iso4217:USD iso4217:USD shares cghp:health_center cghp:clinic cghp:state pure cghp:less_than_wholly_owned_subsidiary cghp:patient cghp:class_action_lawsuit 0002014596 false --12-31 2024 Q2 0.233 0.233 10-Q true 2024-06-30 false 001-42188 CONCENTRA GROUP HOLDINGS PARENT, INC. DE 30-1006613 4714 Gettysburg Road P.O. Box 2034 Mechanicsburg PA 17055 717 972-1100 Common Stock, par value $0.01 per share CON NYSE No Yes Non-accelerated Filer false false false 126593503 50669000 31374000 228964000 216194000 2010000 7979000 38663000 38871000 320306000 294418000 399464000 397852000 186879000 178370000 1233406000 1229745000 105459000 117259000 107409000 107510000 10415000 8406000 2363338000 2333560000 73517000 72946000 4682000 1455000 23674000 20413000 4360000 3354000 158920000 176466000 265153000 274634000 359736000 357310000 3048000 3291000 420000000 470000000 21994000 23364000 23015000 27522000 1092946000 1156121000 18410000 16477000 0 470303000 0.01 447081000 104094000 104094000 1041000 0 461520000 0 784217000 685293000 1246778000 1155596000 5204000 5366000 1251982000 1160962000 2363338000 2333560000 477915000 467079000 945513000 923377000 339273000 329836000 676263000 657914000 36828000 37003000 73737000 71653000 17870000 18283000 36355000 36593000 393971000 385122000 786355000 766160000 0 151000 284000 151000 83944000 82108000 159442000 157368000 -3676000 0 -3676000 -526000 9318000 11500000 19289000 22576000 205000 17000 94000 -44000 71155000 70625000 136571000 134222000 18096000 16593000 33233000 32759000 53059000 54032000 103338000 101463000 1322000 1290000 2645000 2457000 51737000 52742000 100693000 99006000 0.50 0.50 0.51 0.51 0.97 0.97 0.95 0.95 3800000 3700000 7700000 7300000 447081000 470303000 0 0 0 685293000 1155596000 5366000 1160962000 48956000 48956000 48956000 0 -270000 -270000 -6891000 -6891000 -6891000 0 369000 369000 -1901000 -1901000 -1901000 -447081000 -463412000 104094000 1041000 462371000 0 0 0 0 104094000 1041000 462371000 732348000 1195760000 5267000 1201027000 51737000 51737000 51737000 0 -244000 -244000 -851000 -851000 -851000 0 307000 307000 132000 132000 132000 0 0 104094000 1041000 461520000 784217000 1246778000 5204000 1251982000 435000000 8498000 2770000 464725000 508592000 973317000 6026000 979343000 46264000 46264000 46264000 0 -253000 -253000 2797000 2797000 2797000 248000 178000 178000 178000 0 221000 221000 -435000 -435000 -435000 435000000 8498000 3018000 467700000 554421000 1022121000 6058000 1028179000 52742000 52742000 52742000 0 -297000 -297000 -3352000 -3352000 -3352000 -195000 -195000 495000 300000 0 343000 343000 -3000 -3000 -3000 435000000 8498000 3018000 464543000 607160000 1071703000 5517000 1077220000 103338000 101463000 36355000 36593000 59000 185000 -3676000 -526000 -42000 14000 332000 178000 -1618000 -3265000 12829000 27011000 -1224000 9944000 4217000 -1796000 -11307000 -966000 115055000 99541000 5144000 1446000 0 4382000 32494000 25864000 23000 20000 -37615000 -31672000 10000000 0 60000000 70000000 6618000 5471000 4378000 4074000 2643000 3130000 7742000 555000 -58145000 -72288000 19295000 -4419000 31374000 37657000 50669000 33238000 19512000 22784000 34009000 32445000 Organization<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentra Group Holdings Parent, LLC (“Concentra Group Holdings Parent”) was formed in October 2017 and converted to a Delaware corporation, Concentra Group Holdings Parent, Inc., on March 4, 2024. At the time of formation, Concentra Group Holdings Parent elected to be taxed as a corporation. The Company conducts substantially all of its business through Concentra Inc. and its subsidiaries. Concentra Group Holdings Parent and its subsidiaries are collectively referred to as the “Company.”</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is the largest provider of occupational health services in the United States based on number of facilities. As of June 30, 2024, the Company operated 547 occupational health centers and 154 onsite clinics at employer worksites in 42 states. The Company provides a diverse and comprehensive array of occupational health services, including workers’ compensation and employers services, and consumer health services. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently operates as an operating segment of Select Medical Corporation (“Select” or the “Parent”). As of June 30, 2024, Select Medical Corporation (“Select” or the “Parent”) owns 100.0% of the outstanding common shares of the Company on a fully diluted basis. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 3, 2024, Select announced its intention to separate the Company into a new, publicly traded company through a spin-off distribution in 2024. On February 27, 2024, Select received a private letter ruling from the U.S. Internal Revenue Service to the effect that the distribution of Concentra’s common stock to Select and its stockholders will be tax-free for U.S. federal income tax purposes. On March 4, 2024, the member interests of the Company converted to common shares on a one-for-one basis. On June 24, 2024, the Company’s Board of Directors approved a reverse stock split at a ratio of one share of common stock for every 4.295 shares of common stock, which was effectuated on June 25, 2024. In accordance with ASC 260, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the recapitalization of the Company into a stock corporation and the reverse stock split have been retrospectively reflected in the Company’s earnings per unit calculation for all periods presented, see Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earning per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On July 26, 2024, Concentra completed an initial public offering (“IPO”) of 22,500,000 shares of its common stock, par value $0.01 per share, at an initial public offering price of $23.50 per share for the net proceeds of $499.7 million after deducting underwriting discounts and commission of $29.1 million. See Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on the IPO and the related debt transactions.</span></div> 547 154 42 1.000 1 22500000 0.01 23.50 499700000 29100000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Policies</span><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically operated as part of Select. The unaudited condensed consolidated financial statements of the Company have been prepared from Select’s historical accounting records and are derived from the condensed consolidated financial statements of Select to present Concentra as if it had been operating on a standalone basis. The unaudited condensed consolidated financial statements of the Company as of June 30, 2024, and for the three and six month periods ended June 30, 2024 and 2023, have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim reporting and the accounting principles generally accepted in the United States of America (“U.S. GAAP”). Accordingly, certain information and disclosures required by GAAP, which are normally included in the notes to the consolidated financial statements, have been condensed or omitted pursuant to those rules and regulations, although the Company believes the disclosure is adequate to make the information presented not misleading. In the opinion of management, such information contains all adjustments, which are normal and recurring in nature, necessary for a fair statement of the financial position, results of operations and cash flow for such periods. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the full fiscal year ended December 31, 2024. These unaudited condensed consolidated financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes as contained in the Company’s registration statement on Form S-1, as amended (File No. 333-280242) (the “Registration Statement”).</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the assets, liabilities, revenue, and expenses based on our legal entity structure as well as direct and indirect costs that are attributable to our operations. Indirect costs are the costs of support functions that are partially provided on a centralized basis by Select and its affiliates, which include finance, human resources, benefits administration, procurement support, information technology, legal, corporate governance and other professional </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services. Indirect costs have been allocated to us for the purposes of preparing the condensed consolidated financial statements based on a specific identification basis or, when specific identification is not practicable, a proportional cost allocation method, primarily based on headcount or other allocation methodologies that are considered to be a reasonable reflection of the utilization of services provided or the benefit received by us during the periods presented, depending on the nature of the services received.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax amounts in these condensed consolidated financial statements have been calculated based on a separate return methodology and are presented as if our income gave rise to separate federal and state consolidated income tax return filing obligations in the respective jurisdictions in which we operate. Adjustments to income tax expense resulting from the application of the separate return methodology, as compared to tax obligations determined by the Company’s inclusion in the Parent’s consolidated income tax provision, were assumed to be immediately settled with the Parent through Contributed Capital/Capital in Excess of Par as reflected on the Condensed Consolidated Balance Sheets, and reflected as a (Distribution)/Contribution to Parent on the Condensed Consolidated Statements of Changes in Stockholders’/Members’ Equity and the Condensed Consolidated Statements of Cash Flows within financing activities. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of Concentra and the subsidiaries and variable interest entities in which Concentra has a controlling financial interest. All intercompany balances and transactions within the Company are eliminated in consolidation. Transactions between the Company and Select have been included in these consolidated financial statements. The transfers with Select are expected to be settled in cash, other than the assumed income tax settlement noted above, and are reflected within the consolidated statement of cash flows as an operating or financing activity determined by the nature of the transaction. Select’s third-party debt and related interest expense have not been attributed to the Company because the Company is not the primary legal obligor of the debt and the borrowings are not specifically identifiable to the Company. However, the Company was a guarantor for Select’s senior notes and credit facilities until the guarantee was released at the closing of the IPO. The Company maintains its own cash management system and does not participate in a centralized cash management arrangement with Select.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance Not Yet Adopted</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, FASB issued ASU 2023-07,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which is intended to improve disclosure of segment information so that investors can better understand an entity’s overall performance. The ASU requires entities to quantitatively disclose significant segment expenses that are regularly provided to the chief operating decision maker for each reportable segment, as well as the amount of other segment items for each reportable segment and a description of what the other segment items are comprised. Disclosure of multiple measures of profit or loss will be permitted by the ASU.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASU is effective for annual reporting periods beginning on or after December 15, 2023, and interim periods with fiscal years beginning after December 15, 2024; however, early adoption is permitted. The ASU is required to be applied retrospectively to all periods presented in the financial statements. The Company is currently reviewing the impact that ASU 2023-07 will have on the disclosures in our consolidated financial statements.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which is intended to improve the transparency and decision usefulness of income tax disclosures. The ASU includes enhanced requirements on the rate reconciliation, including specific categories that must be disclosed, and provides a threshold over which reconciling items must be disclosed. The amendments in the update also require annual disclosure of income taxes paid, disaggregated by federal, state, and foreign taxes, as well as any individual jurisdictions in which income taxes paid is greater than 5% of total income taxes paid.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASU is effective for annual periods beginning after December 15, 2024; however early adoption is permitted. The ASU can be applied either prospectively or retrospectively. The Company is currently reviewing the impact that ASU 2023-09 will have on the disclosures in our consolidated financial statements.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Actual results could differ from those estimates.</span></div> <div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically operated as part of Select. The unaudited condensed consolidated financial statements of the Company have been prepared from Select’s historical accounting records and are derived from the condensed consolidated financial statements of Select to present Concentra as if it had been operating on a standalone basis. The unaudited condensed consolidated financial statements of the Company as of June 30, 2024, and for the three and six month periods ended June 30, 2024 and 2023, have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim reporting and the accounting principles generally accepted in the United States of America (“U.S. GAAP”). Accordingly, certain information and disclosures required by GAAP, which are normally included in the notes to the consolidated financial statements, have been condensed or omitted pursuant to those rules and regulations, although the Company believes the disclosure is adequate to make the information presented not misleading. In the opinion of management, such information contains all adjustments, which are normal and recurring in nature, necessary for a fair statement of the financial position, results of operations and cash flow for such periods. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the full fiscal year ended December 31, 2024. These unaudited condensed consolidated financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes as contained in the Company’s registration statement on Form S-1, as amended (File No. 333-280242) (the “Registration Statement”).</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the assets, liabilities, revenue, and expenses based on our legal entity structure as well as direct and indirect costs that are attributable to our operations. Indirect costs are the costs of support functions that are partially provided on a centralized basis by Select and its affiliates, which include finance, human resources, benefits administration, procurement support, information technology, legal, corporate governance and other professional </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services. Indirect costs have been allocated to us for the purposes of preparing the condensed consolidated financial statements based on a specific identification basis or, when specific identification is not practicable, a proportional cost allocation method, primarily based on headcount or other allocation methodologies that are considered to be a reasonable reflection of the utilization of services provided or the benefit received by us during the periods presented, depending on the nature of the services received.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax amounts in these condensed consolidated financial statements have been calculated based on a separate return methodology and are presented as if our income gave rise to separate federal and state consolidated income tax return filing obligations in the respective jurisdictions in which we operate. Adjustments to income tax expense resulting from the application of the separate return methodology, as compared to tax obligations determined by the Company’s inclusion in the Parent’s consolidated income tax provision, were assumed to be immediately settled with the Parent through Contributed Capital/Capital in Excess of Par as reflected on the Condensed Consolidated Balance Sheets, and reflected as a (Distribution)/Contribution to Parent on the Condensed Consolidated Statements of Changes in Stockholders’/Members’ Equity and the Condensed Consolidated Statements of Cash Flows within financing activities. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of Concentra and the subsidiaries and variable interest entities in which Concentra has a controlling financial interest. All intercompany balances and transactions within the Company are eliminated in consolidation. Transactions between the Company and Select have been included in these consolidated financial statements. The transfers with Select are expected to be settled in cash, other than the assumed income tax settlement noted above, and are reflected within the consolidated statement of cash flows as an operating or financing activity determined by the nature of the transaction. Select’s third-party debt and related interest expense have not been attributed to the Company because the Company is not the primary legal obligor of the debt and the borrowings are not specifically identifiable to the Company. However, the Company was a guarantor for Select’s senior notes and credit facilities until the guarantee was released at the closing of the IPO. The Company maintains its own cash management system and does not participate in a centralized cash management arrangement with Select.</span></div> <div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically operated as part of Select. The unaudited condensed consolidated financial statements of the Company have been prepared from Select’s historical accounting records and are derived from the condensed consolidated financial statements of Select to present Concentra as if it had been operating on a standalone basis. The unaudited condensed consolidated financial statements of the Company as of June 30, 2024, and for the three and six month periods ended June 30, 2024 and 2023, have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim reporting and the accounting principles generally accepted in the United States of America (“U.S. GAAP”). Accordingly, certain information and disclosures required by GAAP, which are normally included in the notes to the consolidated financial statements, have been condensed or omitted pursuant to those rules and regulations, although the Company believes the disclosure is adequate to make the information presented not misleading. In the opinion of management, such information contains all adjustments, which are normal and recurring in nature, necessary for a fair statement of the financial position, results of operations and cash flow for such periods. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the full fiscal year ended December 31, 2024. These unaudited condensed consolidated financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes as contained in the Company’s registration statement on Form S-1, as amended (File No. 333-280242) (the “Registration Statement”).</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the assets, liabilities, revenue, and expenses based on our legal entity structure as well as direct and indirect costs that are attributable to our operations. Indirect costs are the costs of support functions that are partially provided on a centralized basis by Select and its affiliates, which include finance, human resources, benefits administration, procurement support, information technology, legal, corporate governance and other professional </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services. Indirect costs have been allocated to us for the purposes of preparing the condensed consolidated financial statements based on a specific identification basis or, when specific identification is not practicable, a proportional cost allocation method, primarily based on headcount or other allocation methodologies that are considered to be a reasonable reflection of the utilization of services provided or the benefit received by us during the periods presented, depending on the nature of the services received.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax amounts in these condensed consolidated financial statements have been calculated based on a separate return methodology and are presented as if our income gave rise to separate federal and state consolidated income tax return filing obligations in the respective jurisdictions in which we operate. Adjustments to income tax expense resulting from the application of the separate return methodology, as compared to tax obligations determined by the Company’s inclusion in the Parent’s consolidated income tax provision, were assumed to be immediately settled with the Parent through Contributed Capital/Capital in Excess of Par as reflected on the Condensed Consolidated Balance Sheets, and reflected as a (Distribution)/Contribution to Parent on the Condensed Consolidated Statements of Changes in Stockholders’/Members’ Equity and the Condensed Consolidated Statements of Cash Flows within financing activities. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of Concentra and the subsidiaries and variable interest entities in which Concentra has a controlling financial interest. All intercompany balances and transactions within the Company are eliminated in consolidation. Transactions between the Company and Select have been included in these consolidated financial statements. The transfers with Select are expected to be settled in cash, other than the assumed income tax settlement noted above, and are reflected within the consolidated statement of cash flows as an operating or financing activity determined by the nature of the transaction. Select’s third-party debt and related interest expense have not been attributed to the Company because the Company is not the primary legal obligor of the debt and the borrowings are not specifically identifiable to the Company. However, the Company was a guarantor for Select’s senior notes and credit facilities until the guarantee was released at the closing of the IPO. The Company maintains its own cash management system and does not participate in a centralized cash management arrangement with Select.</span></div> <div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance Not Yet Adopted</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, FASB issued ASU 2023-07,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which is intended to improve disclosure of segment information so that investors can better understand an entity’s overall performance. The ASU requires entities to quantitatively disclose significant segment expenses that are regularly provided to the chief operating decision maker for each reportable segment, as well as the amount of other segment items for each reportable segment and a description of what the other segment items are comprised. Disclosure of multiple measures of profit or loss will be permitted by the ASU.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASU is effective for annual reporting periods beginning on or after December 15, 2023, and interim periods with fiscal years beginning after December 15, 2024; however, early adoption is permitted. The ASU is required to be applied retrospectively to all periods presented in the financial statements. The Company is currently reviewing the impact that ASU 2023-07 will have on the disclosures in our consolidated financial statements.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which is intended to improve the transparency and decision usefulness of income tax disclosures. The ASU includes enhanced requirements on the rate reconciliation, including specific categories that must be disclosed, and provides a threshold over which reconciling items must be disclosed. The amendments in the update also require annual disclosure of income taxes paid, disaggregated by federal, state, and foreign taxes, as well as any individual jurisdictions in which income taxes paid is greater than 5% of total income taxes paid.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASU is effective for annual periods beginning after December 15, 2024; however early adoption is permitted. The ASU can be applied either prospectively or retrospectively. The Company is currently reviewing the impact that ASU 2023-09 will have on the disclosures in our consolidated financial statements.</span></div> <div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Actual results could differ from those estimates.</span></div> Redeemable Non-Controlling Interests<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s redeemable non-controlling interests are comprised of membership interests held by equity holders other than the Company in five less than wholly-owned subsidiaries. These interests are subject to redemption rights. The changes in redeemable non-controlling interests are as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,477 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,772 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,053 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">914 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to and purchases of redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,656)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redemption value adjustment on redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,901 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">436 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,257 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,466 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,078 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to and purchases of redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(793)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redemption value adjustment on redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of June 30</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,410 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,852 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> Redeemable Non-Controlling InterestsThe Company’s redeemable non-controlling interests are comprised of membership interests held by equity holders other than the Company in five less than wholly-owned subsidiaries. These interests are subject to redemption rights. 5 The changes in redeemable non-controlling interests are as follows:<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,477 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,772 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,053 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">914 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to and purchases of redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,656)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redemption value adjustment on redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,901 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">436 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,257 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,466 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,078 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to and purchases of redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(793)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redemption value adjustment on redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of June 30</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,410 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,852 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 16477000 16772000 1053000 914000 1174000 1656000 -1901000 -436000 18257000 16466000 1078000 993000 793000 610000 132000 -3000 18410000 16852000 Variable Interest Entities<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states prohibit the “corporate practice of medicine,” which restricts the Company from owning medical practices that directly employ physicians and from exercising control over medical decisions by physicians. In these states, the Company enters into long-term management agreements with affiliated professional medical groups (referred to as “Managed PCs”) that are owned by licensed physicians which, in turn, employ or contract with physicians who provide professional medical services in its occupational health centers. The Company also enters into a stock transfer restriction agreement with the respective equity holders, which provide for the Company to direct the transfer of ownership of the Managed PCs to other licensed physicians at any time. The long-term management agreements provide for various administrative and management services to be provided by the Company to the Managed PCs, including, but not limited to, billing and collections, accounting, non-physician personnel, supplies, security and maintenance, and insurance. The Company has the right to receive income as an ongoing management fee, and effectively absorbs all of the residual interests of the Managed PCs. Based on the provisions of the management and stock transfer agreements, the Managed PCs are variable interest entities for which the Company is the primary beneficiary and consolidates the Managed PCs under the VIE model. There are no restrictions on the use of the assets of the Managed PCs or on the settlement of its liabilities. Additionally, the Company fully indemnifies the licensed physician owners from all claims, demands, costs, damages, losses, liabilities, and other amounts arising from the ownership and operation of the medical practices, excluding gross negligence.</span></div> Variable Interest Entities<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states prohibit the “corporate practice of medicine,” which restricts the Company from owning medical practices that directly employ physicians and from exercising control over medical decisions by physicians. In these states, the Company enters into long-term management agreements with affiliated professional medical groups (referred to as “Managed PCs”) that are owned by licensed physicians which, in turn, employ or contract with physicians who provide professional medical services in its occupational health centers. The Company also enters into a stock transfer restriction agreement with the respective equity holders, which provide for the Company to direct the transfer of ownership of the Managed PCs to other licensed physicians at any time. The long-term management agreements provide for various administrative and management services to be provided by the Company to the Managed PCs, including, but not limited to, billing and collections, accounting, non-physician personnel, supplies, security and maintenance, and insurance. The Company has the right to receive income as an ongoing management fee, and effectively absorbs all of the residual interests of the Managed PCs. Based on the provisions of the management and stock transfer agreements, the Managed PCs are variable interest entities for which the Company is the primary beneficiary and consolidates the Managed PCs under the VIE model. There are no restrictions on the use of the assets of the Managed PCs or on the settlement of its liabilities. Additionally, the Company fully indemnifies the licensed physician owners from all claims, demands, costs, damages, losses, liabilities, and other amounts arising from the ownership and operation of the medical practices, excluding gross negligence.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2024, and December 31, 2023, the total assets of the Company’s variable interest entities were $224.8 million and $212.3 million, respectively, and are principally comprised of accounts receivable. As of June 30, 2024, and December 31, 2023, the total liabilities of the Company’s variable interest entities were $53.7 million and $56.4 million, respectively, and are principally comprised of accounts payable and accrued expenses. These variable interest entities have obligations payable for services received under their management agreements with the Company of $171.7 million and $156.2 million as of June 30, 2024, and December 31, 2023, respectively. These intercompany balances are eliminated in consolidation.</span></div> 224800000 212300000 53700000 56400000 171700000 156200000 Leases<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s total lease cost is as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,077 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,549 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,034 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,556 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,577 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,868 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,173 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> Leases<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s total lease cost is as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,077 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,549 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,034 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,556 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,577 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,868 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,173 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s total lease cost is as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,077 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,549 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,034 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,556 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,577 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,868 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,173 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 25077000 24296000 49867000 48424000 109000 261000 320000 512000 77000 100000 132000 203000 5293000 4920000 10549000 10034000 30556000 29577000 60868000 59173000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Term Debt and Notes Payable</span><div style="margin-bottom:15pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the Company’s long-term debt are as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term revolving promissory note with related party</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">470,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,730 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">427,730 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">474,746 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="margin-bottom:9pt;margin-top:7pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)        Other debt is primarily comprised of insurance financing arrangements, promissory notes executed in connection with business combinations, and finance leases.</span></div><div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2024, principal maturities of the Company’s long-term debt were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:25.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolving promissory note with related party</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt, including finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,819 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,024 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">351 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">397 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,692 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,730 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,819 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,024 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">351 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">397 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">421,692 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">427,730 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a description of the debt financing transactions which occurred in connection with the IPO on July 26, 2024.</span></div> <div style="margin-bottom:15pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the Company’s long-term debt are as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term revolving promissory note with related party</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">470,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,730 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">427,730 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">474,746 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="margin-bottom:9pt;margin-top:7pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)        Other debt is primarily comprised of insurance financing arrangements, promissory notes executed in connection with business combinations, and finance leases.</span></div> 420000000 470000000 7730000 4746000 427730000 474746000 <div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2024, principal maturities of the Company’s long-term debt were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:25.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolving promissory note with related party</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt, including finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,819 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,024 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">351 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">397 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,692 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,730 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,819 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,024 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">351 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">397 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">421,692 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">427,730 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 0 0 0 0 420000000 420000000 3819000 1024000 351000 397000 447000 1692000 7730000 3819000 1024000 351000 397000 447000 421692000 427730000 Accrued and Other Liabilities<div style="margin-bottom:9pt;margin-top:9pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of accrued and other liabilities:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued payroll</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,439 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62,824 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued vacation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,983 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,488 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,484 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,755 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,014 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">399 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,920 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176,466 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> <div style="margin-bottom:9pt;margin-top:9pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of accrued and other liabilities:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued payroll</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,439 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62,824 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued vacation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,983 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,488 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,484 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,755 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,014 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">399 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,920 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176,466 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 57439000 62824000 42983000 41488000 55484000 71755000 3014000 399000 158920000 176466000 Revenue <div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company’s revenue for the three and six months ended June 30, 2024 and 2023: </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:42.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Occupational health centers:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workers’ compensation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">288,405 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">278,554 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">568,271 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">546,894 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employer services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">153,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">153,164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">304,040 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">305,337 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consumer health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,669 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,802 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,995 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,987 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other occupational health center revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,861 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,254 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,006 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,672 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total occupational health center revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">451,240 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">441,774 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">892,312 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">872,890 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Onsite clinics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,539 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,396 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,805 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">477,915 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">467,079 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">945,513 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">923,377 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company’s revenue for the three and six months ended June 30, 2024 and 2023: </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:42.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Occupational health centers:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workers’ compensation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">288,405 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">278,554 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">568,271 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">546,894 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employer services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">153,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">153,164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">304,040 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">305,337 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consumer health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,669 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,802 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,995 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,987 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other occupational health center revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,861 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,254 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,006 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,672 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total occupational health center revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">451,240 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">441,774 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">892,312 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">872,890 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Onsite clinics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,539 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,396 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,805 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">477,915 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">467,079 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">945,513 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">923,377 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 288405000 278554000 568271000 546894000 153305000 153164000 304040000 305337000 7669000 7802000 15995000 15987000 1861000 2254000 4006000 4672000 451240000 441774000 892312000 872890000 15539000 14705000 31396000 29250000 11136000 10600000 21805000 21237000 477915000 467079000 945513000 923377000 Earnings per Share<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2023, there were 435,000 Class A units, 8,498 Class B units, and 3,583 Class C units (in thousands) outstanding which converted to common shares on a one-for-one basis effective March 4, 2024. On June 25, 2024, the Company effectuated a reverse stock split at a ratio of one share of common stock for every 4.295 shares of common stock and resulted in 104,094 shares (in thousands) outstanding. There were no participating shares or securities outstanding during the three and six months ended June 30, 2024.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of earnings per share (EPS) in 2024:</span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Attributable to the Company</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Attributable to the Company</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except for per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,737 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,094 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,693 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,094 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.97 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">At June 30, 2023, Concentra’s capital structure included Class A, B and C units outstanding and unvested restricted interests and outstanding options. To calculate EPS for the three and six months ended June 30, 2023, Concentra applied the two-class method because its unvested restricted interests and outstanding options were participating securities.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the net income attributable to the Company, its units outstanding, and its participating units outstanding: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,032 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101,463 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,290 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,457 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to the Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,742 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,006 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Distributed and undistributed income attributable to participating shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">287 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributed and undistributed income attributable to outstanding shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,594 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98,719 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of EPS in 2023, under the two-class method:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except for per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding Class A, Class B, and Class C shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,594 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103,962 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98,719 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.95 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Participating shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">292 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">287 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,742 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,006 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)    The recapitalization of the members units into common shares has been treated as such for earnings per share purposes and has been reflected retrospectively for all periods, along with the one for 4.295 reverse stock split, as described in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Organization.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)    Represents the weighted average units outstanding during the period.</span></div> 435000000 8498000 3583000 1 104094000 0 0 <div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of earnings per share (EPS) in 2024:</span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Attributable to the Company</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Attributable to the Company</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except for per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,737 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,094 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,693 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,094 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.97 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the net income attributable to the Company, its units outstanding, and its participating units outstanding: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,032 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101,463 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,290 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,457 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to the Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,742 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,006 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Distributed and undistributed income attributable to participating shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">287 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributed and undistributed income attributable to outstanding shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,594 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98,719 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of EPS in 2023, under the two-class method:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.287%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except for per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding Class A, Class B, and Class C shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,594 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103,962 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98,719 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.95 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Participating shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">292 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">287 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,742 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,006 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)    The recapitalization of the members units into common shares has been treated as such for earnings per share purposes and has been reflected retrospectively for all periods, along with the one for 4.295 reverse stock split, as described in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Organization.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)    Represents the weighted average units outstanding during the period.</span></div> 51737000 51737000 104094000 104094000 0.50 0.50 100693000 100693000 104094000 104094000 0.97 0.97 54032000 101463000 1290000 2457000 52742000 99006000 148000 148000 287000 287000 52594000 52594000 98719000 98719000 52594000 52594000 103962000 103962000 0.51 0.51 98719000 98719000 103952000 103952000 0.95 0.95 148000 148000 292000 0.51 0.51 287000 287000 302000 0.95 0.95 52742000 99006000 Related Party Transactions<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shared Services Agreement - cost allocations from Select</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company pays Select a fee for the shared support functions provided on a centralized basis by Select and its affiliates. The shared services fee is reassessed and adjusted annually. For the three months ended June 30, 2024 and 2023, the shared service fees were $3.8 million and $3.7 million, respectively. For the six months ended June 30, 2024 and 2023, the shared service fees were $7.7 million and $7.3 million, respectively. These cost allocations reasonably reflect the services and the benefits derived for the periods presented. These allocations may not be indicative of the actual expenses that would have been incurred as a stand-alone entity.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the IPO, and described in the Registration Statement, Select and Concentra entered into a separation agreement, a transition services agreement, a tax matters agreement, and an employee matters agreement on July 26, 2024, which effects the separation of the Company’s business from Select and provides a framework for the Company’s relationship with Select after the separation.</span></div> 3800000 3700000 7700000 7300000 Commitments and Contingencies<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various legal actions, proceedings, and claims, and regulatory and other governmental audits and investigations in the ordinary course of its business, including, but not limited to, legal actions and claims alleging professional malpractice, general liability for property damage, personal and bodily injury, violations of federal and state employment laws, often in the form of wage and hour class action lawsuits, and liability for data breaches. Many of these actions involve large claims and significant defense costs and sometimes, as in the case of wage and hour class actions, are not covered by insurance. The Company cannot predict the ultimate outcome of pending litigation, proceedings, and regulatory and other governmental audits and investigations. These matters could potentially subject the Company to sanctions, damages, recoupments, fines, and other penalties.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To address claims arising out of the Company’s operations, the Company maintains professional malpractice liability insurance and general liability insurance coverages through a number of different programs that are dependent upon such factors as the state where the Company is operating. The Company currently maintains insurance coverages under a combination of policies with a total annual aggregate limit of up to $29.0 million for professional malpractice liability insurance and $29.0 million for general liability insurance. The Company’s insurance for the professional liability coverage is written on a “claims-made” basis, and its commercial general liability coverage is maintained on an “occurrence” basis. These coverages apply after a self-insured retention limit is exceeded. Each of these programs has either a deductible or self-insured retention limit. The Company also maintains additional types of liability insurance covering claims which, due to their nature or amount, are not covered by or not fully covered by the applicable professional malpractice and general liability insurance policies, including workers compensation, property and casualty, directors and officers, cyber liability, and employment practices liability insurance coverages. Our insurance policies generally are silent with respect to punitive damages so coverage is available to the extent insurable under the law of any applicable jurisdiction, and are subject to various deductibles and policy limits. The Company reviews its insurance program annually and may make adjustments to the amount of insurance coverage and self-insured retentions in future years. Significant legal actions, as well as the cost and possible lack of available insurance, could subject the Company to substantial uninsured liabilities. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Physical Therapy Billing. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2021, Select received a letter from a Trial Attorney at the U.S. Department of Justice, Civil Division, Commercial Litigation Branch, Fraud Section (“DOJ”) stating that the DOJ, in conjunction with the U.S. Department of Health and Human Services (“HHS”), is investigating Select in connection with potential violations of the False Claims Act, 31 U.S.C. § 3729, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">et seq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The letter specified that the investigation relates to Select’s billing for physical therapy services, and indicated that the DOJ would be requesting certain records from Select. In October and December 2021, the DOJ requested, and Select furnished, records relating to six of Select’s outpatient therapy clinics in Florida. In 2022 and 2023, the DOJ requested certain data relating to all of Select’s outpatient therapy clinics nationwide, and sought information about the Company’s ability to produce additional data relating to the physical therapy services furnished by Select’s outpatient therapy clinics and the Company. The Company has produced data and other documents requested by the DOJ and is fully cooperating on this investigation. In May 2024, by order of the U.S. District Court for the Middle District of Florida, a qui tam lawsuit that is related to the DOJ’s investigation was unsealed after the U.S. filed a notice declining to intervene in the case, but stating that its investigation is continuing and reserving its right to intervene at a later date. The lawsuit, filed in May 2021 and amended in October 2021 and July 2024, was brought by Kathleen Kane, a physical therapist formerly employed in Select’s outpatient division, against Select Medical Corporation, Select Physical Therapy Holdings, Inc. and Select Employment Services, Inc. The amended complaint alleges that the defendants billed federally funded health programs for one-on-one therapy services when group therapy was performed or overbilled for one-on-one therapy services, and billed for </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unreimbursable unskilled physical therapy services. At this time, the Company is unable to predict the timing and outcome of this matter.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">California Department of Insurance Investigation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 5, 2024, the Company received a subpoena from the California Department of Insurance relating to an investigation under the California Insurance Frauds Prevention Act, Cal. Ins. Code § 1871.7 et seq., which allows a whistleblower to file a false claims lawsuit based on the submission of false or fraudulent claims to insurance companies. The subpoena seeks documentation relating mainly to the Company’s billing and coding for physical therapy claims submitted to commercial insurers and workers compensation carriers located or doing business in California. The Company has produced data and other documents requested by the California Department of Insurance and intends to fully cooperate on this investigation. At this time, the Company is unable to predict the timing and outcome of this matter.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Perry Johnson &amp; Associates, Inc. Data Breach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On November 10, 2023, Perry Johnson &amp; Associates, Inc., a third-party vendor of health information technology solutions that provides medical transcription services (“PJ&amp;A”), notified Concentra Health Services, Inc. (“Concentra”) that certain information related to particular Concentra patients was potentially affected by a cybersecurity event. In February 2024, Concentra sent notices to almost four million patients who may have been impacted by the data breach. During the first quarter of 2024, Concentra became aware of six putative class action lawsuits filed against PJ&amp;A and Concentra related to the data breach. The first was filed in the U.S. District Court for the Eastern District of Michigan on February 19, 2024 by Elliot Curry, individually and on behalf of all others similarly situated. Plaintiff alleged, among other things, that he became the victim of identity theft as a result of the PJ&amp;A data breach and that Concentra had lax data security policies. The second was filed in the U.S. District Court for the Eastern District of New York on February 21, 2024 by Tiffany Williams and Jo Joaquim, individually and on behalf of all others similarly situated. Plaintiffs alleged, among other things, that they face an immediate and heightened risk of identity theft as a result of the data breach and that the defendants failed to take measures to properly safeguard their private information. The third was filed in the U.S. District Court for the Eastern District of Missouri on February 26, 2024 by Stephen Tate, a.k.a. Steven Tate, individually and on behalf of all others similarly situated. Plaintiff alleged, among other things, that he faces a heightened and imminent risk of identity theft as a result of the data breach and that the defendants failed to take measures to properly safeguard his private information. The fourth was filed in the U.S. District Court for the Eastern District of Michigan on February 26, 2024 by Eric Franczak, individually and on behalf of all others similarly situated. Plaintiff alleged, among other things, that he faces a substantially increased risk of fraud and identity theft as a result of the data breach and that the defendants failed to take measures to properly safeguard his private information. The fifth was filed in the U.S. District Court for the Eastern District of Michigan on March 6, 2024 by Lazema Johnson, individually and on behalf of all others similarly situated. Plaintiff alleged, among other things, that she faces a substantially increased risk of fraud and identity theft as a result of the data breach and that the defendants failed to take measures to properly safeguard her private information. The sixth was filed in the Superior Court of California, County of Los Angeles, on April 8, 2024 by Robert Valencia, individually and on behalf of all others similarly situated. Plaintiff alleged, among other things, that he faces a substantially increased risk of fraud and identity theft as a result of the data breach and that the defendants failed to take measures to properly safeguard his private information. Concentra is working with its cybersecurity risk insurance policy carrier and does not believe that the data breach or the lawsuits will have a material impact on its operations or financial performance. However, at this time, Concentra is unable to predict the timing and outcome of these matters.</span></div> 29000000.0 29000000.0 4000000 6 Subsequent Events <div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 26, 2024, the Company completed an IPO of 22,500,000 shares of its common stock, par value $0.01 per share, at an initial public offering price of $23.50 per share for the net proceeds of $499.7 million after deducting underwriting discounts and commission of $29.1 million. In addition, the underwriters exercised the option to purchase an additional 750,000 shares of the Company’s common stock for net proceeds of $16.7 million after deducting underwriting discounts and commission of $1.0 million. The Company’s shares began trading on the New York Stock Exchange under the symbol “CON” on July 25, 2024. In connection with the IPO, Concentra Health Services, Inc. (“CHSI”), a wholly-owned subsidiary of the Company, entered into certain financing arrangements which include senior secured credit facilities of $1,250.0 million (the “Credit Facilities”) and a private offering of $650.0 million aggregate principal amount of 6.875% Senior Notes due 2032 (the “Notes”). The Notes are unconditionally guaranteed, jointly and severally, on a senior unsecured basis by Concentra and certain of its wholly-owned subsidiaries. The Credit Facilities consist of an $850.0 million Term Loan and a $400.0 million Revolving Credit Facility. The Revolving Credit Facility was undrawn at the closing of the IPO. The Term Loan matures on July 26, 2031, and has an interest rate of Term SOFR plus 2.25%, subject to a leverage-based pricing grid. The Revolving Credit Facility matures on July 26, 2029, and has an interest rate of Term SOFR plus 2.50%, subject to a leverage-based pricing grid. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds of the IPO and the debt financing transactions, except for $34.7 million, were paid to Select through the issuance of a dividend, the repayment of the $420.0 million revolving promissory note outstanding, and the repayment of a new promissory note issued subsequent to June 30, 2024 in contemplation of the IPO.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the closing of the IPO, and the exercise of the underwriters’ option to purchase additional shares, Select owns 81.74% of the total outstanding shares of the Company’s common stock. Select intends to make a distribution, which is intended to be tax-free for U.S. federal income tax purposes, to its stockholders of all of its remaining equity interest in the Company within twelve months of the IPO.</span></div> 22500000 0.01 23.50 499700000 29100000 750000 16700000 1000000 1250000000 650000000 0.06875 850000000 400000000 0.0225 0.0250 34700000 420000000 0.8174 false false false false Includes the shared service fee from related party of $3.8 million and $3.7 million for the three months ended June 30, 2024 and 2023, respectively, and $7.7 million and $7.3 million for the six months ended June 30, 2024 and 2023, respectively. See Note 10, Related Party Transactions, for additional information.